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Abstract 
Abstract 
The herpes simplex virus type I (HSV-l) UL12 gene encodes an alkaline nuclease. 
Although the UL12 gene is not absolutely essential for replication, UL12 null mutants 
produce 100-1000 fold less viable virus than wt HSV -1. It has been suggested that the 
alkaline nuclease functions to remove branched structures from high molecular weight 
concatemeric DNA prior to its cleavage into monomeric genomes that are packaged into 
viral capsids. Failure to remove the branches results in unstable packaging of DNA into 
capsids which fail to egress from the nucleus. 
This thesis describes detailed characterisation of the HSV-1 mutant, ambUL12 (Patel et 
at., 1996) which fails to express the alkaline nuclease due to the insertion of an amber 
stop codon into the UL12 open reading frame. The ability of ambUL12 to replicate and 
package both viral genomic DNA and amplicons (plasmids containing the HSV -1 origin 
of replication and DNA encapsidation signal) was examined. In contrast to results 
obtained with other alkaline nuclease mutants, which replicate and package DNA with 
close to wt HSV-l efficiency (Shao et at., 1993; Martinez et at., 1996b), ambUL12 
displayed a 3-5 fold drop in replication and a 15-20 fold drop in packaging of genomic 
DNA. Similar reductions were observed in the replication and packaging of amplicon 
DNA. The replication and packaging of amplicons by ambUL12 in these transient 
assays could be partially complemented when UL12 was supplied in trans. Close 
inspection of the DNA molecules synthesised during transient assays demonstrated that 
amplicon replication intermediates are complex high molecular weight concatemers that 
undergo intermolecular recombination, analogous to viral DNA replication 
intermediates. 
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Abstract 
In agreement with previous results using the AN -1 nuc mutant (Martinez et al., 1996a), 
ambUL12 high molecular weight DNA replication intermediates were found to have a 
more complex structure when analysed by pulsed-field gel electrophoresis (PFGE) than 
those of wt HSV -1. Restriction enzyme digestion of amb UL 12 DNA resulted in a very 
smeared digest pattern, with larger predicted fragments (> 50 kbp) being undetectable as 
discrete bands. These results support the proposition that the alkaline nuclease is 
involved in processing the complex viral DNA replication intermediates into substrates 
more suitable for efficient cleavage and packaging (Martinez et al., 1996a; Goldstein 
and Weller, 1998a). 
Examination of the genomic termini present in DNase-resistant DNA revealed that 
amb UL 12 exhibited reduced specificity of cleavage compared to wt HS V-I. The results 
suggested that aberrant cleavage may occur at either the L or S terminus. In addition, 
the overall efficiency of cleavage was decreased, as judged by the reduced accumulation 
of unit length genomes observed in PFGE studies. This differs from published data 
which indicated that cleavage and packaging were largely unaffected in nuc mutants 
(Shao et al., 1993; Martinez et al., 1996a). Further evidence of aberrant cleavage events 
was provided by PFGE experiments which demonstrated that the majority of 
encapsidated ambUL12 molecules migrated faster than unit length genomes (152 kbp), 
with estimated sizes of 130-150kbp. 
Transient assays utilising various packaging signal mutants indicated that in the absence 
of UL12 the cleavage and packaging machinery may cleave in an abnormal way. The 
ambUL12 mutant was able to package molecules lacking a cleavage and packaging 
signal and these could be further propagated in the presence of wt HSV -1 helper virus. 
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Abstract 
This indicates that the alkaline nuclease may somehow confer cleavage specificity on 
the packaging complex. This conclusion is supported by the observation that when 
UL12 was supplied in trans the packaging of such plasmids was decreased although 
their level of replication was increased. 
Based on the observed packaging defect of ambULl2, a preliminary investigation into 
possible interactions of UL12 with various proteins involved in packaging was also 
performed. The interaction of UL12 with four packaging proteins (UL6, ULI5, UL28 
and UL25) was examined. No convincing evidence for an interaction between UL12 
and any of these proteins was obtained. However, the previously reported interaction of 
UL12 with the DNA replication protein UL29 (Vaughan et at., 1984; Thomas et at., 
1988, 1992) was supported in these experiments. 
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Chapter 1.' Introduction 
Chapter 1: Introduction 
The work presented in this thesis is related to the role that the alkaline nuclease encoded 
by herpes simplex virus type 1 (HSV -1) plays in the replication and packaging of the 
viral genome. The introduction will begin by outlining some general properties of the 
herpesvirus family. This will be followed by more detailed descriptions of the 
processes of DNA replication and packaging in HSV -1. Finally, the literature relating 
to the properties and functions of the HSV -1 alkaline nuclease will be reviewed. 
1.1 Herpesvirus characteristics 
1.1.1 Herpesviridae 
Herpesviruses are large, double stranded DNA viruses, that share a number of common 
morphological features including an icosahedral capsid surrounded by a tegument layer, 
contained within a host derived lipid envelope containing a number of virally encoded 
glycoproteins. 
Herpesviruses infect a wide range of vertebrate hosts including mammals, birds, 
amphibians and fish. More recently they have also been detected in invertebrate marine 
bivalves. A common feature of herpesviruses is their ability to establish a persistent, 
latent infection within the host. The virus may then reactivate in response to stress, such 
as UV light or the host becoming immunocompromised. In addition, the host range of 
individual herpesviruses is usually limited although ostreid herpesvirus-I has been 
shown to infect several species of bivalves (Arzul et at., 2001). This host specificity is 
thought to reflect the co-evolution of the virus and host (McGeoch et at., 1995). 
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Herpesviruses have been broadly separated into three sub-families: 
(i)Alphaherpesvirinae (including HSV-l, HSV-2, VZV and PRY). The viruses 
associated with this subfamily are neurotropic, they have a variable host cell range, 
exhibit a short life cycle and tend to spread rapidly in tissue culture. They are also able 
to latently infect neuronal ganglia in which they generally persist for the life of the host. 
(ii)Betaherpesvirinae (including HCMV, HHV-6 and HHV-7) have a more restrictive 
host cell range. Cell to cell spread of the virus is generally slower than that observed 
with Alphaherpesvirinae and the infected cells are often enlarged. Monocytes, spleen 
and kidney cells are sites where latent infection is known to occur. 
(iii)Gammaherpesvirinae (e.g. EBV, KSHV (HHV-8), EHV-2 and HVS) are 
lymphotropic, and exhibit the most restricted host cell range. Their life cycle span is 
variable and they generally establish latent infections in lymphocytes. 
Although this classification was established largely by biological characteristics it 
correlates closely with genetics groupings that have emerged over the last fifteen to 
twenty years through DNA sequencing studies. The phylogenetic data now available 
suggest that herpesviruses have a common origin, the subfamilies diverging 
approximately 200 million years ago (McGeoch et al., 1993). 
1.1.2 Human herpesviruses 
Eight human herpesviruses have been identified to date, with representatives of each of 
the Herpesviridae subfamilies. Infection is usually asymptomatic and non-life 
threatening although in neonates and in immunocompromised individuals infections are 
occasionally fatal. 
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Alphaherpesviruses: 
Herpes simplex virus type 1 (HSV -1) is the most extensively studied of the 
herpesviruses and is the prototype virus for the family. Infection can occur at a number 
of body sites although the most common sites are around the lips and mouth. The virus 
usually remains latent in sensory neuronal ganglia, and when reactivated it generally 
causes cold sore lesions at, or near, the primary site of infection. HSV -2 is closely 
related to HSV -1 and is generally associated with genital infections. 
Varicella-zoster VIruS (VZV) pnmary infections usually affect children and are 
classically recognised by the appearance of small puss filled vesicles that rupture and 
scab over, this is often associated with intense itching (chicken pox). If reactivated in 
adulthood the virus causes a complaint known as shingles. 
Betaherpesviruses: 
Human cytomegalovirus (HCMV) IS the most extensively studied of the 
betaherpesviruses. As with most herpesviruses infection it is usually asymptomatic. 
However, reactivation often occurs in HIV infected individuals or organ transplant 
patients. In the case of HCMV reactivation is often associated with retinitis. HCMV 
can also cause severe disease in congenitally infected infants. HCMV is thought to be 
responsible for around 10% of infectious mononucleosis cases. Possible complications 
arising from the mononucleosis include pneumonia and hepatitis. 
Two, more recently identified betaherpesviruses are HHV -6 and HHV -7. Both are 
members of the Roseolovirus genus and have very similar genomes and gene products. 
HHV -6 is the causative agent of exanthem subitum, an early childhood disease 
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characterised by a high fever followed by a rash, which lasts for one to two days. As 
with HCMV, reactivation of HHV -6 and HHV -7 can occur in immunocompromised 
individuals. 
Gammaherpesviruses: 
There are two known gammaherpesviruses that infect humans. Epstein-Barr virus 
(EBV) commonly causes infectious mononucleosis in 35 - 50% of adolescent 
infections. The virus has also been associated with Burkitt's lymphoma, 
nasopharyngeal carcinoma and Hodgkin's disease, although in these cases it is not the 
sole causative factor of the disease. 
Kaposi's sarcoma is characterised by skin lesions and occurs in a proportion of AIDS 
sufferers. The most recently identified human herpesvirus is Kaposi's sarcoma 
associated herpesvirus (KSHV) or HHV-8 which appears to be the causative agent of 
these tumours. 
1.1.3 Herpesvirus genomes 
All herpesviruses have linear dsDNA genomes 120 - 220 kbp in length and contain 70 
to 200 open reading frames (ORFs). The genomes contain various arrangements of 
internal and terminal repeats. To date seven genome structures have been identified in 
herpesviruses (Roizman et al., 1992; Davison and McGeoch, 1995) and a diagrammatic 
representation of these can be seen in Figure I. 
Group 0 genomes have a single unique coding region with no repeat units (Roizman et 
al., 1992). Tree shrew herpesvirus is an example of this type (Koch et ai., 1985). 
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Group 1 genomes have single direct repeats at each terminus and are typified by 
Channel catfish virus (Davsion, 1992). Herpesvirus saimiri, with multiple repeats at 
each terminus but no internal repeats, is a representative of Group 2 genomes (Albrecht 
et al., 1992). Group 3 genomes also have multiple repeats at each terminus but, in 
addition, have internal repeats in the opposite orientation resulting in a genome with 
two unique regions. Cottontail rabbit herpesvirus is an example of this group of 
herpesviruses, containing two unique regions of 54 and 47 kbp surrounded by a 925 bp 
repeat present with a variable copy number (Cebrian et al., 1989). Group 4 genomes are 
similar to group 3 except the internal repeats share no similarity to the terminal repeats. 
Epstein-Barr virus (EBV) is characteristic of group 4 genomes (Baer et al., 1984). With 
Varicella-zoster virus (VZV) genomes the inverted repeats surrounding each unique 
sequence (UL and Us) are not related. In addition, the repeats surrounding the Us 
unique region are much larger than those surrounding UL (Davison and Scott, 1986). 
This is a good example of a Group 5 genome. Group 6 genomes, typified by HSV -1, 
are very similar to group 5 genomes except the UL repeats are larger. Group 6 genomes 
also contain a sequence repeats which are found at each terminus and in inverted 
orientation between the internal repeats flanking UL and Us (Roizman, 1979). 
The presence of long inverted repeats flanking Us in the group 5 genomes results in the 
Us region being able to invert through recombination. As a result these group 5 
genomes exist as a mixed population of two isomers. The increased size of the UL 
repeats in group 6 genomes means that both UL and Us regions can invert, resulting in 
four genomic isomers (Hayward et aI, 1975). The functional significance of these 
inversion events in the replication of herpesviruses is unknown, although HSV-l 
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rhich have 'fixed' orientations of UL and Us are unimpaired in tissue culture 
:md Roizman, 1986; Poffenberger et al., 1983). 
ate the problem of replicating the terminal regions of the linear genome, there is 
ntial evidence that herpesviruses circularise their genome prior to replication and 
the replication intermediates are "endless", with DNA synthesis possibly 
eeding by a combination of theta form and rolling circle modes (Umene and 
himoto, 1996; Jacob and Roizman, 1977; Becker et al., 1978) . 
. nalysis of the DNA sequence of the human herpesviruses predicts that between 69 
,VZV) and 220 (HCMV) proteins are encoded by the various viruses (McGeoch and 
Davison, 1999). HSV-l contains ORFs for at least 74 functional proteins (McGeoch et 
al., 1988; Dolan et al., 1998). Comparison with other human herpesviruses reveals that 
of these 74 genes, 40 are conserved throughout the mammalian and avian herpesviruses. 
These core genes express proteins mainly involved in virion structure, DNA replication, 
and cleavage and packaging of DNA (McGeoch and Davison, 1999). 
1.1.5 Herpesvirus capsids 
Herpesvirus capsids are constructed around a protein scaffold, which is subsequently 
lost. The capsid is composed of four main proteins forming an icosahedral structure 
composed of 150 hexamers and 12 pentamers. Groups of three capsomers are separated 
by a heterotrimeric complex known as the triplex. The DNA complement is densely 
packed and forms into a liquid crystalline configuration within the capsid. Despite the 
wide range in genome size all herpesvirus capsids are approximately 125 nm (HSV-l) 
to 130 nm (HCMV) in diameter (Schrag et al., 1989; Booy et al., 1991; Butcher et al., 
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1998). In agreement with the small differences in capsid size, recent studies have 
shown that the HCMV genome, among the largest of herpesvirus genomes, is more 
densely packed than the HSV-l genome (Bhella et at., 2000). 
There are three angularised capsid forms: A, Band C, which can be identified by 
electron microscopy and by ultracentrifugation on sucrose gradients (Gibson and 
Roizman, 1972). Type A capsids are empty structures, devoid of DNA or scaffolding 
protein and type B capsids contain mainly cleaved scaffold protein (Newcomb and 
Brown, 1991). These capsid types are thought to result from abortive packaging events. 
C type capsids contain DNA and are capable of maturing into infectious virus. A short-
lived, more spherical form known as the procapsid is the precursor of A, Band C 
capsids (for a review see: Rixon, 1993; Homa and Brown, 1997). 
1.1.6 Herpesvirus tegument 
The tegument layer that separates the capsid and lipid envelope contains a matrix of 
viral proteins; 15 proteins have been associated with the tegument of HSV-l 
(Mettenleiter, 2001). Although long considered an unstructured mass, recent studies 
have shown that tegument proteins associated with the capsid also have icosahedral 
symmetry (Zhou et at., 1999). 
The function of many tegument proteins remams unclear but, in HSV -1 at least, 
tegument protein functions include transactivation of early viral genes (UL48 gene 
product), the shut off of host protein synthesis (UL41 gene product), and an 
involvement in the cleavage and packaging of the viral genome (UL 17 gene product) 
(Triezenberg et at., 1988; Kwong et at., 1988; Salmon et at., 1998). 
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1.1.7 Herpesvirus envelope 
The lipid envelope that encloses the capsid and tegument was initially thought to be 
derived from the nuclear membrane, with enveloped virus often being observed budding 
into the perinuclear space. More recent studies, however, indicate that the viral capsid 
is de-enveloped as it buds from the nuclear membrane, and is subsequently re-
enveloped with another lipid envelope that contains the viral glycoproteins as it buds 
from trans-Golgi vesicles (For a review see Mettenleiter et al., 2002). 
The membrane embedded, virally encoded, glycoproteins are visible in electron 
micrographs as "spikes" emerging from the membrane of virus particles. The number 
of glycoproteins expressed by different herpesviruses varies but HSV -1 encodes at least 
eleven. The glycoproteins appear to have roles in the secondary envelopment of 
capsid/tegument (Brack et al., 1999), attachment and entry into host cells and inhibition 
of secondary infections (Campadelli-Fiume et al., 1988). 
1.2 Herpes simplex virus type 1 lytic infection 
1.2.1 Virus attachment and entry 
Of the eleven identified HSV-l glycoproteins (gB, gC, gD, gE, gG, gH, gI, gJ, gK, gL 
and gM), five are dispensable in cell culture (gC, gE, gG, gI and gM) and no single 
glycoprotein has been identified as essential in terms of attachment to host cells in 
tissue culture. In polarised cells, however, gC is needed for attachment to the apical but 
not the basal surface of cells (Sears et al., 1991). The main attachment site on the cell 
surface appears to be through heparin sulphate; removal of heparin sulphate or 
competition by heparin reduces attachment by 85% (Shieh et al., 1991; Wudunn and 
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Spear, 1989). Attachment could never be completely abolished in these studies 
suggesting that alternative attachment and entry sites exist. 
By expressing human cDNAs in CHO cells, normally resistant to HSV -1 infection, at 
least two gene groups were identified that could act as entry receptors (Spear et at., 
2000): HVEM, a member of the TNF receptor family (Montgomery et at., 1996), HveC 
and HveB, members of the nectin-l and nectin-2 immunoglobulin family, respectively, 
(Geraghty et at., 1998; Warner et at., 1998). In addition, a modification of heparin 
sulphate that acts as gD mediated receptor site has also been identified (Shukla et at., 
1999). 
Once attached the virus fuses with the cell membrane and penetration of the cell occurs. 
From studies of HSV -1 mutants deleted of various glycoprotein genes, it appears that 
glycoproteins gB, gC, gD, gH and gL are required during this penetration stage (Spear, 
1993). 
After penetration the tegument proteins and capsid dissociate and diffuse into the 
cytoplasm. Transport of the capsids to the nucleus appears to be mediated along 
microtubules utilising the dynein motor complex (Sodeik et at., 1997). Once at the 
nuclear membrane the capsid attaches to the nuclear pore complex and the DNA is 
ejected into the nucleus (Ojala et at., 2000). 
1.2.2 HSV -1 gene expression 
The 74 ORFs encoded by HSV-l are transcribed in a cascade fashion and can be split 
into three broad groups dependent on their temporal transcription pattern: immediate 
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early (a), early (~) and late (y). There are five immediate early proteins: ICP4, ICP27, 
ICPO, ICP22 and ICP47. The genes encoding these proteins are transcriptionally 
activated by a complex consisting of the tegument protein VP 16 which binds to the 
TAATGARAT motif and host proteins Oct 1 and HCF (McKnight et al., 1987; Stem et 
al., 1989; Vogel and Kristie, 2000). The immediate early genes are transcribed in the 
absence of protein synthesis and their proteins are generally considered to have 
regulatory functions, controlling the expression of subsequent gene groups. The 
expression of these genes peaks 2-4 hours post infection but they remain expressed 
throughout an active infection. ICP47, the product of US 12, is expressed with IE 
kinetics but rather than having a regulatory role it appears to prevent major 
histocompatability complex 1 (MHC 1) being presented on the surface of infected cells 
(Jugovic et al., 1998). 
Immediate early proteins also exert regulatory control at the post-transcriptional level 
(Weir, 2001). For example, one role of the ICP27 protein is to inhibit mRNA splicing 
(Hardy and Sandri-Goldin, 1994). This contributes to the virus inhibiting protein 
synthesis in the host cell because only 4 of the 74 HSV-1 genes are spliced, and 
moreover, three of these four are immediate early genes expressed prior to splicing 
inhibition. The fourth spliced gene, UL15, is expressed later in infection but the 
mechanism by which it escapes the inhibitory process is not clear (Weir, 2001). 
The early, or ~, genes include all the genes involved in DNA replication and nucleotide 
metabolism. Transcription of ~ genes occurs prior to the onset of DNA synthesis and 
depends on the prior expression of immediate early proteins, especially a functional 
ICP4 protein. 
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Late genes encode mainly structural proteins, including the capsid components, 
tegument and glycoproteins. They can be split into two subclasses: leaky late (yl) and 
true late (y2). True late genes require the onset of DNA synthesis before transcription 
occurs whereas leaky late genes can be expressed prior to DNA synthesis but only reach 
maximal levels when DNA replication has initiated. Late genes require ICP4 and 
ICP27 for transcription (Preston, 1979; DeLuca and Schaffer, 1985; Godowski and 
Knipe, 1986; Sacks et al., 1985; Rice and Knipe, 1990). It also appears that the 
essential DNA replication protein encoded by UL29 is also required for transactivation 
of late genes (Gao and Knipe, 1991; Chen and Knipe, 1996). 
1.2.3 Viral DNA synthesis and encapsidation 
After entry into the nucleus the viral DNA circularises probably by ligation of the 
genome ends although a recombination mechanism has also been proposed (Garber et 
al., 1993; McVoy et al., 1997; Yao et al., 1997). The genome is then thought to 
replicate initially by theta form replication, followed subsequently by a rolling circle 
mode of replication. This produces head-to-tail concatemers which are cleaved into unit 
length genomes and in a linked process packaged into preformed capsids (Jacobs et al., 
1977; Ben-Porat et al., 1977). The process ofHSV-l genome replication and packaging 
are described in more detail in sections 1.3 and 1.4, respectively. 
1.2.4 Capsid egress and maturation 
The process of nuclear egress and envelopment in herpesviruses has recently been 
reviewed by Mettenleiter (2002). After encapsidation of genomic DNA in the nucleus, 
the capsid is targeted to the nuclear membrane and through the interaction of UL31 and 
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UL34 (a phosphoprotein and C-terminally anchored membrane protein, respectively) it 
acquires its primary envelope as it buds into the perinuclear space. It is unclear whether 
any tegument proteins associate with the maturing virus particles at this stage. 
It is now generally accepted that the capsid is de-enveloped as it leaves the outer-
nuclear membrane and subsequently gains tegument and a lipid envelope containing 
viral glycoproteins in post-endoplasmic reticulum cytoplasmic compartments. A 
previous model suggested that all tegument and lipid anchored glycoproteins were 
gained during perinuclear envelopment and the glycoproteins were then modified in 
situ. However, recent biochemical and immunogold electron microscopy analyses have 
demonstrated that the lipid composition of mature virus particles differs from that of the 
perinuclear membrane (Van Genderen et at., 1994; Skepper et at., 2001). In addition, 
studies in pseudorabies virus have demonstrated that the homologue of the major 
tegument protein, UL49, is present in extracellular and intracytoplasmic enveloped 
virions but is absent from perinuclear enveloped virions (Klupp et at., 2000). 
There are at least 15 proteins associated with the tegument layer. Although this layer 
was previously thought to be an unstructured mixture of proteins, icosahedral symmetry 
has recently been observed close to the capsid, with a protein (possibly UL36) 
associating with the major capsid protein at the pentons (Zhou et at., 1999; McNab and 
Courtney 1992). As well as structural proteins, the tegument also contains viral proteins 
that are required early in infection, such as the viral host shutoff (vhs) protein and 
VP 16 the transactivator of immediate early genes. As well as its role as a transactivator , 
VP 16 also has an essential structural role within the tegument. In its absence virion 
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maturation is blocked after the primary envelopment/de-envelopment step (Mossman et 
ai., 2000). 
1.3 Replication of the HSV -1 genome 
1.3.1 Structure of the HSV-l genome 
The HSV -1 genome is a double stranded DNA molecule, approximately 152 kbp in 
length. It exhibits a group 6 genome arrangement (Figure I), containing two covalently 
linked segments, Land S, each of which comprises a unique region, UL and Us, 
respectively flanked by inverted repeats, TRdIRL and IRs/TRs (Figure II). The a 
sequence represents a terminally redundant region of approximately 400 bp which is 
present in one or more copies at the L terminus and at the junction between the Land S 
segments. A single copy is present at the S terminus. The portions of RL and Rs 
excluding the a sequence are referred to as the band c sequences, respectively. This 
gives HSV-l an arrangement of amb-UL-b'a'nc'-Us-ca, where nand m are variable and' 
indicates an inverted sequence. The UL and Us sequences are 107.9 and 13.0 kbp in 
length, respectively, encoding at least 71 distinct proteins. The UL region contains 58 
ORFs and the Us region 13. Three ORFs are situated in the terminal repeats, 2 in RL 
and 1 in Rs (McGeoch et aI., 1988; Dolan et ai., 1998). Due to the presence of inverted 
repeats flanking the unique sequences, UL and Us can invert with respect to each other 
generating four equimolar arrangements for virion DNA (Figure II) (Hayward et ai., 
1975). A recent paper by Huang et ai. (2002) has proposed that a cellular endonuclease, 
en do G, may be responsible for initiating these recombination events. Endo G has a 
strong preference for G+C rich sequences and was demonstrated to cleave specifically 
within the a sequence, which has an 83% G+C content. 
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Figure II - Genome arrangement of HSV-1 
(A) Diagram of the HSV-l genome. The unique regions, UL and Us, 
denoted by single lines are each flanked by the RL and Rs repeat sequences, 
respectively. The regions of RL and RS which do not contain the a sequence 
are denoted band c, respectively. The terminal (TRL' TRs) and internal (IRL' 
IRs) repeats are inverted with respect to each other, as indicated by the 
arrows. The cis-acting a sequence, required for cleavage and packaging is 
present at each terminus and inverted orientation separating IRL and IRs· (B) 
The four genomic isomers generated by the inversion of UL and Us regions 
are shown: P = prototype, IL = inverted UL, Is = inverted Us' ILS = inverted 
UL and Us· 
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The a sequence contains the cis-acting signals required for cleavage and packaging of 
the viral genome and is central to a number of experiments reported in this thesis. The 
length of this sequence varies both within and between virus strains. In strain 17 syn + it 
is approximately 380 bp in length. The a sequence itself consists of a number of repeat 
sequences (DR1, DR2 and in some strains DR4), and two quasi-unique regions, Ub and 
Uc (Figure III) (Davison and Wilkie, 1981). Each complete copy of the a sequence is 
flanked by a short direct repeat (DR1). Single copies of DR1 separate tandem a 
sequences and during packaging cleavage occurs within DR1 such that the two genomic 
termini each contain an incomplete DR1 with a single 3' nucleotide overhang (Mocarski 
and Roizman, 1982). Upon circularisation of the genome a complete DR1 sequence is 
regenerated. The central region of the a sequence consists of multiple reiterations of the 
DR2 and/or DR4 sequences (11-24 bp). These are separated from DR1 by the Vb and 
Uc sequences. The Uc sequence lies closest to the L terminus whilst Ub is adjacent to 
the S terminus. Vb and Uc contain the pacl and pac2 motifs, respectively, which 
include several conserved sequence elements found near the termini of all mammalian 
and avian herpesviruses (see Figure III for a schematic representation). Deletion and 
substitution mutations within some of these motifs had dramatic effects on the 
packaging and propagation of plasmids which contained the encapsidation signal, 
highlighting their importance in the cleavage and packaging process (Hodge and Stow, 
2001). The results of this study were consistent with a model where signals for the 
initiation and termination of packaging were present in pac2 and pacl, respectively. 
HSV -1 contains three origins of DNA synthesis. One, oriL, is present near the centre of 
the UL region between the divergent UL29 and UL30 ORFs. The other two origins 
(oris), are present as identical copies in the repeat regions flanking Us (Spaete and 
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Figure III - Structure of the HSV -1 strain 17 syn+ a sequence 
c a 
(A) Two complete copies of the HSV -1 a sequence are formed upon 
ligation ofTRL and TRs . (B) The DR1 and DR2 repeats of two consecutive 
a sequences (indicated by arrows) are shown, the quasi-unique regions Ub 
and Uc are also shown. (C) Representation of the conserved pac1 and 
pac2 motifs found within Ub and Uc, respectively. 
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Frenkel, 1982; Stow, 1982; Stow and McMonagle, 1983; Weller et al., 1985). The two 
types of origin share considerable homology and there is a certain degree of redundancy 
between the two; deletion of either oriL or oris does not significantly reduce the 
efficiency of viral replication in tissue culture (Polvino-Bodnar et al., 1987; Igarashi et 
al., 1993). Both oriL and oris contain palindromic sequences of 144 and 45 bp, 
respectively, and are centred around an AT rich region of approximately 20 bp. Either 
side of the AT rich region are sequences termed Box I, Box II and Box III. Box I and II 
are high affinity binding sites for the UL9 encoded origin binding protein (OBP) while 
Box III has a much lower binding affinity. Although the Box II and III motifs differ 
from Box I by only two and one base pair, respectively, they have five and 1000 times 
lower affinity for UL9 than Box I (Olivo et al., 1988; Koff and Tegtmeyer, 1988; Elias 
et al., 1990; Hazuda et al., 1991). The oriL sequence contains a Box I and a Box III 
motif either side of the AT rich region whereas oris contains a Box III and Box I motif 
on one side of the AT region and a Box II motif on the other side. The long perfect 
palindrome of oriL has made the sequence difficult to clone in an intact form in E. coli 
and therefore most studies have concentrated upon oris. (Weller et al., 1985; Hardwicke 
and Schaffer, 1995). 
1.3.2 HSV -1 circularisation 
Soon after transportation into the nucleus the HSV -1 genome circularises (Mocarski and 
Roizman, 1982; Poffenberger and Roizman, 1985; Garber et al., 1993). The 
circularisation of the genome is probably completed by ligation of the incomplete 18.5 
bp DRI repeat found at the L terminus to the 1.5 bp DRI fragment present at the S 
terminus. This can occur in the absence of viral gene expression suggesting that a host 
ligase or component of the virion is involved. 
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The occurrence of ligation is further supported by work on guinea pig cytomegalovirus 
(GPCMV) (McVoy et al., 1997). This herpesvirus has a group 1 type genome, with no 
internal repeat. In addition it has two genome structures which are present in equimolar 
amounts. One genome type has single copies of the Rand M repeats at the left and 
right end of the genome respectively. The other genome lacks the M repeat and is 
designated as containing an 0 terminus. The occurrence of two types of genome 
indicates the presence of two independent cleavage sites. Further analysis indicated 
pac 1 homology in the R repeat and pac2 homology in the M repeat and at the 0 
terminus. Through mutational analysis it was observed that Rand M genomes could 
circularise to form a double repeat and joining of Rand 0 to form a circular molecule 
with a single repeat was also feasible. In this instance ligation is the most likely 
mechanism for end joining since Rand 0 termini share no significant homology. 
Although the majority of experiments reported to date support a ligation mechanism for 
genome end-joining, another possible mechanism for circularisation that has been 
suggested is through non-conservative homologous recombination or an imprecise end-
joining mechansim (Yao et al., 1997). 
1.3.3 Possible modes ofHSV-l DNA replication 
It is widely held that HSV -1 genomes are initially replicated by the theta mode of 
replication followed by a rolling circle mode of replication. Although never proven 
conclusively there are a number of factors consistent with an initial theta mode of 
replication: (i) circularisation of the infecting HSV-l genome (discussed above), (ii) the 
palindromic nature of the origins of replication suggests the ability of bi-directional 
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replication forks to form at the origins, and (iii) the non-linear rate of accumulation of 
viral DNA during replication cannot be accounted for by rolling circle replication alone. 
In addition, the termination of replication at early, but not late, times in infection by an 
inhibitor of host cell topoisomerase II suggests that decatenation of circular molecules is 
required (Hammarsten et at., 1996). However, although the generation of circular 
molecules early after infection has been demonstrated, their accumulation during the 
early stages of DNA replication has not been observed. 
The most commonly accepted evidence for the rolling circle replication mechanism is 
the accumulation of head-to-tail concatemers of the viral genome during replication. 
This was established by both sedimentation analysis, which showed replication 
intermediates with a higher sedimentation value than mature genomes, and restriction 
enzyme analysis which demonstrate that the concatemers were endless (Jacob and 
Roizman, 1977; Jacob et at., 1979; Jongeneel and Bachenheimer, 1981). More recent 
experiments utilising Field Inversion Gel Electrophoresis (FIGE) and Pulsed Field Gel 
Electrophoresis (PFGE) techniques have determined the structure of these intermediates 
(Zhang et at., 1994; Severini et at., 1994). This work demonstrated that the high 
molecular weight DNA replication intermediates are composed of a complex, branched 
network of concatemers which would not enter pulsed field gels. In addition 2D gel 
electrophoresis showed that these concatemers contained many X and Y -junctions. 
Restriction enzyme analysis of this DNA, with an enzyme which cleaved once per 
genome, resulted in a high proportion of the DNA remaining in the well of the gel. 
Failure of this DNA to enter the gel further indicates the presence of frequent branched 
structures, probably the result of unresolved intra and inter-molecular recombination 
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events. Restriction enzyme analysis also showed that within a single concatemer both 
orientations of the Land S segments were present (Bataille and Epstein, 1997). 
Other replication mechanisms exist that could account for the accumulation of the 
HSV -1 high molecular weight replicative intermediates. These include the 
recombination dependent replication mechanisms evident in bacteriophage T4 or the 2 
micron circle mode of replication associated with S. cerevisiae. 
1.3.4 Essential replication genes encoded by HSV -1 
The identification of the viral genes involved in DNA replication was facilitated by the 
development of the transient DNA replication assay by Challberg (1986). Plasmids 
containing fragments of the HSV -1 IRrJIRs region (subsequently shown to contain oris) 
were identified that could be replicated if viral helper functions were supplied in trans 
(Stow, 1982). Co-transfection of cloned HSV-l genome fragments, along with a 
plasmid containing oris, and assaying for replication of the latter plasmid identified 
seven viral genes: UL5, UL8, UL9, UL29, UL30, UL42 and UL52, that were both 
sufficient and necessary for the replication of the origin containing plasmid (Challberg, 
1986; Wu et ai., 1988; Heilbronn and zur Hausen, 1989). Studies using both 
temperature sensitive (ts) and viral null mutants, targeted to each of these genes, 
confirmed their essential role in the replication of viral DNA (reviewed by Challberg, 
1996; Weller, 1991). In addition, the expression of all seven genes in baculovirus 
infected insect cells supported the replication of an oris containing plasmid, indicating 
that any host proteins involved in HSV -1 DNA replication are sufficiently conserved 
between mammalian and insect cells to allow DNA synthesis (Stow, 1992). When the 
set of seven genes were first identified the function of many of the proteins was poorly 
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understood. It is now known that UL9 represents the origin binding protein, UL29 is 
the major single stranded DNA binding protein, UL5, UL8 and UL52 constitute a 
functional helicase/primase complex, and UL30 and UL42 form the viral polymerase 
complex. What follows is a brief description of each of these proteins and their role in 
the replication of the HSV -1 genome. 
UL9 - Origin Binding Protein 
As mentioned earlier, UL9 encodes the origin binding protein (OBP). This 851 amino 
acid protein exists as a homodimer with the N-terminus of each protein possessing ATP 
dependent helicase activity and the C-terminus containing the DNA recognition and 
binding domain. The N-terminus also contains residues important for dimerisation and 
co-operative binding of UL9 to the origins. Amino acids 535-851 are capable of 
sequence-specific binding to DNA but exist as monomers in solution (Elias et al., 
1992). Inspection of the N-terminus reveals a putative leucine-zipper domain that may 
facilitate the protein-protein interaction (Hazuda et al., 1992). 
In its role as an initiator protein, the UL9 homodimer binds the Box I and Box II motifs 
either side of the AT rich region of oris in a co-operative fashion. Hypersensitivity of 
the AT rich region to DNase I and micrococcal nuclease (Koff et al., 1991), and 
observations from electron microscopy have demonstrated that this binding bends the 
DNA by approximately 90 degrees (Makhov et al., 1996). In the presence of ATP the 
he Ii case activity of UL9 was able to unwind up to 1 kbp of DNA from the origin. This 
unwinding was assisted by the function of the single stranded major DNA binding 
protein (mDBP) encoded by UL29. However no cell free system has yet been described 
which will faithfully initiate DNA synthesis. 
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UL29 - Single stranded DNA binding protein 
UL29 encodes a 130 kDa protein that binds ssDNA five times more efficiently than 
dsDNA, binding co-operatively and without any apparent sequence specificity 
(Ruyechan, 1983; Lee and Knipe, 1985). The protein acts as a helix destabilising 
protein, and can lower the melting temperature of duplex DNA (Boehmer and Lehman, 
1993). In the presence of MgCh the major DNA binding protein (mDBP) is also able to 
catalyse the reannealment of complementary strands, suggesting that it may be involved 
in recombination of the viral genome (Bortner et at., 1993). 
In conjunction with UL9, the UL29 protein appears to distort and open up the DNA 
around the origin. Subsequent helicase activity by UL9 and coating of the ssDNA by 
UL29 is presumed to allow the helicase/primase complex and DNA polymerase access 
to the DNA to establish a replication fork. The role of these two proteins in the initial 
establishment of the replication fork is further supported by several observed protein-
protein interactions (Falkenberg et at., 1997; Monahan et at., 1998). 
As well as its association with UL29, UL9 has also been shown, through 
immunoprecipitation experiments, to interact with the helicase/primase complex 
through the UL8 subunit (McLean et at., 1994). UL29 has also been shown to interact 
with the UL8 subunit and to stimulate the helicase/primase acivity of the complex 
(Tanguy Le Gac et at., 1996; Falkenberg et at., 1997). In addition, UL29 and the UL8 
subunit of the helicase/primase complex have been shown to interact (Falkenberg et at., 
1997). The polymerase processivity factor, encoded by UL42, has also been shown to 
interact with UL29 (Vaughan et at., 1984). Finally, the interaction ofUL9 with UL42 
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(Monahan et at., 1998) and UL8 interacting with UL30 (Gallo et at., 1988) demonstrate 
that all the essential replication proteins interact at some level. Taken together, this data 
suggests that the viral DNA replication proteins assemble to form a 'replisome' 
complex at the viral origins following the initial binding of the origin binding protein. 
In support of this, the proteins could be purified as a large multiprotein complex from Sf 
insect cells infected with baculoviruses expressing all seven replication proteins 
(Skaliter and Lehman, 1994). 
UL5, UL8 and UL52 - The helicase/primase complex 
The functional helicase/primase complex is made up of the products of the UL5, UL8 
and UL52 ORFs (Crute et at., 1989). The UL5 protein specifies the helicase activity 
and contains a number of motifs conserved throughout helicases (Gorbalenya et at., 
1989; Klinedinst and Challberg, 1994). The helicase can utilise either ATP or GTP 
(Crute et at., 1988) and has been demonstrated to unwind DNA in the 5' - 3' direction 
(Crute et at., 1988). When expressed alone in recombinant baculovirus infected cells 
UL5 possessed very little helicase activity, but co-expression with UL52 to form a 
heterodimer restored the helicase activity (Calder and Stow, 1990; Dodson and Lehman, 
1991). 
The UL52 protein confers the primase action of the complex. On single stranded 
~X174 DNA the helicase-primase complex produces 10-mer oligoribonucleotides, 
recognising the sequence 3'-AGCCCTCCCA and priming from the underlined C base 
(Tenney et at., 1995). Like UL5, UL52 shows little or no enzymatic activity when 
expressed alone but when co-expressed with UL5 primase activity is restored. 
Although mutational studies have demonstrated that UL5 and UL52 impart helicase and 
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primase activities, respectively, certain mutations in UL5 can affect primase activity, 
similarly certain UL52 mutations affect the helicase function (Klinedinst and Challberg, 
1994; Dracheva et al., 1995; Zhu and Weller, 1992; Graves-Woodward and Weller, 
1996). 
The function of the UL8 subunit was initially unclear because it seemed to contain no 
intrinsic enzymatic activity and the UL5 and UL52 dimeric complex functioned as a 
helicase/primase in its absence (Calder and Stow, 1990; Dodson and Lehman, 1991). 
Subsequent studies have revealed that the addition of the UL8 subunit promotes 
helicase activity and stimulates primase activity by threefold (Tenney et al., 1994, 
1995). Although the precise action of this subunit is unclear it may promote loading of 
the complex onto the DNA through interactions with the mDBP. UL8 has also been 
shown to interact with the viral DNA polymerase and to direct the localisation of UL5 
and UL52 to the nucleus (Calder et al., 1992; Barnard et al., 1997). 
UL30 and UL42 - The DNA polymerase complex 
The viral DNA polymerase exists as a heterodimer of the UL30 and UL42 gene 
products. The polymerase activity is associated with the 136 kDa polypeptide encoded 
by the UL30 gene. This protein shares extensive homology with several other 
polymerases including bacteriophage T4 DNA polymerase and human DNA 
polymerase a-primase (Digard et al., 1990; Blanco et al., 1991). The UL42 subunit is a 
65 kDa protein that acts as an accessory factor which binds to dsDNA in a sequence 
independent manner increasing the processivity of the catalytic subunit (Gallo et al., 
1988; Gottlieb et al., 1990). 
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The polymerase subunit has both 3' -5' exonuclease activity and RNaseH activity. In 
the presence of all four dNTPs the exonuclease has no activity on paired 3' residues but 
completely removes unpaired 3' residues (O'Donnell et al., 1987). This indicates that 
the polymerase has an intrinsic proof reading ability. There are three conserved 
exonuclease motifs present in the UL30 ORF and mutagenesis of motif I greatly 
reduced the exonuclease activity of the protein (Hall et al., 1995). The inability to 
produce a recombinant virus containing this mutation demonstrates the essential nature 
of the exonuclease activity (Hall et al., 1995). The reported 5'-3' exonuclease RNaseH 
activity probably reflects the ability of the polymerase to remove the primers from 
Okazaki fragments during lagging strand synthesis (Crute and Lehman, 1989). 
The UL42 protein binds to the polymerase subunit through multiple interactions 
(Monahan et al., 1993). The role of the UL42 subunit appears to be as a processivity 
factor, which through its interaction with dsDNA, prevents the polymerase subunit from 
dissociating from the DNA template after each round of catalysis (Gottlieb et al., 1990). 
By constructing a model primer with double and single stranded regions, Gottlieb and 
Challberg (1994) demonstrated in DNase I fingerprint studies that the UL30 subunit 
would bind at the ds/ssDNA boundary. With the heterodimeric complex of UL30 and 
UL42 extra protection was given to the dsDNA but not the ssDNA region. In 
conjunction with previous data that demonstrated UL42 bound non-specifically to 
dsDNA (Vaughan et al., 1985; Gallo et al., 1988) it has been proposed that UL42 has a 
role similar to "sliding clamp" processivity factors, such as PCNA. In fact, the crystal 
structure of UL42 has a strong similarity to PCNA (Zuccola et al., 2000). However, 
unlike PCNA, which forms loose hexameric rings around the DNA, UL42 binds to the 
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DNA as a monomer but maintains a high diffusion rate of 17 to 47 bp/s (Randell and 
Coen,2001). 
1.3.5 Non-essential HSV-l proteins with roles in nucleotide metabolism 
Alkaline nuclease 
The alkaline nuclease has 5'-3' and 3'-5' exonuclease activity as well as a low-level 
endonuclease activity. The main function of this protein is thought to be the removal of 
branched structures from DNA replication intermediates to allow efficient packaging of 
viral genomes. The properties and potential functions of this protein are discussed in 
more detail in section 1.5. 
Thymidine kinase 
This protein, encoded by the UL23 ORF, is able to phosphorylate vanous punne 
nucleosides in addition to thymidine. The role of the protein is unclear and UL23 
deletion mutants can grow efficiently in cell culture, although they are impaired in 
resting cells. In animal models thymidine kinase null mutants can replicate in 
peripheral cells, such as in the eye but not in trigeminal ganglia. In addition, the protein 
does however appear to be necessary for reactivation of HSV -1 from latency (Coen et 
at., 1989). 
The main significance of this protein is in its specific phosphorylation of acyclovir 
(ACV), a nucleoside analogue used in the treatment of HSV. Only the viral thymidine 
kinase can catalyse the initial phosphorylation of this nucleoside. Host cell kinases then 
generate the triphosphorylated froms. Incorporation of the triphosphate into replicating 
DNA disables both viral and host polymerases, thus inhibiting viral replication 
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(Reardon and Spector, 1989). However ACV is not phosphorylated in uninfected cells 
and is therefore not toxic. 
Uracil DNA glycosylase 
Uracil glycosylase, encoded by UL2, is involved in repairing the wrongful insertion of 
dUTP into genomic DNA or the deamination of cytosine to uracil. If this latter lesion is 
not repaired the eventual mutagenesis of G-C to A-T occurs. Inactivation of the viral 
gene does not affect the ability of the virus to replicate in tissue culture (Mullaney et at., 
1989). This is probably due to the almost ubiquitous expression of uracil glycosylase in 
mammalian cells. As with the viral thymidine kinase, the virally encoded uracil 
glycosylase appears to be necessary in reactivation from latency (Pyles and Thompson, 
1994). 
Deoxyuridine triphosphatase (dUTPase) 
This protein acts to prevent the incorporation of uracil into the viral genome and 
additionally generates the dTTP precursor, dUMP, by hydrolysing dUTP to dUMP and 
inorganic phosphate. As with thymidine kinase and uracil glycosylase mutants, 
dUTPase knockout mutants are unaffected in cell culture but they are less neurovirulent 
and reactivate poorly from latency (Pyles et at., 1992). 
Ribonucleotide reductase 
The ribonucleotide reductase is a tetramer of two subunits encoded by each of the UL39 
and UL40 genes, forming an a2~2 complex. This complex reduces ribonucleotides to 
deoxyribonucleotides providing dNTPs as precursors for DNA synthesis. Although 
25 
Chapter 1: Introduction 
non-essential in dividing cells, the complex appears to be necessary in neurons and non-
dividing tissue culture cells (Goldstein and Weller, 1988; Idowu et at., 1992). 
1.4 Encapsidation of the viral genome 
1A.1 General description of capsid structure 
As described in section 1.lA, herpesviruses capsids have an icosahedral structure. In 
HSV -1 the capsid shell is 15 nm thick and has a diameter of 125 nm. The capsid is 
constructed around a central core of scaffolding proteins to form a spherical procapsid. 
Upon DNA packaging the scaffolding protein is cleaved and ejected. The capsid then 
becomes angularised and forms the mature icosahedral structure (For reviews see: 
Rixon, 1993; Homa and Brown, 1997). 
1A.2 Major components of the viral capsid 
In HSV -1 the procapsid is constructed from seven major, virally encoded, proteins 
which are the products of the UL18 (VP23), UL19 (VP5), UL26 (VP21 and VP24), 
UL26.5 (VP22a), UL35 (VP26) and UL38 (VPI9C) ORFs. As mentioned in section 
lA.l the capsid shell comprises three distinct units, the pentamers and hexamers, 
collectively know as capsomers, and the triplexes. The pentamers and hexamers 
comprise five and six copies of VP5, respectively. There are 150 hexamers and 12 
pentamers per capsid, giving a total of 960 copies of VP5 in each virion. The 
capsomers protrude from the capsid and flair at the base where they meet neighbouring 
capsomers to form the capsid floor. The triplexes consist of two copies of VP23 and 
one copy of VP 19C. They connect groups of three capsomers, sitting above the capsid 
floor. 
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The procapsid contains an internal core of scaffolding protein, around which the capsid 
is constructed. The main component of the scaffold, pre-VP22a (product of the UL26.5 
gene), binds to the inner face of VP5 via its C-terminus. The UL26 gene product 
encodes the scaffold protease. The full-length UL26 polypeptide is cleaved to form 
VP24, the functional protease, and VP21 (Liu and Roizman, 1993; Dilanni et at., 
1993;Weinheimmer et at., 1993). The scaffolding protein is cleaved 24 amino acids 
from its C-terminus upon the onset of DNA packaging by VP24 and is ejected from the 
capsid by an unknown mechanism. The VP21 polypeptide is also cleaved at this time 
because its C-terminal 328 amino acids are identical to pre-VP22a. 
There are a number of differences between the procapsid and mature capsid. The most 
obvious is that the procapsid is more spherical in shape than the angularised mature 
capsid. Secondly, the capsomers do not form a continuous floor layer in procapsids and 
the hexons are circular in procapsids but hexagonal in mature capsids. Thirdly, a 
channel which runs down the center of pentons in procapsids is closed upon capsid 
maturation, presumably to prevent escape of packaged DNA (Newcomb and Brown, 
1994; Zhou et at., 1999). Finally, the procapsid is less stable than the mature capsid 
(Newcomb et at., 2000). 
1.4.3 Proteins necessary for cleavage and packaging of concatmeric DNA 
Six viral proteins: UL6, ULI5, ULI7, UL28, UL32 and UL33, have been identified as 
necessary for the cleavage and encapsidation of concatemeric DNA (Reviewed in 
Rixon, 1993; Homa and Brown 1997). These proteins were identified through ts or 
deletion mutants with phenotypes that resulted in the accumulation of DNase-sensitive, 
concatemeric DNA lacking free termini. In addition to the expected absence of c-
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capsids these mutants show an accumulation of B-capsids. UL25 null mutants are 
unusual among HSV -1 packaging mutants in that there is also an accumulation of A-
capsids (McNab et at., 1998). 
In contrast to our understanding of HSV -1 DNA replication, comparatively little is 
known about the packaging mechanism. What follows is a brief description of each of 
the HSV -1 proteins listed above and their possible roles in DNA packaging; largely 
inferred from studies involving other large, dsDNA containing viruses, such as 
bacteriophage T4 and bacteriophage lambda (reviewed by Catalano, 1995; Fujisawa and 
Morita, 1997; Catalano, 2000). 
UL6 - Possible portal protein 
UL6 is a 75 kDa protein that is associated with both procapsids and mature capsids. Its 
presence is not however necessary for assembly of procapsids (Patel and MacLean, 
1995; Sheaffer et at., 2001). The creation of UL6 null mutants has demonstrated the 
essential nature of the UL6 protein (Patel et at., 1996; Lamberti and Weller, 1996). 
These mutants were constructed in complementing cell lines, and in non-
complementing cell lines showed wt HSV -1 levels of DNA synthesis but a failure to 
process or package the DNA concatemers. 
A recent study by Newcomb et at. (2001) has indicated that a dodecamer of UL6 
proteins may fonn a portal protein at one of the procapsid vertices. In immunoelectron 
microscopy experiments immunogold labelling using an antibody against UL6 resulted 
in the deposition of particles adjacent to only one vertex of each virus particle. In 
addition, electron microscopy examination of UL6 protein purified from recombinant 
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baculovirus infected insect cells revealed heterogeneous ring structures with the major 
population forming a dodecameric ring with an internal diameter of 5 ± 0.7 nm. 
UL15 and UL28 - A potential terminase complex 
In bacteriophage such as T7 and lambda the terminase complex is responsible for the 
cleavage of the concatemeric genome and, through interaction with the portal protein, 
translocation of the genome into the capsid (for reviews see Catalano, 2000; Fujisawa 
and Morita, 1997). The terminase usually exists as a heterodimeric complex, containing 
a cleavage activity that is dependent on magnesium, and an ATP dependent DNA 
translocating pump. As well as its catalytic activity the terminase is also required to 
bind both genomic DNA and the portal protein complex. 
In HSV-l the UL15 and UL28 proteins have surfaced as potential candidates for the 
terminase complex. Both are essential for cleavage and packaging as initially 
demonstrated in ts mutants and confirmed using deletion mutants (Poon and Roizman, 
1993; Cavalcoli et al., 1993; Baines et al., 1997; Yu and Weller, 1998a). Several 
studies have also shown that UL15 and UL28 physically interact (Koslowski et al., 
1997, 1999; Abbotts et al., 2000). UL15 also shows limited sequence homology to 
gp17, the large subunit of the bacteriophage T4 terminase complex. The homology 
includes a consensus ATP binding motif which, in mutagenesis experiments, has been 
shown to be essential for the function ofUL15 (Yu and Weller, 1998a). Recently the 
UL33 protein, also essential for cleavage and packaging, has also been observed to 
complex with UL15 and UL28 (Beard et al., 2002). 
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ULIS is one of the few HSV-l proteins that are derived from a spliced gene product. 
However the expression of UL IS from a cDNA copy does not appear to affect the 
viability of a recombinant virus (Baines and Roizman, 1992). The UL IS protein 
produces a number of truncated forms that appear to be the result of both proteolytic 
cleavage of the full length protein and expression from a truncated RNA initiated from 
an internal start codon that is within the second exon (UL1S.S protein) (Baines et at., 
1994; Baines et at., 1997; Salmon and Baines, 1998). Complementation of a 
ULlSIULlS.S null mutant with a construct which expressed only ULIS demonstrated 
that, in cell culture at least, ULlS.S is non-essential (Yu and Weller, 1998a). There are 
three ULIS products that are associated with viral B capsids with apparent sizes of 83, 
80 and 79 kDa. However in the absence of other proteins essential for the cleavage and 
packaging of viral DNA only the largest product associates with capsids, suggesting that 
an intact packaging machinery is required for the capsid association of the 80 and 79 
kDa products. This observation also implies that the largest terminase product 
associates with capsid proteins rather than the UL6 portal protein. Interactions of HSV-
1 UL6 with ULlS, and UL6 with UL28 have, however, recently been observed by 
immunoprecipitation and immunofluoresence studies, indicative of an interaction 
between the HSV -1 terminase and portal proteins (c. White, personal communication). 
UL28 encodes an 87 kDa protein which was identified as essential for cleavage and 
packaging of the viral genome through the use of ts mutants (Addison et at., 1990; 
Tengelsen et at., 1993). Its localisation to the nucleus appears to be dependent on the 
co-expression of ULIS (Koslowski et at., 1999). Moreover, the pseudorabies virus 
UL28 homolog can also be localised to the nucleus by HSV-l ULlS, indicating the high 
degree of conservation of this protein between herpesviruses (Koslowski et at., 1997). 
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Although nuclear localisation of UL28 is dependent on ULI5, and both proteins have 
been shown to physically interact, it has been reported that UL28 can independently 
associate with capsids (Taus and Baines, 1998; Yu and Weller, 1998b). 
Recently UL28 has been shown to interact specifically with oligonucleotides containing 
the pac1 motif of the a sequence (Adelman et al., 2001). This interaction was 
dependent on the DNA forming an altered secondary structure upon denaturation and 
renaturation, as judged by a change in mobility of the oligonucleotide in non-denaturing 
gels. Introduction of previously characterised murine cytomegalovirus (MCMV) pac 1 
mutations which impaired packaging (McVoy et al., 1998) into the pac1 
oligonucleotides reduced the binding of UL28 in each case, correlating with a loss of 
function in vivo. 
The physical interaction of UL15 and UL28, the capsid binding properties of both 
proteins, the ability of UL28 to specifically bind the pac 1 motif and, finally, the limited 
homology between UL15 and the large subunit of bacteriophage T4 strongly suggest 
that UL 15 and UL28 form the HSV -1 terminase complex. This is also supported by 
HCMV studies which suggest that the UL56 and UL89 proteins, homologues of HSV-l 
UL28 and ULI5, respectively also form a functional terminase complex. HCMV UL56, 
has similar biochemical properties to the HSV -1 UL28 protein (Bogner et al., 1998). 
Also, resistance of HCMV to the drug TCRB, which inhibits DNA packaging has been 
linked to mutations in both UL56 and UL89 (Krosky et al., 1998). 
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UL33 
As with many of the proteins involved in the cleavage and packaging process, the UL33 
gene was identified through characterisation of a ts mutant (al-Kobaisi et al., 1991). 
The UL33 gene has since been identified as a late gene, in that it requires the onset of 
DNA synthesis to be expressed. In immunofluoresence assays the protein was 
predominantly associated with viral replication compartments, although a small 
proportion was cytoplasmic (Reynolds et ai, 2000). As described above its interaction 
with UL 15 and UL28 suggests that it may form a component of the putative terminase 
complex (Beard et al., 2002). 
UL17 
UL 17 was originally identified as a protein associated with the tegument and is essential 
for viral replication (Baines and Roizman, 1991). The involvement of UL 17 in 
cleavage and packaging was discovered through characterisation of deletion mutants 
grown in complementing cell lines (Salmon et al., 1998). 
The use of UL 17 null mutants revealed that UL 17 is involved in targeting capsids and 
both major and minor capsid associated proteins to sites of viral replication. In wt 
HSV-l infected cells the major capsid proteins UL19 and UL26.5, plus the 
cleavage/packaging protein UL6, were shown to be directed to replication 
compartments. However, in cells infected with the UL 17 null mutant UL 19 and 
UL26.5 formed dense aggregates separated from replication compartments, and UL6 
exhibited a diffuse distribution around the nuclear periphery. In comparison, the use of 
UL28 and UL33 null mutants did not affect the distribution of these proteins (Taus et 
al., 1998). Further studies demonstrated that UL 17, along with UL6 and UL28, was 
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required for the association of various fonns of UL 15 with B-capsids (Salmon and 
Baines, 1998). 
UL32 
The product of the UL32 gene is a 67 kDa protein which accumulates predominantly in 
the cytoplasm of infected cells, although smaller amounts accumulate in the nucleus and 
co-localise with UL29 to replication compartments (Lamberti and Weller, 1998). As 
with other viral proteins involved in cleavage and packaging, UL32 null mutants 
accumulate endless DNA in the nucleus of infected cells with no detectable termini 
(Chang et al., 1996). In common with ULI7, UL32 appears necessary to direct capsids 
to viral replication compartments. Using an antibody specific for capsid hexamers, wt 
HSV -1 capsids were shown to localise to replication compartments, but in UL32 null 
mutants the capsids showed a more diffuse staining (Lamberti and Weller, 1998). 
UL25 
Two ts mutants, ts1204 and ts1208, with temperature sensitive lesions in the UL25 ORF 
were identified (Addison et al., 1984). Electron microscopy studies demonstrated that 
at the non-pennissive temperature both viruses produced large numbers of B-capsids 
and few C-capsids, suggesting a packaging defect. DNA replication was deduced to be 
unaffected as the viral protein profile was almost identical to wt HSV -1. The ts 1208 
mutant exhibited an additional defect involved in virus entry into the host cell. If 
absorption was perfonned at the non-pennissive temperature the virus would bind to the 
cell surface but could not fuse with the plasma membrane. This defect could be 
overcome by subsequent incubation at the pennissive temperature. 
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UL25 has been shown to interact with the major capsid protein, VP5 (Ogasawara et al., 
2001). Immunoelectron microscopy studies show that UL25 locates to both pentamers 
and hexamers with approximately 42 copies per B-capsid. Based upon its ability to 
bind DNA Ogasawara et al. (200 I), proposed that UL25 plays a role in anchoring 
genomIC DNA to the capsid. This work supports that of McNab et al. (1998) who 
isolated a UL25 null mutant, KUL25NS, using a complementing cell line. 
Characterisation of this mutant revealed that viral DNA synthesis was unimpaired and 
there was an accumulation of A-capsids, indicative of abortive packaging events. The 
most striking feature of this mutant was the presence of genome length DNA that 
contained free termini, indicating that the concatemeric DNA had been cleaved, which 
was, however, susceptible to degradation by DNase indicating that it was not 
encapsidated. Taken in conjunction with the accumulation of A capsids it was 
concluded that cleavage and packaging could occur in the absence of UL25, and that 
UL25 was involved in stabilising DNA containing capsids. In its absence cleaved DNA 
was therefore only transiently associated with the capsids. 
In a subsequent study using the same mutant virus, Stow (2001) demonstrated that a 
small amount of genomic length DNA was stably packaged. No DNA could be 
detected in the cytoplasm of infected cells suggesting that there is a defect in capsid 
maturation and egress. Close examination of the size of packaged molecules using 
pulsed field gel electrophoresis demonstrated that the majority of packaged molecules 
were below genome length. In addition there was an over-representation of the long 
terminus compared to the short terminus. These results suggested that packaging was 
efficiently initiated but that UL25 was required for the late stage of the head-filling 
process to occur efficiently. 
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Although there are a number of contrasting features between the work of McNab et al. 
(1998) and Stow (2001), both indicate that UL25 is not absolutely required for the 
cleavage of genomic DNA but is involved in capsid maturation. Interestingly the 
phenotype of the UL25 null mutant described by Stow is not dissimilar from that of 
UL12 null mutants which accumulate A-capsids, package reduced amounts of DNA and 
exhibit a block in transportation of capsids into the nucleus (see Results and section 
1.5). 
1.5 The role of the virally encoded alkaline nuclease in the replication and 
packaging of HSV -1 DNA 
1.5.1 Alkaline nuclease activity of HSV -1 infected cells 
An increase in nuclease activity was first identified in HSV -1 infected cells in 1963 by 
Keir and Gold. The optimum nuclease activity was observed under very basic 
conditions (PH9), hence the name alkaline nuclease (Morrison and Keir, 1968). This 
activity was found to localise mainly to the cell nucleus and had properties distinct from 
known cellular nucleases, such as the ability to degrade dsDNA under alkaline 
conditions and lower stability than cellular nucleases at elevated temperatures (Morrison 
and Keir, 1968). Convincing evidence of the alkaline nuclease being virally encoded 
came from studies on the HSV-2 mutant, tsl3. At the non-permissive temperature cells 
infected with the ts mutant failed to exhibit alkaline nuclease activity, whereas wt virus 
did (Franke et al., 1978). In addition, Preston and Cordingley (1982), demonstrated 
that the injection of specific fragments ofHSV-l DNA (map units 0.155 to 0.185) into 
Xenopus oocytes resulted in production of alkaline nuclease activity. 
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1.5.2 Identification of the alkaline nuclease protein and open reading frame 
The identification of the polypeptide and the mapping of the region of the genome that 
encoded the alkaline nuclease were reported in the late 1970s and early 1980s. The 
purification of the alkaline nuclease by Strobel-Fidler and Francke, (1980) yielded 
polypeptides of 90 kDa, 85 kDa and 70 kDa. Preston and Cordingley, (1982) used a 
reticulocyte in vitro translation system to express an 85 kDa protein, VI85. The VI85 
mRNA co-sedimented with the mRNA which, when injected into Xenopus oocytes, 
displayed exonuclease activity. The alkaline nuclease also likely corresponds to the 
phosphoprotein Vmw85 (Marsden et al., 1978) and is referred to as ICP19 by Banks et 
al. (1985). 
The mRNA reported to encode exonuclease activity by Preston and Cordingley (1982) 
was estimated to be 3.2 kilobases in size. However subsequent studies demonstrated 
that the mRNA transcript for the alkaline nuclease was 2.3-kb (Costa et al., 1983). 
Costa et al. (1983) also identified a 1.9-kb transcript which contained part of the 
nuclease reading frame, later shown to correspond to the UL 12.5 ORF. The ORF 
specifying the alkaline nuclease was mapped and shown to correlate with the leftward 
orientated transcript of 2.3-kb, and to encode a 626 amino acid protein (Banks et ai., 
1985; Draper et al., 1986; McGeoch et al., 1986). 
Following determination of the complete DNA sequence of HSV -1 (McGeoch et ai., 
1988) the alkaline nuclease gene was assigned as ORF UL12 (residues 26889 to 25011). 
The UL12 mRNA is one of five transcripts which share the polyadenylation site at 
position 24807. It is proceeded by a typical TATA box promoter, mapped to residue 
27048 (Costa et aI., 1983; McGeoch et al., 1988) and regulated with early kinetics. 
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1.5.3 Biochemical properties of the alkaline nuclease 
The biochemical properties of purified alkaline nuclease were examined in detail by 
Hoffmann and Cheng (1978). They demonstrated that the nuclease purified from both 
HSV -1 and HSV -2 infected cells was able to degrade dsDNA generating 
5' -monophosphonucleotides. The enzyme had an absolute requirement for a divalent 
cation such as Mg2+ or Mn2+. At the optimal concentration of Mg2+ (5mM) the nuclease 
was 3-5 fold more active than in the presence Mn2+ at its optimal concentration (0.1 -
0.2 mM). Concentrations of Mn2+ above 1 mM inhibited exonuclease activity. This 
study also demonstrated that the activity of both the HSV -1 and HSV -2 nuclease was 
optimal at pH 8-9. Similar properties for the alkaline nuclease were also described by 
Strobel-Fidler and Franke (1980), and Banks et al. (1983). 
Although the main activity of the alkaline nuclease appeared to be as an exonuclease, 
acting in both 5'-3' and 3'-5' directions (Hoffmann, 1981), there was also an associated 
endonuclease activity (Hoffmann and Cheng, 1979; Strobel-Fidler and Francke, 1980; 
Banks et aI, 1983). In comparison to the exonuclease activity the endonuclease activity 
was 10-fold less efficient. Moreover, the endonuclease was inhibited by lower 
concentrations of spermine. The endonuclease action of alkaline nuclease also appears 
to prefer single-stranded regions of DNA as a substrate, degrading supercoiled plasmid 
DNA 60 times more efficiently than relaxed, covalently closed plasmid DNA 
(Hoffmann and Cheng, 1979). In these experiments the endonuclease did not exhibit 
any sequence specificity although Henderson et al. (1998) demonstrated 
hypersensitivity sites specific to the alkaline nuclease in a fragment from plasmid 
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pON114, suggesting that the alkaline nuclease may contain some sequence or structure 
related specificity. 
1.5.4 Interaction of the alkaline nuclease with other proteins 
A number of antibodies have been raised against the alkaline nuclease (Banks et at., 
1983, 1985; Bronstein and Weber, 1996). These antibodies have facilitated studies 
examining the intracellular localisation of the UL 12 protein during infection and the 
interactions ofUL12 with other proteins. 
Immunoabsorbant column chromatography using the monoclonal antibody Q 1, specific 
against the HSV-l alkaline nuclease (Banks et at., 1983), resulted in co-purification of 
large amounts of the major DNA binding protein (mDBP) from infected cell extracts 
(Vaughan et at., 1984). Work by Thomas et at. (1988) has also shown that the mDBP 
and the alkaline nuclease are able to form a complex with the viral DNA polymerse, 
although independent interaction between the polymerase and the alkaline nuclease has 
not been demonstrated. The interaction between the mDBP and the alkaline nuclease 
was confirmed using a collection of monoclonal antibodies (five specific for the alkaline 
nuclease and five specific for the mDBP). The interaction was mapped to the C-
terminus of the mDBP, although the site of interaction in the alkaline nuclease has yet 
to be determined (Thomas et at., 1992). In the same study it was demonstrated that both 
proteins co-localise to replication compartments in the nucleus of infected cells, 
although the alkaline nuclease was also found in the nucleoplasm. Previous studies 
demonstrated that the alkaline nuclease had a more diffuse staining in the nucleus, 
distinct from the viral DNA polymerase (Randall and Dinwoodie, 1986; Puvion-
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Dutilleul et al., 1986). This suggests that the alkaline nuclease may have two distinct 
roles in the nucleus. 
The alkaline nuclease is a highly phosphorylated protein (Marsden et al., 1987), 
suggesting a possible control mechanism through the level of phosphorylation. In HSV-
2, the alkaline nuclease has been reported to be phosphorylated by the US3 gene 
product (Daikoku et al., 1995), although similar processing has not been reported for 
the HSV -1 homologue. An HCMV UL97 null mutant, which does not express the 
HSV -1 UL 13 homologue, has a very similar phenotype to UL 12 null mutants (Wolf et 
al., 2001), suggesting that the protein kinase encoded by this gene may possibly be 
involved in phosphorylation of the alkaline nuclease. 
As will be discussed later the alkaline nuclease has a significant role in the synthesis 
and packaging of viral DNA. Although the nuclease has been shown to associate with 
proteins involved in DNA synthesis it is also possible that it interacts with the viral 
packaging machinery. 
1.5.5 The alkaline nuclease is conserved throughout the herpesvirus family 
Homologues of the HSV -1 alkaline nuclease have been reported in every herpesvirus 
sequenced to date and the homologues in the human herpesviruses are shown in Table I. 
Although there is limited overall sequence homology between alkaline nuclease ORFs, 
seven conserved motifs have been identified (Martinez et al., 1996b). A lineup of the 
alkaline nuclease amino acid sequences for each of the human herpesviruses is shown in 
Figure IV. The HSV-l and HSV-2, and to a lesser extent, HCMV and VZV alkaline 
nuclease polypeptides are unusual in that they have an extention to the N-terminus. The 
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function of the N-terminus is unknown but it is interesting that HSV-l UL12 null 
mutants have been heterologously complemented in trans only by the expression of the 
HCMV UL98 gene indicating that the N-terminal extension may play an important role 
(Gao et al., 1998). The HCMV protein is larger than most alkaline nucleases but still 
lacks 70 amino acids from its N-terminus compared to HSV-l. It is also interesting to 
note that no successful attempts to complement alkaline nuclease null mutants of other 
herpesviruses with the HSV-1 UL12 gene have been reported. 
Table I - Alkaline nuclease ORFs in human herpesviruses 
Herpesvirus HSV-1 HSV-2 VZV HCMV EBV HHV-6 HHV-7 KSHV 
gene name 
protein size (a.a.) 
UL12 
626 
UL12 ORF48 UL98 BGLF5 
620 551 584 470 
U70 U70 ORF 37 
488 480 486 
HSY-l - herpes simplex virus type 1; HSY-2, herpes simplex virus type 2; YZY, varicella-zoster virus; EBV 
Epstein-Barr virus; HHY-6, human herpesvirus 6; HHY-7, human herpesvirus 7; KSHV, Kaposi's sarcoma 
associated herpes virus. 
Mutational analysis of the HSV-1 alkaline nuclease has demonstrated that the N-
terminal 126 amino acids can be removed without detectably altering the nuclease 
activity of the protein. This protein, which closely corresponds to the UL12.5 product, 
cannot complement a UL12 null mutant when expressed in trans (Henderson et al., 
1998). In contrast if only 49 amino acids of the C-terminus are removed nuclease 
activity is lost (Henderson et al., 1998). Therefore, the N-terminus of the HSV-l 
nuclease contains an unrecognised functional domain, although whether this domain 
possesses an enzymatic property or if it is required for the interaction with some, as yet 
unidentified, viral or cellular protein has yet to be determined. 
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Figure IV - Alignment of the eight human herpesvirus alkaline nucleases 
The eight human herpesvirus alkaline nuclease amino acid sequences are shown. Their 
corresponding SWISS-PROT (sp) or TrEMBL (tr) acquisition numbers are given alongside. 
The alignment was performed using the Quick BlastP search function and the Clustal W 
(multiple alignment) function of ExPASy (http://ca.expasy.orgl) and related links. The 
highlighted regions define the conserved motifs as described by Goldstein and Weller 
(1998a). 
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1.5.6 Phenotype ofUL12 null mutants 
Three HSV-l, UL12 null mutants (nuc mutants) have been created (Weller et at., 1990; 
Patel et at., 1996; Martinez et at., 1996b). In each case it was necessary to use a 
complementing cell line, confirming the necessity of the alkaline nuclease during viral 
replication. A schematic diagram indicating the lesions in each of the mutants is shown 
in Figure V. 
Virus Yield 
All nuc mutants produce a small amount of infectious virus in non-complementing cell 
lines, although the yield is reduced 100 - 1000 fold compared to wt virus. Another 
interesting feature of these mutants is that plaque size is reduced approximately five 
fold compared to wt virus. This phenotype is repaired upon growth in complementing 
cell lines (Weller et at., 1990; Patel et at., 1996). 
DNA replication 
Initial characterisation of the AN-l nuc mutant demonstrated that the virus was not 
impaired in its ability to replicate viral DNA (Weller et at., 1990). However, 
subsequent studies examining the ability of this virus and other nuc mutants to replicate 
both viral and plasmid (amplicon) DNA indicate that synthesis was reduced. Shao et al. 
(1993) reported that the AN-l mutant synthesises DNA at 50 - 63% of wt amounts, 
similarly the ANF-l mutant shows DNA synthesis at 60 - 90% ofwt levels (Martinez et 
at., (1996b). Patel et at. (1996) also report that the ambUL12 nuc mutant is impaired in 
DNA synthesis, although no quantitative data was given. 
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Figure V - Schematic representation of various alkaline nuclease null 
mutants 
(A) The region of the genome containing the UL 12 ORF is enlarged and 
shows the overlapping ORFs ofUL12, UL12.5 and ULIl. (B) The AN-I 
mutant was generated by deleting a portion of the UL12!UL12.5 ORF and 
inserting the lacZ gene under the control of the HSV -1 ICP6 promoter 
(Weller et al., 1990). ambUL12 was generated by inserting an in-frame 
amber stop codon into the UL12!UL12.5 ORF (Patel et al. , 1996). A 2bp 
frame shift was inserted into the UL 12 0 RF to generate ANF -1 (Martinez 
et al., 1996b). The AN-l and ambUL12 mutations prevent expression of 
functional UL12 and UL12.5 gene products whereas ANF-l is blocked 
only in the expression ofUL12. 
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Although the mechanism for impairment is not known, it has been suggested that the 
interaction of the alkaline nuclease with the mDBP indicates that it may have some 
direct, but non-essential, role in DNA synthesis. Bacteriophage T4, which has a 
bimodal replication mechanism, requires endonuclease VII in the second phase of 
replication. This endonuclease is required to initiate new replication forks through 
recombination dependent mechanisms (Mosig, 1998), and it is possible that the alkaline 
nuclease may have a similar role. Martinez et at. (1996a), however, demonstrated that 
the AN-l mutant remains capable of intramolecular recombination. This does not 
completely exclude a role for the alkaline nuclease in DNA synthesis or intermolecular 
recombination. 
Cleavage and packaging 
Further characterisation of the AN-l mutant demonstrated that packaging of viral DNA 
was reduced by 50% (Shao et at., 1993). However the cleavage of viral DNA appeared 
to be almost unaffected, occurring 85 - 90% as efficiently as with wt virus. Moreover 
the cleavage appeared to exhibit normal specificity. Later studies, using the ANF-l 
mutant, reported that cleavage activity was 54 - 68% of wt, although the sites of 
cleavage still appeared specific for the a sequence (Martinez et at., 1996b). 
Therefore, although slight impairments were observed in the replication and packaging 
of viral DNA, this did not account for the 100 - 1000 fold drop in virus yield. Electron 
microscopy and sucrose gradient ultracentrifugation experiments revealed that although 
DNA was packaged very few mature capsids were produced (Weller et at., 1990; Shao 
et at., 1993). In the nucleus only small numbers of C-capsids were present while there 
was an overabundance of A and B-capsids. Moreover, very few C-capsids were 
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detectable in the cytoplasm of infected cells. DNase and micrococcal nuclease 
treatment of cytoplasmic and nuclear fractions demonstrated that DNase resistant DNA 
could only be detected in the nucleus of AN-l infected cells whereas protected DNA 
was present in both nuclear and cytoplasmic fractions of cells infected with wt virus 
(Shao et al., 1993), From these results it was proposed that the capsids produced in nuc 
mutant infected cells were unstable, possibly due to insertion of incorrectly processed 
genomic DNA, resulting in DNA containing capsids that were unable to transverse the 
nuclear membrane and egress into the cytoplasm (Shao et al., 1993). Similarly, empty 
A-capsids arise due to packaging events that are aborted at a relatively early stage. 
Structure of DNA replication intermediates in nuc mutant infected cells 
As described previously, replication of viral DNA produces endless, head-to-tail 
concatemers which are highly recombinogenic. This results in a complex DNA 
intermediate that contains numerous X and Y junctions. It is therefore likely that this 
intermediate needs to be processed into a more suitable substrate for cleavage and 
packaging. Failure to do so likely results in genomic DNA which contains a number of 
branches capable of stalling the packaging process or destabilising packaged capsids. 
Evidence for the involvement of the alkaline nuclease in processmg replication 
intermediates comes from analysis of hmw intermediates produced in wt HSV -1 and 
nuc mutant infected cells and the ability of purified alkaline nuclease to digest hmw 
DNA in vitro (Martinez et al., 1996a; Goldstein and Weller, 1998b). Digestion ofhmw 
DNA from wt HSV-l or AN-l infected cells with the restriction enzyme SpeI, which 
cuts only once per genome, released a small amount of genome length molecules from 
the wt HSV -1 but not AN-l samples, indicating that AN-l bmw DNA was more 
43 
Chapter 1: Introduction 
complex than that ofwt (Martinez et al., 1996a). Similar conclusions were drawn from 
enzymes which cleaved more frequently although considerable cross linking is clearly 
present in wt HSV -1 intermediates. 
From these results it was postulated that the alkaline nuclease could act as a resolvase 
similar to endo VII of bacteriophage T4 or endonuclease I of bacteriophage T7, which is 
known to linearise X and Y junctions (Severini et al., 1996). Experiments using various 
synthetic cruciforms revealed that while endo VII of bacteriophage T4 would resolve 
these structures into linear molecules alkaline nuclease degraded them to completion 
(Goldstein and Weller, 1998b). Therefore, if the alkaline nuclease is involved in 
processing the HSV -1 hmw DNA intermediates it either functions in a manner not 
typical of other resolvases or perhaps requires the presence of an additional protein(s) to 
gain the appropriate specificity. Surprisingly, although the alkaline nuclease could 
degrade both the synthetic cruciforms and HSV -1 genomic DNA to completion it was 
unable to do so with hmw intermediates produced from wt HSV -1 infected cells. This 
degradation block did not appear to be sequence specific and the DNA released from 
hmw DNA ran as a heterogeneous smear on a pulsed field gel (Goldstein and Weller, 
1998b). In addition, through the use of purified, mutant forms of the alkaline nuclease 
it was demonstrated that only the exonuclease activity of the alkaline nuclease was 
necessary for the release of hmw DNA. However, construction of mutant viruses which 
expressed these mutated forms of the alkaline nuclease proved impossible (Goldstein 
and Weller, 1998a). 
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Complementation of nuc mutants 
Two independent, complementing cell lines have been developed for the propagation of 
nuc mutants. The 6-5 cell line (Shao et al., 1993) was developed when it was realised 
that the S22 cell line (Carmichael et al., 1988) was not fully complementing the AN-l 
nuc mutant. However, despite producing 4-fold more alkaline nuclease activity the 6-5 
cell line did not complement the nuc mutant significantly better than the S22 cells. This 
suggests the kinetics of synthesis or amount of alkaline nuclease may be critical for 
efficient virus replication. 
The creation of plasmids expressing stable forms of alkaline nuclease which contain 
point mutations knocking out either exonuclease activity alone or exo- and 
endonuclease activity together has demonstrated that the endonuclease activity alone is 
not able to complement the AN-I mutant, and that the exonuclease activity is essential 
(Goldstein and Weller, 1998a). 
Finally, recombinant virus (ANF-l) that expresses the UL12.5 but not UL12 product 
was shown to be as impaired in growth as the AN-I mutant which expresses neither 
protein (Martinez et al., 1996a). The UL12.5 protein lacks the N-terminal 126 amino 
acids and is of equivalent size to alkaline nucleases produced by other herpesviruses. 
The nuclease produced by the ANF -1 virus also possessed both exo- and endonuclease 
activity. This further suggests that the N-terminus of the HSV-l alkaline nuclease 
possesses some extra function or is needed for interaction with some cellular or viral 
protein. 
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1.6 Aims of the work presented in this thesis 
Although the alkaline nuclease is well characterised III terms of its biochemical 
properties, its precise role in the replication and packaging of the viral genome has 
remained elusive. The UL12 null mutant, ambUL12, was isolated and partially 
characterised by Patel et al. (1996). The work presented in this thesis further 
characterises the ambUL12 virus, and investigates the role of the alkaline nuclease in 
the replication of HSV -1. 
Initial work focused on the ability of ambUL12 to replicate and package the viral 
genome, paying particular attention to the structure of replicated DNA, cleavage of viral 
concatemers and the size of molecules encapsidated. In the course of these experiments 
it became evident that ambUL12 was severely impaired in its ability to package DNA. 
Therefore, preliminary experiments were performed to investigate whether UL 12 might 
interact directly with a number of the essential packaging proteins. 
The ability of ambUL12 to replicate and package amplicons was investigated in a 
transient transfection assay. The results demonstrate that the amplicons behave 
similarly to the ambUL12 genome, both in terms of the replication and packaging 
defects and the structure of replication intermediates. Work with the amplicon system 
was extended to investigate recombination and the sequence requirements for 
encapsidation. 
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Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 Chemicals and reagents 
Most chemicals were supplied by BDH or Sigma Chemical Co. Ltd. and were of 
AnalaR grade. Other sources are listed below: 
Bio-Rad Laboratories 
Fluka Chemical Ltd. 
Gibco BRL 
- Ammonium persulphate 
- TEMED 
- Formaldehyde 
- Acrylamide 
- Acrylamide:N ,N' -methylene-bis-acrylamide 19: 1 
Joseph Mills (Denaturants) Ltd. 
Melford Laboratories Ltd. 
Pharmacia Biotech 
SmithKline Beecham Research 
2.1.2 Enzymes 
- Absolute alcohol 100 
- Caesium chloride 
- dATP, dTTP, dCTP and dGTP 
- Ampicillin (Penbritin) 
Restriction enzymes were supplied by New England Biolabs or Roche (Boehinger 
Mannheim). Other enzymes used are listed below: 
Sigma Chemical Co. Ltd. - Protease XIV 
- Lysozyme 
- RNase A 
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New England Biolabs 
Roche 
2.1.3 Stock solutions 
f3-galactosidase fix 
f3-galactosidase stain 
Blot wash 
Boiling mix 
BufferE 
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- RNase Tl 
- DNase I 
- DNA polymerase I 
- T 4 DNA ligase 
- Calf intestinal phosphatase 
- Proteinase-K 
-2% formaldehyde, 0.2% glutaraldehyde, in PBS 
-S mM potassium ferricyanide, S mM potassium 
ferrocyanide, 2 mM MgCI2, O.S mg mr! X-Gal, in 
PBS. 
- 2 x SSC, 0.1% SDS. 
- 6% w/v SDS, 30% v/v stacking gel buffer, 30% v/v 
glycerol, 0.3% w/v bromophenol blue, 210 mM f3-
mercaptoethanol. 
- 100 mM Tris-HCI pH8, 100mM NaCI, 2mM 
EDTA, 2mM EGTA, 1% NP40, O.S% Sodium 
deoxycholate. 
Calf thymus DNA (denatured) - 2 mg mr! in TE, incubated at 100°C for 30 min. 
Calf thymus DNA (transfections) - 2 mg mr! in TE. 
- chloroform:isoamyl alcohol 24: 1 v/v. Chloroform: isoamyl alcohol 
CLB (2x) - 20 mM Tris-HCI pH7.S, 2 mM EDTA, 1.2% SDS. 
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Denhardt's solution (50x) 
DNase I dilution buffer 
DNase I reaction buffer 
Gel soak I 
Gel soak II 
HeBS 
Hybridisation mix 
Loading buffer dyes 
Loening's buffer 
Methyl cellulose 
Nick translation buffer 
PFGE cell suspension buffer 
PFGE WASH (Ix) 
Phosphate Buffered Saline 
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- 10 mM Tris-HCI pH7.2, 50 mM EDTA, 85 mM 
NaCl. 
- 1 % ficoll 400, 1 % polyvinylpyrolidone, 1 % BSA. 
- 20 mM Tris-HCI pH7.6, 50 mM NaCI, 1 mM DTT, 
50% glycerol, 0.1 mg mr! BSA. 
- I M NaAc pH5, 5 mM MgCh. 
- 0.6 M NaCI, 0.2 M NaOH. 
- 0.6 M NaCI, 1.0 M Tris-HCI pH8.0 
- 137 mM NaCI, 5 mM KCI, 0.7 mM Na2HP04, 5.5 
mM D-glucose, 21 mM Hepes, to pH6.95 - 7.15 
with NaOH. 
- 6x SSC, 5x Denhardt's solution, 0.05% SDS, 50 
)lg mr! denatured CT-DNA, 20 mM Tris-HCI 
pH7.5, 1 mMEDTA. 
- 50% w/v sucrose, 0.25% bromophenol blue, in 5x 
running buffer. 
- 40 mM Na2P04, 36 mM Tris-HCI, 1 mM EDTA. 
- 3% methyl cellulose sodium salt in H20. 
- 0.5 M Tris-HCI pH7.5, 0.1 M MgCh, 10 mM DTT, 
0.5 mg mr! BSA. 
-10 mM Tri-HCI pH7.2, 20 mM NaCI, 50 mM 
EDTA. 
- 20 mM Tris-HCI pH8.0, 50 mM EDTA. 
- 170 mM NaCI, 3.4 mM KCI, 10 mM Na2HP04, 1.8 
mM KH2P04, 6.8 mM CaCh, 4.9 mM MgCh. 
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Pre-hybridisation buffer 
Proteinase-K reaction buffer 
Resolving gel buffer (4x) 
Reticulocyte standard buffer 
Sample buffer 
SOB 
SOC 
Solution I 
Solution II 
Solution III 
ssc (20x) 
Stacking gel buffer (4x) 
Sucrose reagent 
Tank buffer 
TBE 
TE 
Transfer buffer 
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- 6x SSC, 5x Denhardt's solution, 0.1 % SDS, 20 Jlg 
mrl denatured CT-DNA. 
- 100 mM EDTA, 0.2% sodium deoxycholate, 1% 
sodium lauryl sarcosine, 1 mg mrl Proteinase K. 
- 1.5 M Tris-HCl pH 8.9, 0.4% w/v SDS. 
- 10 mM Tris-HCI pH7.5, 10 mM KC1, 1.5 mM 
MgCh. 
- 33% v/v boiling mix. 
- 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCh, 10 mM MgS04. 
- 20 mM D-glucose in SOB. 
- 50 mM glucose, 25 mM Tris-HCl pH8.0, 10 mM 
EDTA. 
- 0.2 M NaOH, 1 % SDS. 
- 5 M potassium acetate, 11.5 ml glacial acetic acid, 
up to 100 ml with H20. 
- 3 M NaCI, 0.3 M tri-sodium citrate. 
- 488 mM Tris-HCI pH 6.8, 0.4% w/v SDS. 
- 0.25 M sucrose, 2 mM MgCh, 50 mM Tris-HCI 
pH8.0. 
- 52 mM Tris, 53 mM glycine, 0.1 % w/v SDS. 
- 90 mM Tris, 89 mM boric acid, 1 mM EDT A. 
- 10 mM Tris-HCI pH7.5 or pH8.0, 1 mM EDTA. 
- (25 mM Tris, 192 mM glycine, 20% v/v methanol) 
pH8.3. 
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Triton reagent 
Trypsin 
Versene 
2.1.4 Radiochemicals 
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- 0.5% Triton X-100, 62.5 mM EDTA, 50 mM Tris-
HCI pH8.0. 
- 0.25% trypsin in Tris-saline. 
- 0.6 /-lM EDTA, 0.02% phenol red in PBS. 
a_
32p deoxyribonucleoside triphosphates (dNTPs) were obtained from Perkin Elmer at 
3000 Ci mMole -1 (10 /-lCi /-ll -1 ) 
2.1.5 Cells and culture media 
The following cell lines were used throughout this work, from recovery to passage 30: 
BHK-21 C13 
Vero 
S22 
FG293 
UL19-1 
SpodopteraJrugipreda (S.f.) 
- Syrian hamster kidney fibroblasts 
- African green monkey kidney fibroblasts 
- Modified Vero cell line (Carmichael et al., 1988) 
- human embryonal kidney cells transformed with 
sheared Ad5 DNA 
- rabbit skin cell line containing HSV -1 UL19 gene 
under control of the HSV -1 ribonucleotide reductase 
large subunit promoter (V. Preston, unpublished) 
- strain IPLB-SF-21 (Kitts et al., 1990) 
51 
Chapter 2: Materials and Methods 
The above cell lines were grown and maintained in: 
EC5 (Vero and S22) 
ETCI0 (BHK) 
FG293 medium 
UL 19-1 medium 
TCI00 (Sf) 
WASH 
Vero cell overlay 
2.1.6 Viruses 
-Dulbecco's Modified Eagles Medium (DMEM), 
5% Foetal Calf Serum (FCS), 1% Penicillin / 
Streptomycin. 
-BHK 21 Ix medium, 10% New Born Calf Serum 
(NBCS), 7% tryptose phosphate broth, 1 % penicillin 
/ streptomycin. 
- DMEM, 10% FCS, 1 % non-essential amino acids, 
1 % 100 x glutamine, 1 % penicillin / streptomycin. 
- DMEM, 10% FCS, 2% 100 x glutamine, 1 % 
penicillin / streptomycin. 
- TCI00 medium, 5% Foetal Calf Serum, 1% 
Penicillin / Streptomycin. 
-DMEM, 1 % penicillin / streptomycin. 
-200ml methyl cellulose, 140ml Eagles A, 40ml 
Eagles B (with phenol red), 5% FCS, 1% penicillin 
/ streptomycin. 
The following herpesviruses were used during this work: 
HSV -1 strain 17 syn + - McGeoch et al. (1988) 
ambUL12 - Patel et al. (1996) 
amb UL 12R - Patel et at. (1996) 
K5L1Z - Desai et al. (1993) 
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The following baculoviruses, expressing the indicated HSV -1 gene, were used in co-
immunoprecipitation studies: 
AcUL6 - Patel et al. (1996) 
AcUL12 - N.Stow (unpublished) 
AcUL15-pp65 - Abbotts et al. (2000) 
AcUL25 
AcUL28 
AcUL29 
- Targett-Adams (2001) 
- Abbotts et al. (2000) 
- Stow (1992) 
2.1.7 Bacterial Strains 
Commercially available competent DH5 (Life Technologies) or SoloPack Gold 
(Stratagene) E. coli were used for the growth and maintenance of all plasmids used in 
this study. 
2.1.8 Plasmids 
The following plasmids were used during transient replication and packaging assays: 
pS 1 - contains a 540bp fragment from HSV -1 strain 17 syn + which spans 
the Oris region inserted into the BamHI site of pAT153 (Stow and 
McMonagle, 1983). 
pSAI 
pYI 
- pS 1 containing the (Uc-DRI-Ub) fragment of two tandemly repeated 
'a' sequences (Hodge and Stow, 2001). 
_ pSI including a 1762 bp HinfI fragment from the L-S junction of 
HSV -1 strain 17 syn+ containing a single 'a' sequence (Stow et at., 
1983). 
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pZl 
pPHll 
pPH12 
pPH21 
pPH22 
Chapter 2: Materials and Methods 
- pS 1 including a 2161 bp Hinfl fragment from the L-S junction of 
HSV -1 strain 17 syn+ containing two tandemly repeated 'a' sequence 
(Stow et al., 1983). 
- As pSAI except for a pac1 GC element deletion (Hodge and Stow, 
2001). 
- As pSAI except for a pac1 GC element substitution (Hodge and 
Stow, 2001). 
- As pSAl except for a pacl proximal GC element deletion (Hodge 
and Stow, 2001). 
- As pSA 1 except for a pac 1 proximal GC element substitution 
(Hodge and Stow, 2001). 
Plasmids expressmg the seven essential HSV -1 encoded replication proteins were 
provided by N. Stow, Institute of Virology, Glasgow. The backbone for each of these 
vectors is the pCMVI0 plasmid which contains the HCMV immediate early promoter 
upstream of the MCS (Stow et al., 1993): 
pE5 - UL5, helicase. 
pE8 -UL8, helicase-primase accessory factor. 
pE9 -UL9, origin binding protein. 
pE29 -UL29, major DNA binding protein. 
pE30 -UL30, viral DNA polymerase. 
pE42 -UL42, polymerase accessory factor. 
pE52 -UL52, primase. 
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The following plasmids were 32P-Iabeled to produce probes for use during Southern 
blotting: 
pAT153 
pGX153 
pBE1 
pBNl 
pST17 
2.1.9 Antibodies 
Ql 
BwP12 
MAb 7381 
Anti-UL25 
Anti-pp65 
- high copy number plasmid derived from pBR322 
(Twigg and Sherratt, 1980) 
- pAT153 containing the HSV-1 BamHI P fragment. 
- contains a fragment from the TRu'IRL region of 
HSV-l (Stow, 2001; Figure 14). 
- contains a fragment from the TRs/IRs region of 
HSV-1 (Stow, 2001; Figure 14). 
- contains a fragment from the TRs/IRs region of 
HSV-1 (Stow, 2001; Figure 14). 
_ monoclonal antibody against UL12 (Banks et al., 
1983) 
_ polyclonal antibody against UL12 and UL12.5 
(Bronstein and Weber, 1996) 
_ monoclonal antibody against UL29 (unpublished, 
Anne Cross, Institute of Virology, Glasgow). 
_ monoclonal antibody against UL25 (Targett-
Adams, 2001). 
_ monoclonal antibody against HCMV pp65 epitope 
tag (purchased from Capricorn Products). 
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- polyclonal antibody against UL6 (Patel et ai., 
1996). 
Cell lines were grown and passaged in 175 cm2 tissue culture flasks containing the 
appropriate media. Confluent mono layers were washed in versene and trypsinised with 
a 1:4 dilution of trypsin:versene. Cells were then resuspended in appropriate media to a 
final volume of 10 ml. 175 cm2 flasks containing fresh media were seeded with 6xl06 
cells and incubated until confluent in a 5% CO2 environment at 37°C. 
The complementing cell lines, S22 and ULI9-1, had 300 ~g mr! G418 added every 
third passage after recovery. 
S.f. cells were grown and passaged in 175 cm2 tissue culture flasks containing 
supplemented TC 1 00 media. Confluent mono layers were washed in TC 1 00 and 
removed from the flask by gentle agitation. The cells were then resuspended in 10 ml 
supplemented TC 1 00 and seeded into fresh flasks. Cells were grown and maintained at 
28°C. 
2.2.2 Preparation of Virus Stocks 
Five 175cm2 tissue culture flasks containing Vero and S22 cells at 90% confluency 
were infected with wt-HSVI and ambUL12 respectively at 0.01 p.f.u./ml. Three days 
post infection the infected cells were gently tapped into the media, the supernatant 
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pooled and centrifuged at 2000 rpm for 5 min. 
Cell released virus (CRV) was prepared by centrifuging the supernatant at 12000 rpm 
for 3 h. The resulting pellet was resuspended in 5 ml WASH, sonicated extensively, 
and stored in 1 ml aliquots at -70°C. Cell associated virus (CA V) was prepared by 
resuspending the pellet in 5 ml WASH, and sonicating the suspension extensively. The 
cellular debris pelleted by centrifugation at 2000 rpm for 5 min and the supernatant 
stored in 1 ml aliquots at -70°C. 
2.2.3 Determination of virus stock titres 
To determine the titre of virus stocks 10-fold serial dilutions of the stock were made. 
35 mm Petri-dishes containing near confluent monolayers of Vero or S22 cells were 
inoculated with 100 /-ll of diluted stock virus. The plates were incubated at 37°C, 5% 
CO2 for 45 min. 2 ml of Vero overlay was then added and the monolayers incubated at 
37°C, 5% C02 for three days. The overlay was removed and 1ml of Geimsa stain added 
for 2 h. The Geimsa stain was then washed off and the number of plaques in each 
dilution counted. The virus titre was determined by the following calculation: 
Titre = number of plaques on 10-n dilution x IOn x10 p.f.u./ml 
e.g. 20 plaques on a -5 dilution plate corresponds to 20 x 105 X 10 = 2x107 p.f.u./ml 
The average titre of at least two dilutions was used to determine the virus titre. 
2.2.4 Agarose Gel Electrophoresis 
LB or TBE buffer containing the desired percentage of agarose was boiled and allowed 
to cool. Once the agarose had cooled to approximately 60°C ethidium bromide was 
added to 0.5 /-lg mrl and the agarose poured into a mould containing a well forming 
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comb. Once set the gel was placed in an electrophoresis tank containing the appropriate 
buffer. DNA samples containing 1 x loading dye were added to individual lanes and 
were generally electrophoresed overnight at a constant voltage of between 10 and 50 V. 
2.2.5 General Cloning Strategies 
Restriction Enzyme Digests 
Twenty micrograms of vector were digested with 50 U of the appropriate restriction 
enzyme in 100 J.lI of the recommended 1 x buffer. If further modification of the 
digested vector was required the reaction was extracted once in an equal volume of 
phenol, then in an equal volume of chloroform:isoamyl alcohol. The vector was then 
precipitated in 2.5 volumes of ethanol and resuspended in TE, pH7.5. 
Preparation of Phosphatased Vector 
To prevent re-circularisation during subsequent ligation reactions the vector backbone 
was dephosphorylated with calf intestinal phosphatase (CIP). Five micrograms of 
linearised vector were incubated with 10 U CIP and incubated at 37°C for 3 h. The 
vector was then phenol Ichloroform extracted, ethanol precipitated and resuspended in 
TE, pH7.5. 
Purification of DNA fragments 
DNA was digested with the appropriate restriction enzyme to produce the desired DNA 
fragment, and run out on a 1 % TBE agarose gel containing ethidium bromide. The 
DNA was visualised using long wave UV and the desired fragment excised from the gel 
and transferred to dialysis tubing containing 4 ml 0.5 x TBE. The DNA was then 
electroeluted from the agarose at 200 V for 2 h. The buffer containing the DNA was 
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then added to a DEAE sephacel column and the column washed with 3ml TE containing 
0.1 M NaCl. The DNA was then eluted from the column with 1 ml TE containing 1 M 
NaCl. The DNA was precipitated in 2.5 volumes of ethanol and resuspended in 20 ~l 
TE. 
Ligation of DNA fragments 
One microgram each of vector backbone and DNA fragment were mixed with 1 unit of 
T4 DNA ligase in 1 x ligation buffer with a total volume of 20 ~l. The reaction mix 
was incubated overnight at 16°C, phenol/chloroform extracted and ethanol precipitated 
before transformation into E. coli. 
2.2.6 Maintenance and Manipulation of Competent E. coli 
Transformation of competent E. coli 
Competent DH5 or SoloPack Gold cells were transformed as per the suppliers 
instructions. Essentially, 50 ~l of competent cells were allowed to thaw slowly on ice. 
DNA from a ligation reaction was diluted five fold in 10 mM Tris-HCI pH7.5, 1 mM 
Na2EDTA and between 1 and 10 ng of DNA was added to the cells. The cells were 
incubated on ice for 30 min, heat shocked at 42°C for 45 sec and then placed on ice for 
another 2 min. 450 ~l of S.O.C. medium was then added and incubated at 225 rpm, 
37°C for 1 h. This was diluted as appropriate and 1 00 ~l was plated out on LB-agar 
plates containing the appropriate antibiotic and incubated overnight at 37°C. 
Lysis by alkali (mini-preps) (Sambrook et al., 1989) 
Individual colonies from the transformation streak plate were picked and used to 
inoculate 4 ml universals of L-Broth. The samples were then incubated overnight at 
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37°C, 220 rpm. 1.5 ml of the culture was spun down in a sterile eppendorf and 
resuspended in 100 J.lI ice cold solution I. 200 J.lI of solution II was added and gently 
mixed. 150 J.lI of solution III was then added, the eppendorf gently vortexed in an 
inverted position, and incubated on ice for 5 min. The sample was then centrifuged at 
13000 rpm for 5 min and the supernatant transferred to a clean tube. The sample was 
phenol/chloroform extracted and ethanol precipitated. The DNA was then 
resuspended in 100 J.lI TE containing 1 x RNase A mix and stored at -20°C. The 
plasmid contained in each transformed cell was then analysed by restriction enzyme 
digestion and agarose gel electrophoresis. 
Storage of E. coli 
Four millilitres L-broth, containing the appropriate antibiotic, was inoculated with 
transformed DR5 or SoloPack Gold E. coli and grown overnight at 37°C, 220 rpm. 900 
J.lI of the overnight culture was added to 100 J.lI DMSO and stored at -70°C. 
2.2.7 Large Scale Plasmid Preparation 
Ten micro litres of bacterial stock containing the appropriate plasmid were added to 4 
ml L-broth (LB) containing 50 J.lg mr! ampicillin and incubated overnight in a rotary 
shaker (37°C, 220 rpm). The overnight cultures were then added to 350 ml LB broth 
containing 50 J.lg mr! ampicillin in 2 I flasks and incubated overnight in a rotary shaker 
at 37°C, 220rpm. The bacteria were pelleted by centrifuging at 6000 rpm for 5 min at 
40C in a Sorvall GS3 rotor. Pellets were resuspended in 8 ml TE, pR8.0 and transferred 
to Oakridge tubes. Following centrifugation at 5000 rpm for 5 min at 4°C in a Beckman 
SS34 rotor, the pellets were resuspended in 2 ml sucrose reagent containing 400 J.lI 20 
mg mr! lysozyme freshly dissolved in TE and incubated on ice for 30 min. 800 J.ll of 
60 
Chapter 2: Materials and Methods 
0.25 M EDTA and 3.2 ml Triton reagent were then added and the sample incubated on 
ice for a further 15 min. 
Cell debris was then spun out at 35000 rpm for 30 min at 4°C in a Sorvall T865 rotor. 
The supernatant was decanted into a fresh tube and the volume adjusted to 7.5 ml using 
200 /-11 10 mg mr! ethidium bromide and distilled water. 7.5 g of caesium chloride was 
added to give a final density of 1.55 - 1.6 g mr!. This solution was then transferred to a 
T1270 tube and the remaining volume filled with paraffin oil. The tube was sealed and 
then centrifuged in a Sorvall T1270 rotor at 44000 rpm, 15°C for at least 36 h. The 
lower of the two bands in the gradient, containing the supercoiled plasmid DNA, was 
removed using an 18 gauge needle and 2 ml syringe and the ethidium bromide was 
removed by at least three extractions with equal volumes of isoamyl alcohol. The final 
aqueous phase was then dialysed twice, for at least 2 h, in 3 1 TE, pH7.5. The DNA was 
stored at -20°e. 
The concentration of the plasmid stock was determined by measuring the absorbance at 
260 nm, assuming that an A260 reading of 1.0 corresponds to a dsDNA concentration 
of 50 /-1g mr!. The identity of the plasmid was determined by selective restriction 
digests. 
2.2.8 Calcium phosphate transfection of mammalian cells 
Preparation of Calf thymus (CT) carrier DNA 
CT DNA was dissolved in TE to approximately 4 mg mr!. This was incubated with 
0.5% SDS and 100 /-1g mr! Proteinase-K for 1 h at 55°e. 0.3 M NaCl and 5 mM EDTA 
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were added, the solution sequentially extracted with phenol / chloroform:isoamyl 
alcohol and ethanol precipitated. The DNA was resuspended in TE to a final 
concentration of approximately 2 mg mr!. 
Calcium phosphate transfection 
For every 35 mm Petri dish containing a monolayer of the appropriate cell line (2 x 106 
cells per plate) 12 Ilg of calf thymus carrier DNA and 1 Ilg of plasmid DNA was added 
to 0.5 ml of HeBS (optimised pH) and precipitated with 35 III 2M CaCb. The 
precipitate was added to the monolayers and incubated at 37°C, 5% CO2 for 45 min. 
Two millilitres of EC5 was then added to the plate and incubated for at 37°C, 5% CO2. 
After 4 h incubation the mono layers were washed and "boosted" by the addition of 1 ml 
22.5% DMSO for 4 min (Stow and Wilkie, 1976). The mono layers were then washed 
twice and incubated with 2 ml EC5 at 37°C, 5% C02. 
~-Galactosidase staining of pElaeZ transfected cells 
Monolayers were transfected with pElaeZ as described above. Twenty four hours post 
transfection (h.p.t.) the media was removed and the monolayers washed with 2 ml of 
PBS. The cells were fixed by incubation with 1 ml of FIX solution for 30 min, then 
washed with 2 ml PBS and incubated overnight at 37°C with 1 ml ~-gal staining 
solution. Transfection efficiency was estimated by counting the number of positive 
(blue) cells and averaging the percentage from five fields of view. Typically, 2 - 5% of 
Vero and S22 cells would be transfected while BHK cells had a transfection rate of 10 -
30%. 
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2.2.9 Isolation HSV-1 genomic DNA 
HSV -1 infected cells were gently removed from the surface of 5 x 175 cm2 flasks using 
sterile glass beads. The cells were pelleted by centrifugation at 2000 rpm for 10 min. 
Extracellular virions were isolated by centrifugation of the supernatant at 12000 rpm for 
3 h. The supernatant was removed and the pellet resuspended in 2ml of TE. 40 ~l, 
0.25M EDTA; 25 ~l, 20% SDS; 50 ~l 20 mg mrl proteinase K was added, mixed gently 
and incubated at 50°C for 30 min. 100 ~14 M NaCI / 50 mM EDTA was added and the 
DNA gently phenol/chloroform extracted using cut pipette tips. The aqueous phase 
was subsequently dialysed against 2 litres TE overnight at 4°C and again for 2 h at room 
temperature. The samples were then stored at -20°C. 
2.2.10 Transient replication and packaging assays 
Single Round Transient Transfections 
Transfections were performed as described above. Six hours post transfection 
monolayers were superinfected with helper-virus at 3 p.f.u.lcell. The monolayers were 
incubated at 37°C, 5% CO2 for 45 min to allow the virus to adsorb then 2 ml of EC5 
was added and the mono layers incubated at 37°C, 5% CO2. The mono layers were 
generally harvested 16 h.p.i. and DNA prepared as described below. 
Serial Propagation of Amplicons 
Monolayers were transfected and superinfected as described above. 20 h.p.i. the 
supernatant was removed and extensively sonicated. Pairs of fresh mono layers were 
inoculated with 0.5 ml of supernatant together with 6 x 106 p.f.u. of wt HSV-1 and 
incubated for 1 h at 37°C, 5% CO2• The inoculum was removed and residual virus was 
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inactivated by washing with 2 ml 0.14 M NaCl and exposing to 0.1 M glycine, 0.14 M 
NaCl pH 3.0. After 1 min the cells were washed once with WASH, once with EC5, 
then incubated for 16 h at 37°C, 5% CO2 in 2 ml EC5 before being harvested and the 
DNA prepared as described below. One of each pair of mono layers had PAA added to 
a final concentration of200 ~g mr1 to prevent replication of the propagated amplicon. 
Preparation of total cellular DNA 
16 h.p.i. media was removed from transfected I superinfected monolayers, the 
mono layers washed with 2 ml TS, scraped into 1 ml TS and centrifuged for 4 min at 
3000 rpm. The cell pellets were then resuspended in 184 ~l RSB I 0.5% NP40 and 
incubated on ice for 10 min. 184 ~l of 2 x CLB, 0.5 mg mr1 protease was then added 
and the samples incubated for 2 h at 37°C. Samples were made up to 400 ~l with 
distilled H20, 32 ~l of 4 M NaCI/O.5 M EDTA was added, and sequentially extracted 
with phenol I chloroform : isoamyl alcohol, ethanol precipitated and resuspended in 
1 00 ~l TE containing 1 x RNase A mix. 
Preparation of DNase resistant DNA 
Harvested cells were divided into two aliquots. One aliquot was processed for total 
DNA as described above. The other aliquot had 200 ~g mr1 DNase I added to the RSB 
10.5% NP40 mix. After incubation at 37°C for 15 min the samples were treated as for 
total DNA except the samples were resuspended in 50 ~l TE I RNase A mix. 
Nuclear and Cytoplasmic fractionation 
Harvested cells were resuspended in 184 ~l RSB I 0.5% NP40 and incubated on ice for 
10 min. The sample were then centrifuged at 3000 rpm for 2 min to pellet the nuclei. 
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The supernatant, containing the cytoplasmic fraction, was transferred to a fresh 
eppendorf and the nuclei resuspended in a further 184 J.lI of RSB / 0.5% NP40. The 
samples were then processed for total or DNase resistant DNA as describe above. 
2.2.11 Southern Blotting (Southern, 1975) 
DNA samples representing the yield from 6.5 x 105 cells were digested with a suitable 
restriction enzyme in a 30 J.lI reaction. The reaction was stopped by the addition of 5 J.lI 
5 x loading dye and the samples loaded on a large 0.6 - 0.8% LB agarose gel containing 
0.5 mg mrl ethidium bromide and electrophoresed overnight at 15 - 30 V. A 
photograph of the gel was taken under long wave UV to confirm digestion had occurred 
and that all the lanes contained equivalent amounts of DNA. 
The gel was soaked in Gel Soak I for 45 min to denature the DNA. This was followed 
by shaking in Gel Soak II for 45 min to neutralise the alkali. The DNA was blotted onto 
a nitrocellulose membrane by capillary transfer in 6 x SSC for 16 h at room 
temperature. Crosslinking the DNA to the membrane was achieved by exposure to 120 
m] / cm UV light. The membrane was blocked by incubation in pre-hybridisation 
buffer for at least 2 h at 68°C. Specific bands were detected by incubating the 
membrane overnight at 68°C in 10 ml hybridisation buffer containing suitably nick-
translated DNA. Following 3 x 30 min washes in blotwash the membrane was exposed 
to a phosphorimager screen and analysed on a BioRad Personal FX FluorS 
Multilmager. 
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Preparation of radio-labelled DNA probes by nick-translation (Rigby et al., 1977) 
300 ng of DNA was incubated with 15 !J.Ci each of a 32 P dCTP and a 32 P dGTP 2 , 
units of DNA polymerase I and lxl0-7 mg DNase I at 16°C for 90 min in a final volume 
of30!J.1 of Ix NTB (containing 2!J.I each of 1 mM 'cold' dATP and dTTP). 
The reaction mix was made up to 100 !J.I with distilled H20 and extracted once with an 
equal volume of phenol. The aqueous layer was then fractionated though a G50 
Sephadex chromatography column to separate the radio-labelled probe from the 
unincorporated nucleotides. The fractions containing the probe were pooled and the 
volume made up to 1 ml with distilled H20 and the DNA denatured with 0.17 M NaOH. 
After 10 min the solution was neutralised by the addition of 0.17 M HCl. The probe 
was then added to 8.6 ml hybridisation buffer and used immediately. 
2.2.12 Western blotting 
35 mm Petri dishes of near confluent BHK21 cells were transfected or infected as 
described previously. 24 h.p.t. or 16 h.p.i. the cells were harvested and resuspended in 
100 !J.I boiling mix. The samples were then placed in a boiling water bath for 10 min 
and the proteins separated by SDS-PAGE. IO!J.I of sample was run on an 8% running 
gel (39:1 acrylamide to bisacrylamide) and a 5% stacking gel (19:1 acrylamide to 
bisacrylamide) at 150 V using a BioRad 'Mini-protean' kit. Using a BioRad transfer kit 
gels were blotted onto ECL compatible nitrocellulose (Amershan Pharmacia) for 16 hat 
4°C, 25 V in I x transfer buffer. Blotting was confirmed by the transfer of Rainbow 
marker onto the membrane. 
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The membrane was blocked in PBS, 0.05% Tween (PBST), 5% Marvel for 1 h. The 
primary antibody was diluted 1 :2500 in PBST, 5% Marvel. After 1 h incubation the 
blot had 3 x 5 min washes in PBST, 5% Marvel, before being incubated in a 1: 1000 
dilution of the secondary antibody (HRP conjugated protein A sepharose) for 30 min. 
Following 3 x 5 min washes in PBST and a final wash in PBS specific bands were 
detected by the addition of 1 ml ECL mix, for 1 min, and exposed to auto-radiographic 
film. 
2.2.13 Pulsed Field Gel Electrophoresis 
Preparation of DNase resistant DNA for PFGE 
35 mm Petri dishes of cells were scraped into 1 ml TS and centrifuged at 3000 rpm for 4 
min, the pellet resuspended in 184 ~l RSB, 0.5% NP40, 0.1 mg mr! DNase I and 
digested at 37°C for 15 min. The reaction was terminated by the addition of a one-third 
volume of 4 x CLB and gel loading buffer. The sample was gently mixed and a volume 
representing 6.5 x 105 cells was loaded directly onto a 1 % PFGE grade agarose, 0.5 x 
TBE gel. 
Preparation of agarose embedded cell suspensions 
2 x 106 BHK21 or Vero cells were transiently transfected or infected as described 
above. 24 h.p.t. or 16 h.p.i. cells were harvested and resuspended in 50 ~l cell 
suspension buffer and equilibrated to 50°C in a water bath. 50 ~l of BioRad 2% 
CleanCut Agarose was then added, mixed, and the cell suspension added to BioRad 
plug moulds. The suspension was then placed at 4°C to allow the agarose blocks to set. 
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Preparation of total cellular DNA from agarose blocks 
Agarose blocks were incubated overnight at 55°C in 0.5 ml Proteinase K reaction buffer 
containing I mg mrl Proteinase K. Blocks then had 4 x 30 min washes in 0.5 ml 1 x 
PFGE WASH and stored in 0.5 mIl x PFGE WASH. If the blocks were to be digested 
by restriction enzymes at a later stage the second wash contained I mM PMSF. 
Preparation of DNase resistant DNA in agarose blocks 
The agarose embedded cells were incubated at 37°C for 2 h in 0.5 ml RSB / 0.01 % 
NP40 followed by a 30 min incubation in 0.5 ml DNase reaction buffer. This was then 
replaced with fresh DNase reaction buffer containing 0.1 mg mrl DNase I. After 2 h 
incubation the blocks were incubated in 0.5 ml 0.5 M EDTA for 30 min followed by 30 
min in 0.5 ml Proteinase K reaction buffer. The buffer was replaced with fresh 
Proteinase K reaction buffer containing 1 mg mr! Proteinase K and placed on ice for 30 
min before being incubated overnight at 55°C. The blocks were then washed as 
described in the preparation of total DNA. 
Restriction enzyme digestion in agarose blocks 
Agarose blocks containing total or DNase resistant DNA, prepared as described above, 
were washed twice in 0.1 x PFGE WASH to reduce the EDTA concentration. One third 
of each block was incubated in 200 ).11 of the appropriate I x restriction buffer at 37°C 
for 30 min. The blocks were then digested for 4 - 16 h in 200 ).11 fresh buffer containing 
40 U of restriction enzyme. The blocks were washed twice in 0.5ml PFGE WASH 
before electrophoresis. 
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Electrophoresis and Southern blotting of PFGE samples 
One gram of PFGE grade agarose was melted in 100 ml 0.5 x TBE, allowed to cool to 
80°C and poured into the CHEF-DR II casting mould. One third of an agarose block 
was placed in each well of the gel ensuring there were no air bubbles. The wells were 
then sealed by filling with 1 % low melting point agar. The gel was then removed from 
the casting stand and placed in the CHEF-DR II electrophoresis tank containing 2 I of 
0.5 x TBE pre-cooled to 14°C. DNA was generally separated using a run parameter of 
6 V/cm for 16 h at 14°C with a ramped switch time of 1 - 15 sec. After electrophoresis 
the gel was stained for 20 min in distilled water containing 0.5 mg mrl ethidium 
bromide before being photographed. 
For Southern blotting the gel was soaked in 0.25 M HCI for 15 min, neutralised in Gel 
soak I for 15 min then treated as described above. 
2.2.14 Co-immunoprecipitation 
Each well of a 12 well plate was seeded with 6 x 105 Sf cells in 1 ml of TCI00 
complete medium and incubated overnight at 28°C. The cells were then single, double 
or triply infected with 5 p.f.u. / cell of the appropriate recombinant baculoviruses. 24 
h.p.i. the medium was replaced with 500 ~l mer TCI00 containing 30 ~Ci 35S-L-Met. 
After incubation for 16 h at 28°C the cells were scraped into the media and centrifuged 
at 6000 rpm for 1 min. The supernatant was removed and the cell pellet washed twice 
in ice cold, unsupplemented TCI00. The pellets were resuspended in 150 ~l of Buffer 
E with 1 ~l of 0.5 M PMSF added freshly to the buffer. The sample was then incubated 
on ice for 20 min with occasional vortexing. Before proceeding a 15 ~l sample was 
removed to represent the total protein fraction. 
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The samples were centrifuged at 35000 rpm for 20 min in a benchtop ultracentrifuge 
pre-chilled to 4°C. The supernatant was removed and the pellet discarded. 15 III of the 
supernatant was removed to represent the soluble protein fraction. A predetermined 
amount of the appropriate antibody was added to the remainder of the sample and the 
samples incubated on an end-over shaker for 2 h at 4°C. 50 III of a 50% (v/v) Protein A 
/ Buffer E solution was added to the sample and incubated for a further 60 min at 4°C. 
The protein A and any bound protein was pelleted by centrifugation at 4°C and washed 
in Buffer E for 3 min, while kept on ice. This washing procedure was repeated three 
times. Prior to the final wash the pellet was transferred to a fresh tube. 
The pellet was then resuspended in 30 III sample buffer and incubated at 100°C for 5 
min. The Protein A was pelleted and 15 III of the sample was loaded onto an 8% SDS-
P AGE gel along with the total and soluble protein fractions. The gel was subsequently 
dried and exposed to a phosphorimager screen and analysed using the BioRad Personal 
FX FluorS MultiImager. 
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3.1 Comparison of wt, ambUL12 and ambUL12R 
3.1.1 Introduction 
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Several HSV -1 mutants with lesions in the UL 12 gene, which fail to produce a 
functional alkaline nuclease, have been constructed (Weller et ai., 1990; Martinez et ai., 
1996; Gao et ai., 1998). These UL12 null mutants (nuc mutants) are reported to 
synthesise near wt levels of viral DNA but produce mature, infectious progeny 
inefficiently, yielding only 0.1 - 1 % as much viable virus as wt HSV -1 (Shao et al., 
1993). 
The HSV -1 strain 17 syn + UL 12 null mutant, amb UL 12, which contains a stop codon 
after amino acid 129 (downstream of both the UL12 and UL12.5 ATG codon), and was 
used throughout these studies, was reported to have similar properties (Patel et ai., 
1996). In this section the phenotypes described above were confirmed for the 
ambUL12 virus and the characterisation of the mutant extended. A phenotypically wt 
virus, ambUL12R, generated by marker rescue of ambUL12 with a fragment containing 
only the UL12 gene (Patel et ai., 1996) was compared to demonstrate that the amber 
nonsense mutation introduced into ambUL12 is responsible for the altered properties of 
the mutant virus. 
3.1.2 Single step growth curves ofwt HSV-l, ambUL12 and ambUL12R 
Single step growth curves were used to compare the ability of ambUL12, the marker 
rescued virus, ambUL12R, and wt HSV-1 to produce viable virus over a single round of 
infection. 
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Stocks of ambUL12 were prepared and titrated on S22 cells, a Vero derived cell line 
containing the HSV -1 EcoRI D fragment (which encodes the complete ORFs of UL8 _ 
ULI4) that is permissive for the propagation of ambUL12 (Carmichael et al., 1988; 
Carmichael and Weller, 1989; Patel et al., 1996). Replicate 35 mm plates of S22, BHK 
and Vero cells were infected with 3 p.f.u. / cell of each of the viruses. At various times 
infected cells were scraped into the media and sonicated to lyse the cells. The samples 
were titrated on S22 cells and the yield of progeny virus for each sample established 
(Figure 1). 
Throughout the time course, wt HSV-I and ambUL12R produced similar titres of virus 
in each of the three cell lines. However, in BHK and Vero cells the growth of 
ambUL12 was clearly impaired. By 24 h.p.i. the titre was reduced approximately 700-
fold in Vero cells and 300-fold in BHK cells compared to wt and ambUL12R. The 
reduced yield of the UL 12 null mutant in Vero cells is similar to that previously 
reported (Weller et al., 1990; Shao et al., 1993 and Patel et al., 1996). The experiment 
shown in Figure 1 demonstrates a comparable impairment also occurs in BHK cells. 
Moreover, the plaques produced in ambUL12 infected BHK and Vero cells were very 
small and easily distinguishable from the plaques produced by wt HSV -1. 
The Vero derived S22 cell line partially complements the ambUL12 defect but the yield 
of ambUL12 in this cell line was still reduced 6 - 8 fold compared to wt HSV-l and 
ambUL12R (Figure 1; Patel et al., 1996). The failure of ambUL12 to grow to wt titres 
in S22 cells may result from the poor expression of alkaline nuclease in these cells. In 
S22 cells the UL 12 ORF is under the control of its own promoter and should be induced 
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Figure 1- One step growth curves ofwt HSV-l , ambUL12 and ambUL12R. 
35mm plates of BHK, Vero or S22 cells were infected at 3 p.f.u / cell. At the time 
points indicated the cells were scraped into the media, sonicated and subsequently 
titrated on 35mm plates of S22 cells. 72 h.p.i . the infected monolayers were 
stained with Giemsa stain and the plaques counted. 
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upon infection with ambULl2. However, western blots of ambUL12 infected S22 cells 
show that expression of UL12 is either undetectable (Weller et al., 1990) or is 
significantly reduced compared to wt (Patel et al., 1996). A second complementing cell 
line (6-5 cells) derived from Vero cells containing only the UL12 ORF was developed 
(Shao et al., 1993). Upon infection with a nuc mutant 6-5 cells were shown to express 
30-fold higher levels of the nuclease than S22 cells. Despite the increased expression of 
the nuclease, complementation of the nuc mutant was only slightly better than that 
observed in S22 cells. Two possible reasons were suggested for the incomplete 
complementation in the 6-5 cells: firstly, the nuclease requires to be expressed at some 
threshold level not yet reached in these cells and secondly, the temporal and spatial 
expression of the nuclease may be altered. Although complete complementation is not 
seen with either cell line they still enable sufficient virus to be obtained for experimental 
purposes. 
3.1.3 Expression of the UL12 product in wt HSV-l, ambUL12 and ambUL12R infected 
cells 
To confirm that ambUL12 failed to synthesise the alkaline nuclease protein and that 
synthesis had been restored in ambUL12R a western blot of infected BHK cells was 
performed. 35 mm plates of BHK cells infected with 3 p.f.u. / cell were harvested 16 
h.p.i. and lysates from one fifth of a plate were separated on an 8% SDS-PAGE gel. 
The UL 12 protein was detected on the blotted gel using monoclonal antibody Q 1, which 
reportedly recognises an epitope within the first 126 a.a. of UL12 (Costa et al., 1983; 
Patel et al., 1996) and polyclonal antibody BwP12 (Bronstein and Weber, 1996). 
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As shown in Figure 2, alkaline nuclease was readily detected in both the wt HSV -1 and 
ambUL12R samples using either antibody. In addition to the 85 kDa band 
corresponding to the full length protein (Banks et al., 1983) there are a number of other 
major bands, also reported by Patel et al. (1996) and Gao et al. (1998), which most 
likely represent breakdown products of the protein. In contrast no bands could be 
detected in the ambUL12 samples. 
3.1.4 Levels of DNA replication and packaging III wt HSV-l, ambUL12 and 
ambUL12R infected cells 
Previous studies of alkaline nuclease mutants indicated that the levels of viral DNA 
synthesis were similar to wt (Weller et al., 1990) or slightly reduced (Shao et ai., 1993; 
Patel et al., 1996) and that encapsidation of viral DNA was unaffected (Shao et ai., 
1993). The amount of viral DNA synthesised and packaged by wt, ambUL12 and 
ambUL12R in BHK and Vero cells was analysed by Southern blotting. 
Vero and BHK mono layers were infected with 3 p.f.u. / cell wt HSV-l, ambUL12 or 
ambUL12R and harvested 16 h.p.i .. Whole cell extracts (Figure 3A) or separate nuclear 
and cytoplasmic fractions (Figure 3B) were prepared and processed for total and DNase 
I resistant DNA. Samples were cleaved with BamHI and Southern blots hybridised to a 
32p labelled pGX153 probe, which detects the HSV-l BamHI P fragment located in UL. 
The membranes were exposed to a phosphorimager screen and an image captured using 
a BioRad Personal Molecular Imager. The radioactivity present in the bands was 
quantified using the band analysis function of the Quantity One software supplied by 
BioRad. 
74 
A 
B 
97kDa> 
66kDa> 
47kDa> 
97kDa> 
66kDa> 
47kDa> 
M wt amb 12R 
Monoclonal Ab: Q 1 
M wt amb 12R 
Polyclonal Ab: BwP12 
Figure 2 - Western blots of infected BHK cells. 
Monolayers of BHK cells were infected with 3 p.f.u. I cell wt HSV-l(wt), 
ambUL12 (amb) and ambUL12R (12R) or mock infected (M). Samples were 
harvested 16 h.p.i. and resuspended in 50 ~l of boiling mix. After incubating at 
100°C for 10 min, duplicate 1 0 ~l samples were separated on 8% SDS-PAGE gels . 
The gels were blotted and the membranes reacted with (A) monoclonal Ab: Q lor, 
(B) polyclonal Ab: BwP12. Protein A conjugated HRP was used to detect bound 
antibody, and in tum was detected by EeL. The blot was exposed to 
autoradiographic film. The positions of molecular weight markers (Rainbow 
markers) are shown. 
Chapter 3,' Results 
Compared to wt HSV-1 and ambUL12R the level of DNA synthesis in the ambUL12 
samples was reduced in both cell lines by approximately 2 to 3-fold (Figure 3a, upper 
panel and Figure 3b). This result is in broad agreement with previous results that show 
up to a 50% reduction in DNA synthesis for the AN-1 mutant in Vero cells (Shao et al., 
1993). The amount of DNA packaged in ambUL12 infected cells was reduced 
approximately 7-fold and 13-fold in Vero and BHK cells, respectively, when compared 
to wt HSV-1 and ambUL12R. This contrasts with published results which suggest that 
packaging of viral DNA is unaffected in the nuc mutants and the main block is in the 
egress of capsids from the nucleus into the cytoplasm (Shao et al.,1993). Figure 3B 
does demonstrate that DNase-resistant ambUL12 DNA was detected in the cytoplasm in 
lower amounts than wt HSV-l or ambUL12R but it cannot be concluded whether this is 
due to an additional defect in the nuclear egress processes, or is merely a reflection of 
reduced packaging in the nucleus. 
3.2 Further examination of replication and packaging in wt and ambUL12 infected 
cells 
3.2.1 Introduction 
The above experiments established that the amber nonsense mutation in ambUL12 
results in inefficient growth of the virus, due at least in part to a defect in the ability of 
the virus to package viral DNA. In addition, marker rescue can restore the virus to a wt 
phenotype. To quantify the effect of the mutation in greater detail replication and 
packaging of ambUL12 and wt HSV-1 were compared in repeat experiments (at least 3) 
in BHK and Vero cells. In addition FG293 cells were also used. 
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Figure 3 - Replication and packaging ofwt, ambUL12 and ambUL12R. 
(A) 35 mm plates of Vero and BHK cells were infected with wt, ambUL12 (amb) 
and ambUL12R (12R) at 3 p.f.u / cell. Cells were harvested 16 h.p.i. and processed 
for total DNA (upper panel) and DNase resistant DNA (lower panel). (B) 35 mm 
plates of BHK cells were infected with wt, ambUL12 and ambUL12R at 3 p.f.u / 
cell. Cells were harvested 16 h.p.i. , split into nuclear (nuc) and cytoplasmic (cyt) 
fractions and processed for total (-) and DNase resistant DNA (+). Samples 
representing 1/6 of a plate (A) or 1112 of a plate (B) were digested with Bam HI, 
separated on a 0.8% LB-agarose gel and Southern blotted. The membranes were 
probed with 32P-Iabelled plasmid pGX153 , exposed to a phosphorimager screen and 
analysed using a BioRad Personal Molecular Imager. 
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3.2.2 Effect of cell line on replication and packaging of ambUL12 
S22, Vero, FG293 and BHK monolayers were infected with 3 p.f.u. / cell wt HSV-1 or 
ambUL12. Nuclear and cytoplasmic fractions were prepared 16 h.p.i. and processed for 
total or DNase resistant DNA. Samples representing 1112 of a plate were digested with 
BamHI, Southern blotted and probed with pGX153. The panels in Figure 4 represent 
typical results for each of the four cell lines, and quantitative data were obtained from 
the nuclear fraction of at least three separate experiments (Table 1). The data is 
presented as the counts in the wt bands divided by the counts in the corresponding 
ambUL12 bands (± SD) for total nuclear and DNase resistant nuclear DNA. 
Table 1. Decrease in replication and packaging of ambUL12 compared to wt. 
Total nuclear DNA DNase resistant DNA 
Cell line wt/ambUL12c wtlambUL12c 
S22a 1.66 ± 0.47 6.1 ±2.17 
Veroa 2.83 ± 2.34 16.5 ± 8.64 
BHKb 3.20 ± 1.92 18.85 ± 10.96 
FG293a 1.58 ± 0.52 15.45 ± 8.76 
an = 4 for S22, Vero n = 3 for FG293 celis, where n = number of individual experiments. 
b n = 11 for replicated DNA and n = 15 for packaged DNA 
c Replication and packaging efficiency calculated as the ratio ofwt counts 7 ambUL12 counts ± SD. 
From these results it can be seen that viral DNA synthesis was reduced to a small extent 
in each cell line, with a reduction of less than 2-fold in S22 and FG293 cells and 
approximately a 3-fold reduction in Vero and BHK cells. Clearly a more significant 
defect in ambUL12 is in the packaging of DNA. Again, the S22 cell line shows 
inefficient complementation with packaging being reduced by 6-fold. Vero, FG293 and 
BHK cells all show reductions in DNA packaging of approximately 15 to 20-fold. 
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Figure 4 - Effect of cell line on replication and packaging of ambUL12 
35mm plates of S22 (A), Vero (B), FG293 (C) and BHK (D) cells were infected at 
3 p.f.u. / cell. Cells were harvested 16 h.p.i., split into nuclear and cytoplasmic 
fractions and processed for total and DNase resistant DNA. Samples representing 
1112 of a plate were digested with BamHI, separated on a 0.8% LB-agarose gel and 
Southern blotted. The membrane was probed with 32P-Iabelled plasmid pGX1S3. 
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The ability to detect viral DNA in the cytoplasm also appears to be cell type dependent 
(Figure 4). Vero and FG293 cells showed a similar reduction in nuclear packaging 
efficiency but DNase-resistant DNA could be clearly detected in the cytoplasm of only 
FG293 cells. Although cytoplasmic DNase-resistant DNA is not detectable in Figure 
4B this was not always the case (e.g. Figure 3B). Further examination of the samples in 
Figure 4 show that a proportion of cytoplasmic DNA was sometimes DNase sensitive 
(Figure 4: Vero, wt HSV-l; FG293, ambULI2). The most likely explanation for this is 
contamination of the fraction with small amounts of nuclear DNA from lysed or 
damaged nuclei. 
3.2.3 Time course of viral DNA synthesis and packaging 
Bacteriophage T4 has two distinct phases of viral DNA replication. An initial origin-
dependent replication phase is inactivated and followed by recombination-dependent 
replication initiation at later stages of infection (Luder and Mosig, 1982; Mosig, 1998). 
Recombination-deficient T4 mutants can initially replicate viral DNA with wt 
efficiency. However at later times in infection replication is inhibited as recombination-
dependent replication initiation is implemented (Mosig et al., 1995). Endonuclease VII 
(Endo VII), encoded by phage T4, is known to resolve Holliday and Y -Junctions. The 
role of Endo VII is to remove branched DNA prior to packaging, and mutations in this 
gene cause branched structures to remain umesolved resulting in inhibition of 
replication and packaging. 
It is also known that HSV -1 nuc mutants produce branched high molecular weight 
(hmw) DNA intermediates that are structurally more complex than those found in wt 
HSV -1 infected cells (Martinez et al., 1996a). In these experiments high molecular 
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weight DNA isolated from infected cell lysates was digested with restriction enzymes 
which cut only once or twice per genome. A small proportion of DNA was released 
into the pulsed field gel with wt HSV -1 but not the nuc mutant samples suggesting that 
the alkaline nuclease is also involved in resolving branched structures. However, the 
inability of purified alkaline nuclease to resolve synthetic cruciforms and Y -junctions in 
vitro suggests that the UL12 product may not function in the same way as en do VII 
(Goldstein and Weller, 1998b). It is, nevertheless, possible that early in infection HSV-
1 nuc mutants replicate their DNA similarly to wt HSV -1, but as complex DNA 
intermediates are formed viral DNA synthesis and packaging is inhibited. To determine 
if this is the case a time course of viral DNA synthesis and packaging was performed. 
35 mm plates of Vero cells were infected with 3 p.f.u. / cell wt HSV-l or ambULl2. 
After 1 h incubation at 37°C the mono layers were washed with "acid glycine" to 
inactivate any unabsorbed virus. Cells were harvested at 0, 6, 8, 12 and 24 h.p.i., total 
and DNase resistant DNAs were prepared, digested with BamHI and hybridised to 
radiolabelled pGX153 which detects the HSV-l Bam HI P. The number of counts in 
each band of the Southern blot in Figure 5a was determined by phosphorimager and 
represented graphically (Figure 5b). It is apparent that from the earliest time point 
ambUL12 synthesises and packages viral DNA less efficiently than wt. The 12 and 24 
h.p.i. time points also support earlier results (Table 1), with ambUL12 samples showing 
a 3-fold drop in replication and a 13 - 24-fold drop in packaging compared to wt HSV-
1. From Figure 5c it can be seen that at all times during infection wt HSV -1 has 
encapsidated approximately the same proportion of replicated DNA. The same is true 
for ambUL12 although only 5 - 10% of the replicated DNA is packaged compared to 35 
- 50% for wt HSV-l. 
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Figure 5 - Time course of viral DNA synthesis and encapsidation in wt and 
ambUL12 infected Vero cells. 
(A) Vero cells were infected with 3 p.f.u. / cell wt or ambUL12. At the time points 
shown cells were harvested and whole cell extracts were processed for total and 
DNase resistant DNA. Samples were then treated as described in Figure 3. (B) The 
counts in each band of (A) were plotted against h.p.i . (C) For each time point the 
data is represented as the percentage of total DNA which was DNase resistant. 
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3.3 Pulsed Field Gel Analysis of replicated and packaged ambUL12 DNA 
3.3.1 Introduction 
Conventional agarose gel electrophoresis can routinely resolve only DNA fragments up 
to - 40 kbp in size. By cyclically changing the orientation of the electric field around a 
gel, Pulsed Field Gel Electrophoresis (PFGE) enables resolution of DNA fragments up 
to 2000 kbp in size (Schwartz and Cantor, 1984; Wagner and Lai, 1994). 
A number of studies have made use of PFGE to investigate the structures of HSV-l 
DNA replication intermediates (Severini et al., 1994; Zhang et al., 1994; Severini et al., 
1996) including those of nuc mutants (Martinez et ai., 1996a; Goldstein and Weller, 
1998). Therefore, it was important to develop PFGE techniques in the laboratory to 
analyse the replication intermediates and cleavage / packaging products of ambULl2. 
3.3.2 Establishment of PFGE run parameters 
All PFGE experiments were performed on a Chef-DR II Pulsed Field Gel 
Electrophoresis System from BioRad. This system allows a wide degree of flexibility 
in the size ranges of molecules that can be separated so it was necessary to define 
parameters that would be useful for the present work. The following equation (Ausubel, 
1999) was used to determine parameters for resolution: 
Maximum well-resolved sizeQ (kbp) = 0.034 x (T + 40) x Vl.l x (3 - A)O.6 x to.875 
Where T = temperature in °C; V = volts / cm; t = longest pulse time in sec; A = % 
agarose. 
Q Resolution is poor above this size. 
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For example a gel run with the following parameters: T = 14°C, V = 6 v / cm, t = 15 
sec, A = 1 % will resolve fragments up to 213 kbp. Increasing the switch time gradually 
to t during the course of the electrophoresis alters the separation of the fragments within 
the resolvable range. 
To test the resolution, five ~g of BioRad 5 kbp ladder and 5 x 5 x 1 mm agarose blocks, 
containing approximately 5 ~g of BioRad lambda ladder (48.5 kbp ladder), were loaded 
into the pulsed field gel. With voltage, run time, temperature and agarose percentage 
kept constant at 6 v / cm, 16 h, 14°C, and 1% agarose throughout, two sets of switch 
times were identified as being most useful (Figure 6). A linearly ramped switch time of 
1 - 50 sec allowed very large fragments, up to 800 kbp, to be resolved, suitable for 
analysing hmw replication intermediates. In contrast, a switch time of 1 - 15 sec could 
separate fragments up to only 250 kbp, more useful for investigating the mobility of 
encapsidated DNA molecules. 
3.3.3 Preparation of agarose embedded cellular DNA 
To avoid shearing of hmw DNA, infected cells were embedded in agarose and 
manipulated in situ, essentially using the protocols supplied by the CHEF-DR II 
manufacturer (BioRad) and described in detail in Methods. 
3.3.4 PFGE time course of infection 
It is generally accepted, although not conclusively demonstrated, that HSV -1 DNA is 
replicated via a rolling circle mechanism that gives rise to hmw replication 
intermediates. In addition branched structures are generated through homologous 
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Figure 6 - Run parameters for PFGE. 
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1% PFGE grade agarose gels were loaded with 5/-l1 of 5 kbp ladder (5 kbp) or 5 x 5 
xl mm agarose blocks of BioRad 48.5 kbp lambda ladder (A. ), each containing 
approximately 5 ug of DNA. (A) Run parameters: 6 v / cm, 16 h, 14°C, 1% agarose, 
linearly ramped switch time of I - 50 sec. (B) Run parameters: 6 v / cm, 16 h, 
14°C, 1 % agarose, linearly ramped switch time 1 - 15 sec. 
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recombination events. This complex, concatemeric DNA IS then cleaved into 
monomeric molecules which are packaged into viral capsids. The formation of hmw 
replication intermediates and successive appearance of unit length genomes can be 
monitored using PFGE (Severini et al., 1994). 
In order to compare wt HSV-l and ambUL12 replicative intermediates, monolayers of 
Vero cells were infected with 3 p.f.u. / cell wt HSV-l or ambULl2. The cells were 
harvested at 0, 2, 4, 6, 8, 12 and 24 h.p.i. and embedded in agarose blocks as described 
in methods and processed for total cellular DNA. The DNA was fractionated using the 
conditions described by Severini et al. (1994): 1 % PFGE grade agarose, 6 v / cm for 18 
h at 14°C in 0.5 x TBE using pulse times from 2 - 70 sec, increasing linearly. The gel 
was then Southern blotted and probed with radiolabelled pGX153. 
Figure 7 shows that in the wt HSV -1 samples monomeric units were detected at 0 h.p.i., 
representing the input genomes. Severini et al. (1994) report the disappearance of this 
input band until 8 h.p.i. suggesting that circularisation of the genome causes altered 
migration. The continued low-level presence of these bands in the 2 and 4 h.p.i. 
samples could be accounted for by the presence of virus that has not been uncoated. 
Reduction of this residual band could possibly have been achieved by acid-glycine 
washing of the cells after infection. In agreement with Severini et al. hmw DNA, which 
failed to enter the gel, was detected by 4 h.p.i. and steadily increased in amount as 
infection progressed. However, there was no significant increase in the level of 
monomeric DNA until 6 h.p.i., demonstrating that the viral DNA probably has to go 
through a hmw intermediate before cleavage into unit length genomes. In the ambUL12 
samples hmw intermediates also increased steadily with time. However, in contrast to 
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Figure 7 - Analysis ofwt HSV-l and ambUL12 DNA replication by PFGE. 
Vero monolayers were infected at 3 p.f.u. / cell. The cells were harvested 0,2, 4, 6, 
8, 12 and 24 h.p.i. , embedded in agarose blocks and total DNA was prepared in situ. 
5 x 3 x 1 mm blocks, representing 113 of a plate, were loaded into a 1 % 0.5 x TBE-
agarose gel. The DNA was separated at 6 v / cm for 18 h at 14°C in 0.5 x TBE 
using pulse times from 2 - 70 sec, increasing linearly. The gel was pre-soaked in 
0.25M HCI for 15 min, Southern blotted and probed with radiolabelled pGX153 . 
The positions of HSV -1 genomic DNA, the highest resolved marker band (800 kbp) 
and the wells of the gel are indicated. 
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wt HSV-l, very little unit length genome was generated and at 24 h.p.i. approximately 
10-fold less linear DNA had migrated into the gel. 
Since cleavage and packaging are so closely linked it is reasonable to surmise that the 
unit length DNA represents encapsidated genomes. Therefore, this experiment suggests 
that packaged ambUL12 DNA is predominantly unit length, although further studies 
will be required to confirm this. In agreement with previous experiments cleavage / 
packaging of ambUL12 is clearly less efficient than wt HSV-l. Figure 7 shows that the 
12 and 24 h.p.i. wt HSV-l samples contain a large amount of cleaved DNA that 
migrates slower than unit length genomes. This effect was also observed by Severini et 
al. (1994) and Zhang et al. (1994), and is most probably a result of retarded migration 
caused by overloading of the gels with genome length molecules. 
3.3.5 Structure of ambUL12 DNA 
To investigate the structure of replicated ambUL12 DNA, restriction digest patterns of 
total DNA from infected cells were examined. 
BHK cells were infected with 3 p.f.u. / cell wt HSV-l or ambULl2. The cells were 
harvested 16 h.p.i. and embedded in agarose plugs. Total cellular DNA was prepared in 
situ and one third of each plug, corresponding to 6.5 x 105 cells, was incubated with 
XbaI, HindIII or left undigested. The DNA was then separated in a 1% PFGE grade 
agarose / 0.5 x TBE gel at 6 v / cm for 16 h at 14°C in 0.5 x TBE buffer using pulse 
times from 1 - 15 sec, increasing linearly. The gel was then Southern blotted and 
hybridised to radiolabelled HSV -1 genomic DNA (Figure 8). 
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Once again undigested wt HSV-l DNA produced a major band at 150 kbp 
corresponding to released, unit length genomes and a "well" band where hmw DNA had 
failed to enter the gel. XbaI digestion of wt HSV -1 DNA is expected to produce seven 
bands of approximately 55, 36, 34, 29, 28, 25 and 11 kbp. Examination of the wt 
HSV -1 XbaI sample shows distinct 11 and 55 kbp bands and an intense band which falls 
within the sizes of the expected 25, 28 and 34 kbp bands. There are another three 
predicted bands of 84, 65 and 47 kbp that corresponds to XbaI restriction fragments 
between two head-to-tail molecules within a concatemer. The 84 and 65 kbp bands are 
clearly visible and the 47 kbp band is probably a constituent of the intense band 
described above. 
In contrast to wt HSV-I, the undigested ambULI2 sample contained no detectable full 
length ambULI2 genomes and the XbaI digested ambULI2 sample generated only a 
single smeared band that fell within the size range of the 24, 25 and 34 kbp bands, 
failing to produce discrete bands at 10, 55 and 65 kbp. The lack of detectable genome 
length molecules in ambUL12 samples was not uncommon and further emphasises the 
cleavage / packaging defect of the virus. 
HindIII digestion of wt HSV -1 samples produced the expected fragments from 
concatemeric DNA molecules, ranging from 4 - 40 kbp whereas ambULI2 produced a 
very smeared restriction pattern with the 34, 36 and 40 kbp bands underrepresented in 
comparison to the other bands. In both wt HSV-I and ambULI2 samples there was a 
substantial amount of DNA that failed to leave the wells of the gel. 
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Figure 8 - Restriction enzyme digestion of agarose embedded viral DNA. 
35 mm BHK plates were infected with 3 p.f.u. / cell wt HSV-l (wt) or ambUL12 
(amb). Cells were harvested 16 h.p.i. and embedded in agarose blocks. Total DNA 
was prepared in situ. As indicated one third of each block was digested with XbaI , 
HindIII or left undigested. The samples were then separated by PFGE using the 
following parameters: 1 % PFGE grade agarose, 0.5 x TBE gel at 6 v / cm for 16 h 
at 14°C in 0.5 x TBE buffer using pulse times from 1 - 15 sec, increasing linearly. 
The gel was stained with ethidium bromide, photographed and Southern blotted. 
The membrane was then probed with 32p labelled HSV -1 genomic DNA. The 
positions of molecular markers (BioRad 5 kbp ladder) are indicated. 
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No conditions could be established to fully remove this "well" DNA, even using the 
restriction enzyme BamHI which cut the HSV -1 genome up to 42 times. This could 
suggest that a proportion of HSV -1 replication intermediates contain structures that are 
not accessible to restriction enzymes. However this seems unlikely because complete 
digestion of well DNA has been reported by other investigators (Martinez et al., 1996a) 
and digestion of samples obtained by phenol chloroform extraction produce DNA that is 
able to migrate from the wells in conventional agarose gel electrophoresis. Therefore, it 
is more likely that Proteinase K was not completely removed from the agarose blocks or 
the restriction enzymes were not given adequate opportunity to fully diffuse into the 
agarose blocks. Nevertheless, it is clear from these results that ambUL12 DNA is 
structurally different from wt HSV -1 DNA, perhaps containing more single stranded 
nicks or branched structures. In addition it shows that ambUL12 fragments greater than 
~ 1 0 kbp do not run as discrete bands and appear to be underrepresented compared to 
smaller bands (e.g. the 5 kbp band in lanes 5 and 6). 
3.3.6 Restriction digest patterns of DNA purified from extracellular virions 
A major defect in nuc mutants was reported to be in the egress of DNA containing 
capsids into the cytoplasm, possibly because of capsid instability due to the insertion of 
incorrectly processed DNA (Shao et al., 1993). However, nuc mutants do produce a 
small amount of viable virus in non-complementing cells and it might be expected that 
the DNA in these virions would be fully processed and indistinguishable from that of wt 
HSV-l. 
To investigate the structure of ambUL12 DNA in extracellular virions 175 cm
2 
flasks of 
Vero and BHK cells were infected with 0.01 p.f.u. / cell wt HSV-l or ambUL12. Three 
84 
Chapter 3: Results 
days post infection the cells were suspended in the media and pelleted by centrifugation. 
Extracellular virions were isolated as described in Methods and DNA prepared. The 
DNA concentration of each of the samples was estimated from ethidium bromide 
stained agarose gels and the size of the isolated DNA was determined by PFGE. 0.5 J.lg 
samples of DNA were digested with either XbaI or HindIII or left undigested and 
sUbjected to PFGE. The gel was Southern blotted and the membrane hybridised to 
radio labelled HSV -1 genomic DNA (Figure 9). 
The undigested samples in both BHK and Vero cells produced a distinct band of 150 
kbp corresponding to full size, packaged genomes. Also, in contrast to the results of 
3.3.5, both wt HSV-l and ambUL12 samples digested with XbaI or HindIII produced 
distinct restriction fragments of the expected sizes. This experiment indicates that the 
DNA present in released ambUL12 virions has a similar structure to that ofwt HSV-l. 
3.3.7 S 1 nuclease digestion of DNA purified from extracellular virions. 
Studies by Wilkie (1973) and Frenkel and Roizman (1972) showed that DNA within 
HSV -1 particles contained a number of nicks, although the number and distribution of 
the nicks was disputed. Frenkel and Roizman demonstrated that there were seven 
unique nicks whereas the results of Wilkie indicated that alkali labile sites were 
randomly distributed throughout the genome. Since the presence of single stranded 
nicks within the HSV -1 genome has implications for the mechanisms of replication and 
packaging of the genome, their frequency in the wt HSV-l and ambUL12 genomes was 
compared by digesting genomic DNA samples with S 1 nuclease, which cuts single 
stranded DNA. 
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Figure 9 - Restriction digest patterns of DNA purified from extracellular 
VIrions. 
175cm2 flasks ofBHK (A) or Vero (B) cells were infected with 0.01 p.f.u. I cell wt 
HSV-l (wt) or ambUL12 (amb). DNA was extracted from extracellular virions 
three days post infection. As indicated 0.5 ~g of each sample was digested with 
XbaI, HindlII or left undigested. The DNA was separated on 1 % PFGE grade 
agarose I 0.5 x TBE gel at gel at 6 v I cm for 16 h at 14°C in 0.5 x TBE buffer using 
pulse times from 1 - 15 sec, increasing linearly. The gel was Southern blotted and 
the membrane hybridised to radiolabelled HSV -1 genomic DNA. The positions of 
selected bands from a 5 kbp ladder, supplied by BioRad, are indicated. 
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Extracellular virion DNA, obtained from Vero and BHK cells described in section 
3.3.6, was used to compare the number of single stranded nicks in packaged wt HSV-l 
and ambUL12 DNA. 0.5 ~g of DNA was digested with 10 U of SI nuclease in a final 
volume of 30 ~l with 1 x SI nuclease buffer (0.15 M NaAc pH 4.5, 0.5 M NaCl, 25mM 
ZnS04). The DNA was then separated by PFGE using the run parameters described in 
section 3.3.6, Southern blotted and the membrane hybridised to 32p labelled HSV-l 
genomic DNA. 
Figure 10 ahows that S 1 digestion of packaged DNA from wt HSV -1 produces 
fragments that are evenly distributed between the bottom of the gel (~3 kbp) and 20 
kbp. The SI fragments generated from the digestion of ambUL12 DNA was very 
similar in the BHK samples and was practically indistinguishable from wt HSV -1 in the 
Vero samples. This supports the results from section 3.3.6 that the DNA from 
extracellular ambUL12 virions is very similar to wt HSV-l. 
Since no buffer was supplied with the enzyme, SI nuclease buffer was made in the 
laboratory. To ensure the buffer did not contain any contaminating nucleases Ix SI 
buffer and 0.5 ~g of viral DNA were mixed and incubated at 37°C for 1 hr. As can be 
seen in Figure lOA (lanes 2 and 5), no degradation of genomic DNA occurred when 
compared with undigested samples. 
3.4 Determination of the size of packaged ambUL12 DNA using PFGE 
3.4.1 Introduction 
Section 3.3.4 demonstrated that ambUL12 was able to cleave and presumably package 
unit length genomes, although at reduced levels compared to wt HSV -1. However the 
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Figure 10 - SI nuclease digestion of DNA purified from extracellular virions. 
Approximately 0.5 ~g samples of the DNAs described in section 3.3.6 were left 
undigested (-), incubated with 1 x S 1 buffer alone (b) or with IOU of S 1 nuclease 
in 1 x S 1 nuclease buffer (S 1). After incubation at 37°C for 1 hr the samples were 
separated by PFGE. The gel was Southern blotted and the membrane hybridised to 
radiolabelled HSV -1 genomic DNA. The migration of selected bands from a 5 kbp 
ladder, supplied by BioRad, are indicated. 
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DNA used in that experiment was obtained from total cell extracts. To confirm that 
encapsidated DNA present in the nucleus of ambUL 12 infected cells migrated with a 
similar mobility to wt HSV-l, PFGE analysis of DNase-resistant DNA was performed. 
3.4.2 Preparation of DNase-resistant DNA by the gentle lysis method 
35 mm plates of Vero cells were infected with 3 p.f.u. / cell wt HSV-l, ambUL12 or 
ambUL12R and harvested 16 h.p.i. The cells were harvested, nuclei prepared and 
incubated in 184 ~l RSB, 0.5 % NP40, 0.1 mg mr! DNase for 15 min at 37°C. 184 ~l 
4xCLB / loading buffer (1: 1) was then added. To minimise shearing of the DNA no 
phenol/chloroform extraction was performed and 1 00 ~l of each sample was loaded 
directly onto a 1 % PFGE grade agarose / 0.5 x TBE gel. Samples were separated at 6 v 
/ cm for 16 h at 14°C in 0.5 x TBE buffer using pulse times increasing from 1 - 15 sec. 
The gel was Southern blotted and hybridised to 32p labelled wt HSV -1 genomic DNA. 
From Figure 11 it is evident that wt HSV-l and ambUL12R produced considerable 
amounts of genome size DNA that is resistant to DNase digestion. However, ambUL12 
produced significantly less DNase-resistant DNA and this appeared to exhibit an 
increased and more heterogeneous mobility (size range of 130 - 150 kbp). This 
experiment initially suggests that a significant proportion of packaged ambUL12 DNA 
may be slightly smaller than genome length. However, it is possible that the change in 
mobility of these molecules may be due to other factors, such as the presence of 
branched structures and not an actual change in length of the packaged molecules. It is 
also possible that ambUL12 DNA is more fragile than wt HSV-l DNA and that portions 
of the genome are susceptible to mechanical shearing. 
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Figure 11- Mobility of encapsidated wt HSV-l, ambUL12 and ambUL12R 
DNAs. 
35 nun plates of Vero cells were infected with 3 p.f.u. I cell wt HSV -1 (wt), 
ambUL12 (amb) or ambUL12R (12R). Cells were harvested 16 h.p.i. and nuclei 
prepared. The samples were then incubated in 184 J.lI RSB, 0.5% NP40, 0.1 mg ml- J 
DNase for 15 min at 37°C. 184 J.lI 4 x CLB containing loading buffer was added. 
100 J.lI of each sample was loaded directly into a 1 % PFGE grade agarose I 0.5 x 
TBE gel. Samples were separated at 6 v I cm for 16 h at 14°C in 0.5 x TBE buffer 
using pulse times from 1 - 15 sec, increasing linearly. The gel was Southern blotted 
and hybridised to 32p labelled wt HSV -1 genomic DNA. The size markers are 
indicated. 
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3.4.3 Preparation of DNase-resistant DNA in agarose blocks 
To exclude the possibility that shearing of viral DNA might be having an effect it was 
important to develop a technique that allowed the preparation of DNase-resistant viral 
DNA within agarose blocks thereby avoiding any mechanical cleavage of the DNA 
molecules. 
Initial experiments using the approach of in situ DNase digestion described by Martinez 
et al. (1996a) resulted in degradation of the DNA that had been packaged. Several 
approaches, including the use of lower DNase I concentrations and buffers with higher 
EDT A concentrations were tried in an attempt to solve this problem. Eventually it was 
found that sensitivity of the packaged DNA to DNase I was associated with the 
presence of NP40. The effect of NP40 concentration in the lysis buffer was therefore 
examined. 
35 mm plates of BHK cells were infected with 3 p.f.u. / cell wt HSV-l. 16 h.p.i. the 
cells were harvested and embedded in agarose blocks as described in Methods. The 
embedded cells were lysed by incubating the plugs at 37°C for 2 h using RSB / NP40, 
with NP40 content ranging from 0.05 to 0.5%. The agarose blocks were washed in 0.5 
ml DNase digestion buffer. This was replaced with fresh DNase digestion buffer 
containing DNase I ranging in concentration from 0.04 - 0.4 mg mrl and incubated at 
37°C for a further 2 h. The blocks were washed in 0.5 M EDTA and digested overnight 
with Proteinase K as described in Methods. The DNA from one third of each agarose 
block was separated by PFGE, Southern blotted and probed with radio labelled HSV-1 
genomic DNA. 
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Figure 12 shows that using NP40 at 0.5 % results in recovery of little or no DNase-
resistant DNA (Figure 12 upper panel, lane 9 and 12 lower panel, lane 4), and even at 
0.2%, the concentration routinely used by Martinez et al., (1996a), very little DNA 
could be recovered, even when using reduced concentrations of DNase I (Figure 12 
upper panel, lanes 2 - 5). It is not until NP40 is used at 0.1 % that significant amounts 
of DNA are recovered. It was decided to use an NP40 concentration of 0.05% because 
this gave the most consistent recovery of DNase-resistant DNA. It can also be seen in 
Figure 12B that at this concentration of NP40 increasing the DNase concentration 10-
fold reduced DNA recovery by less than 2-fold indicating that the capsids were stable 
and not permeable to DNase. 
3.4.4. Mobility of packaged ambUL12 DNA prepared in agarose blocks 
To examine the mobility of DNA molecules packaged by ambULl2, DNase-resistant 
DNA was prepared as described in Methods using the technique developed in section 
3.4.2. Unfortunately no ambUL12 DNase-resistant DNA could be detected. Reasoning 
that ambUL12 capsids may be less stable than wt HSV-l capsids, and therefore more 
sensitive to NP40 treatment, the concentration of NP40 was lowered even further. 35 
mm plates of BHK cells were infected with 3 p.f.u. I cell wt HSV-l or ambULl2. The 
cells were harvested 16 h.p.i. and total or DNase-resistant DNA was prepared. For the 
preparation of total DNA an NP40 concentration of 0.5% was used whereas in the 
preparation of DNase-resistant DNA NP40 concentrations of 0.05, 0.01, 0.005 and 
0.001 % were used during the lysing of cells and DNase was used at a concentration of 
0.1 mg mrl. The samples were subsequently prepared as described in Methods. One 
third of each sample was separated by PFGE in a 1 % PFGE grade agarose I 0.5 x TBE 
gel at 6 v I cm for 16 h at 14°C in 0.5 x TBE buffer using pulse times from 1 - 15 sec, 
89 
DNase (mglml) 
%NP40 
DNase (mglml) 
%NP40 
150kbp> 
- 0.04 0.1 0.2 0.4 
0.2 0.2 0.2 0.2 0.2 
0.1 0.1 0.1 0.1 
0.05 0.1 0.2 0.5 
0.1 0.1 0.1 0.1 
0.05 0.1 0.2 0.5 
0.02 0.04 0.1 0.2 
0.05 0.05 0.05 0.05 
Figure 12 - Effect of NP40 and DNase concentrations in obtaining DNase 
resistant DNA in agarose embedded cells. 
BHK cells were infected with 3 p.f.u. I cell wt HSV -1. 16 h.p.i. the cells were 
harvested and embedded in agarose blocks. The blocks were incubated in O.Sml 
RSB containing NP40 at the percentage indicated for 2 h at 37°C. Blocks were 
incubated in 0.5 ml DNase reaction buffer containing DNase I at the concentrations 
shown for a further 2 h at 37°C. Following overnight incubation with Proteinase K 
one third of each block was separated by PFGE, Southern blotted and hybridised to 
32p labelled HSV-I genomic DNA. The position of unit length genomic DNA is 
indicated. 
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times from 1 - 15 sec, increasing linearly. The gel was Southern blotted and hybridised 
to 32p labelled wt HSV -1 genomic DNA. 
Figure 13 shows that with NP40 below 0.05% there is no significant increase in the 
recovery of encapsidated wt HSV -1 DNA. It also shows that at all NP40 concentrations 
only a very small amount of DNase-resistant ambUL12 DNA can be detected. In 
agreement with Figure 11, the packaged ambUL12 DNA band is less sharp than that of 
wt HSV -1 forming a smear of molecules exhibiting apparent sizes in the range of 
130 - 150 kbp. This experiment demonstrates that packaged ambUL12 molecules are 
close to genome length but show heterogeneity due to either being physically shorter, 
by up to 20 kbp, or because of some other structural defect causing altered migration. 
It is unknown why capsids embedded in agarose are so sensitive to NP40. When 
preparing DNase-resistant DNA in the normal fashion NP40 concentrations of 0.5% and 
0.2% have been routinely used in many laboratories with no adverse problems reported. 
It is interesting to note that even when using concentrations of NP40 as low as 0.001 % 
(Figure 13) the amount of genomic length DNA recovered from DNase treated samples 
is still significantly lower than that of total DNA samples. This suggests that either the 
encapsidated DNA is partially sensitive to DNase using this method or the higher NP40 
concentrations promote loss of DNA from the plugs during the subsequent washing 
stages needed to ensure removal of DNase from the agarose blocks. One way to address 
the latter scenario would be to treat the total DNA samples exactly as the DNase treated 
samples with exclusion of only the DNase. 
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Figure 13 - Mobility of packaged ambUL12 DNA. 
BHK mono layers were infected with 3 p.f.u. / cell wt HSV-l or ambULl2 . The 
cells were harvested 16 h.p.i. , embedded in agarose blocks and processed for total 
(T) or DNase-resistant DNA. Total DNA was prepared by lysing cells using RSB 
and 0.5% NP40. DNase-resistant samples were lysed using RSB with NP40 at the 
percentages indicated followed by digestion with 0.1 mg ml- 1 DNase I. After 
Proteinase K treatment one third of each block was resolved by PFGE, Southern 
blotted and hybridised to 32p labelled HSV -1 genomic DNA. The position of the 
wells and various markers are indicated. 
3.5 Terminal fragments of packaged ambUL12 DNA 
3.5.1 Introduction 
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One way to determine if the SIze heterogeneity seen in encapsidated ambUL12 
molecules was due to a failure to package a complete genome length of DNA was to 
examine the termini contained in packaged molecules. 
Previous studies by Martinez et al. (1996a) suggest that there is no apparent difference 
in the terminal fragments of nuc mutants when compared to wt HSV -1. However, these 
studies also indicated that cleavage and packaging were unimpaired with respect to 
wtHSV-1, which clearly differs from the results with the ambUL12 mutant seen in this 
study. 
3.5.2 Terminal fragments in ambUL12 molecules 
BHK and Vero cell mono layers were infected with wt HSV-1 or ambUL12. The cells 
were harvested 16 h.p.i. and processed for total and DNase resistant DNA. Duplicate 
DNA samples were digested with BamHI, separated on a 0.8% LB-agarose gel and 
Southern blotted. The membrane was divided and hybridised to radiolabelled probes 
that would detect the terminal repeats. pBE 1 was used to detect the BamHI K and S 
fragments, representing the joint and long terminus respectively and either pST17 or 
pBN1 was used to detect BamHI K and Q, the joint and short terminal fragments 
(Figure 14). 
Figures 15A and B show typical results from these experiments. Total DNA samples 
contain concatemeric as well as unit length viral DNA molecules. The joint fragment 
(BamHI K) is therefore expected to be over-represented when compared to the long 
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tenninal (TRd and short tenninal (TRs) fragments (BamHI Sand Q respectively). 
Figure 15A shows that this is true for the long terminus of both wt HSV -1 and 
ambUL12. A similar result was obtained with the short terminal probe (data not 
shown). Furthermore, when total and DNase-resistant DNA were prepared from the 
same sample the amount of terminal fragment found in each was similar, indicating that 
the majority of termini were associated with packaged molecules (results not shown). 
When considering packaged molecules, it is expected that the ratio of the joint 
fragments to each of the terminal fragments will be one. Figure 15B shows DNase-
resistant DNA samples from infected BHK or Vero cells digested with Bam HI and 
probed with pBE1 or pST17. When the counts in the joint and terminal fragments were 
determined for Figure 15B and the ratio of joint to each terminus was calculated it was 
found that the wt HSV -1 samples gave a ratio very close to one. Although not obvious 
by eye, the joint fragment in the ambUL12 samples was always over represented 
compared to the termini. The value of joint / TRL and joint / TRs was calculated for 
five independent experiments using BHK and Vero cells. As can be seen in Figure 15C 
all the wt samples gave a ratio very close to one with very little deviation from the 
mean. In contrast the ambULl2 samples show that the joint fragment is generally in 
excess over both tennini although all the ratios showed a higher standard deviation. 
There is mounting evidence that HSV -1 packages DNA molecules in the direction of UL 
to Us with encapsidation of herpesvirus genomes being initiated by cleavage and 
insertion of the pac2 sequence, which is contained within TRL of HSV -1, into a viral 
capsid (McVoy and Adler, 1994; McVoy et al., 2000; Stow, 2001). If packaging was 
initiated by cleavage at the pac2 site within TRL we would expect the TRL fragment to 
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Figure 14 - Position of HSV-l fragments used as probes for Southern blots. 
(A) Schematic of the HSV-1 genome. The position of the unique sections UL and 
Us are shown along with the repeat sequences TRL, IRL, IRs and TRs. The shaded 
regions represent the position of the a sequences, only single copies are shown for 
simplicity. The location of the BamHI S, P, Q and K fragments are also shown. 
(B) Expansion of the S, Q and K fragments showing the regions inserted into the 
plasmids pBE1 , pBN1 and pST17. Aadapted from Stow, (2001). 
(C) Diagram demonstrating the size distribution of molecules which will be 
detected by probes specific for RL and Rs, assuming packaging occurs from U L to 
Us. Dark and light bars represent RL and Rs specific probes, respectively. 
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Figure 15 - Ratio of joint to termini in encapsidated wt HSV-l and ambUL12 
DNA. 
BHK and Vero cell mono layers were infected with wt HSV-1 or ambUL12. 
(A) Total DNA was prepared 16 h.p.i. Samples were digested with BamHI, 
separated on a 0.8% LB-agarose gel, Southern blotted and the membrane probed 
with 32p labelled pBEl. (B) DNase-resistant DNA was prepared 16 h.p.i . 
Duplicate samples were digested with BamHI and Southern blotted. The membrane 
was divided and probed with 32p labelled pBE1 or pST17. The position of the 
BamHI K, Sand Q fragments are indicated. Note that (S) indicates the position of 
the fragment containing a single a sequence, the bands above contain 2, 3, and 4 
copies of the a sequence. (C) The counts in each BamHI K, Sand Q fragments from 
five independent experiments, including those in (B), were determined and the ratio 
of KlS and KlQ calculated. 
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be in excess, or present in the same amount as the joint fragment during any incomplete 
packaging event and TRs to be present in relatively lower amounts. Data for ambUL12 
are therefore not consistent with small genomes being generated simply by failure to 
complete packaging. Rather, the data seems to indicate that the majority of packaged 
molecules have aberrant termini at either or both ends. 
3.5.3 Detection of joint and terminal fragments in PFGE 
The experiments described in section 3.4 demonstrated that a large proportion of the 
packaged ambUL12 genomes were below unit length. PFGE was used to determine the 
size distribution of molecules that contained joint and/or terminal fragments. 
DNase-resistant DNA was prepared from wt HSV-l and ambULl2 infected BHK 
monolayers as described in section 3.4.1. Replicate samples were separated at 6 v / cm 
for 16 h at 14°C in 0.5 x TBE buffer using pulse times from 1 - 15 sec, increasing 
linearly. The gel was Southern blotted, the membrane divided and each section 
hybridised to 32p labelled wt HSV-l genomic DNA, pBEl (from Rd or pST17 (from 
Rs). The results are shown in Figure 16. 
If packaging does occur from UL to Us as discussed in section 3.5.2 then the pBE1 
probe would detect partially encapsidated molecules containing TRL (but not IRL or Rs) 
migrating with apparent sizes of ~5 to 120 kbp. Molecules above this size would 
generate a signal by hybridisation to TRL and/or IRL. In contrast the pSTl7 probe 
would detect partially encapsidated molecules only above ~ 130 kbp in size by 
hybridisation to IRs. Additional hybridisation to TRs would occur only with full length 
molecules (Figure 14C). 
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With wt HSV -1 all three probes detected a band that migrated at, or slightly above 152 
kbp indicating that the majority of DNase-resistant DNA is full length genomic DNA. 
In agreement with the above model the greatest degree of hybridisation to molecules 
smaller than approximately 120 kbp was detected when using the pBEI probe and 
probably represents the detection of partially packaged molecules, the encapsidation of 
which was interrupted when the cells were harvested. 
In the ambUL12 samples it is evident that although a small proportion of molecules 
migrated as full length genomes, much of the DNA migrated slightly faster, with 
apparent sizes of 130-150 kbp. Previously, Figure 15C demonstrated that both terminal 
fragments were detected in packaged ambUL12 DNA, and that there was a small excess 
of joint fragments over terminal fragments, most noticeably IRs over TRs. This 
suggests that the molecules in the size range 130-152 kbp probably correspond to the 
packaged molecules detected in Figure 15. The full length (152 kbp) molecules 
detected with both probes presumably contain both a normal TRL and TRs. The 
molecules between about 130 kbp and full length, however, are likely to contain an 
authentic terminal fragment from only one end suggesting non-specific cleavage may be 
occurring. In conjunction with the results from Figure 15C this suggests that, in BHK 
cells at least, the aberrant cleavage occurs more often within TRs than TRL. It remains 
possible that aberrant cleavage may take place at either or both termini within the same 
genome. 
It should be pointed out that the data presented in Figures 15 and 16 are consistent with 
a model in which packaging can occur in either direction and the molecules in the size 
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Figure 16 - Distribution of termini in packaged ambULl2. 
< 150kbp 
< 130kbp 
BHK monolayers were infected with 3 p.f.u. / cell wt HSV-l (wt) or ambUL12 
(amb). 16 h.p.i. DNase-resistant DNA was gently extracted with no phenol 
chloroform extraction and duplicate samples representing 6.6 x 105 cells were 
immediately resolved by PFGE. The gel was blotted, divided and probed with 
HSV-l genomic DNA, pBEI or pSTI7. The 5 kbp marker (M) was used to 
determine the position of the 130 and 150 kbp fragments. 
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range 130-150 kbp represent specIes where packaging has stalled. An alternative 
possibility is that molecules of this size are observed because the ends of packaged full 
length ambUl2 genomes are more susceptible to DNase than completely packaged 
HSV -1 molecules. 
3.5.4 Investigation of the termini in extracellular ambUL12 virions 
The packaged DNA investigated in sections 3.5.2 and 3.5.3 was derived from whole 
cells and therefore contains molecules originating from the nucleus and cytoplasm. 
Although nuc mutants are compromised in producing infectious virus small amounts are 
nevertheless generated. Egress of capsids from the nucleus into the cytoplasm appears 
to be linked to a head full packaging event (Homa and Brown, 1997). It was therefore 
decided to examine the termini of DNA molecules obtained from extracellular 
ambUL12 and wt HSV-l virions (section 3.3.6). 
Duplicate 0.5 J.lg DNA samples were digested with BamHI and separated on a 0.8% 
LB-agarose gel. The gel was Southern blotted, the membrane divided and probed with 
32p labelled pBEI and pSTI7. The blot was then analysed on a phosphorimager. 
Figure 17 shows the results obtained from infected BHK cells although the results 
derived from infected Vero cells were essentially identical. Although only one set of 
samples was tested from each cell line, all samples showed ratios close to one for both 
junction:long terminal fragments and junction:short terminal fragment. This suggests 
that ambUL12 capsids that egress into the cytoplasm and are released from the cells are 
correctly processed at both termini. 
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Figure 17 - Terminal fragments contained in extracellular virions. 
Duplicate DNA samples from purified extracellular virions derived from infected 
BHK cells were digested with BamHI and separated on a 0.8% LB-agarose gel. 
After blotting the membrane was divided and probed with pBEI and pSTI7. The 
position of the joint fragment (K) and the terminal fragments (S or Q) are indicated. 
The numbers below the blot indicate the ratio of the K fragment to the total of the S 
or Q fragments. 
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3.5.5 Investigation of terminal fragments in high molecular weight DNA 
A number of studies have shown that hmw HSV -1 DNA contains free long but not short 
termini (McVoy and Adler, 1994; Severini et al., 1994; Zhang et al., 1994; Martinez et 
al., 1996; Goldstein and Weller, 1998; McVoy et al., 2000). Since ambUL12 appears to 
cleave viral DNA with lower efficiency and specificity than wt HSV -1 the termini 
present in hmw ambUL12 DNA were examined. 
BHK and Vero cell monolayers were infected with wt HSV-l and ambULl2. 16 h.p.i. 
the cells were harvested, embedded in agarose blocks and processed for total cellular 
DNA. Each block was cut in three and subjected to PFGE (DNA was separated at 6 v / 
cm for 16 h at 14°C in 0.5 x TBE buffer using pulse times from 1 - 50 sec, increasing 
linearly). The blocks were cut from the well of the gel and the gel ethidium bromide 
stained to ensure that the unit length DNA had migrated into the gel. Each of the blocks 
were then digested with 40 U of BamHI in a final volume of 200 /-11 at 37°C for 4 h. 
Following electrophoresis of duplicate samples in a 0.8% LB agarose gel the samples 
were Southern blotted, the membrane divided and probed with radiolabelled pBE 1 or 
pSTI7. 
Figure 18 shows that although there is a lot of smearing, possibly due to branched 
structures or partial cleavage of the DNA by the restriction enzyme, the wt HSV-l 
samples generate a strong, distinct band corresponding to the joint fragment detected by 
both pBEI and pSTI7. Bands corresponding to the long terminus containing one and 
two a sequences were also detected in the wt HSV-l samples with the pBEI probe. 
Although not very clear in Figure 18 ambUL12 also contained similar bands from the L 
terminus in hmw DNA. Surprisingly, the pST17 probe detected small amounts of 
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Figure 18 - Termini in high molecular weight DNA. 
BHK and Vero mono layers infected with 3 p.f.u. / cell wt HSV-l (wt) or ambULl2 
(amb) were harvested 16 h.p.i. , embedded in agarose blocks and total DNA 
prepared. The blocks were divided in three and the "well" DNA was separated 
from linear genomic DNA by PFGE. The well DNA was removed, and duplicate 
samples were digested with BamHI and separated on a 0.8% LB-agarose gel. The 
gel was blotted, divided and probed with radiolabelled pBEI or pSTI7. The 
postions of the joint (K) and terminal fragments (S and Q) are indicated. 
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tenninal fragment corresponding to Rs. Previous studies have never detected the short 
tenninus in hmw DNA, presuming it to be released or degraded after the initial cleavage 
event. Therefore its presence in the wt HSV -1 samples here cannot be easily explained. 
Nonetheless, the prominent smear found in the hmw ambUL12 DNA samples which 
were probed for the short tenninus clearly differs from the equivalent wt HSV-1 
samples. The presence of a similar smear has also been reported for other nuc mutants 
probed with S tenninal DNA fragments (Martinez et al., 1996a) and further 
demonstrates aberrant cleavage events in nuc mutant infected cells. 
3.6 Discussion 
The experiments described in this section extend the characterisation of the ambUL12 
HSV -1 mutant. Although the general properties of nuc mutants were confirmed there 
were also a number of novel observations. (i) The ambUL12 mutant is deficient in both 
the replication and packaging of viral DNA, (ii) there appears to be an additional 
impainnent in release of packaged DNA into the cytoplasm, (iii) the phenotype of the 
virus is similar in three different cell lines, (iv) cleavage of concatemeric DNA is 
aberrant and inefficient (v) replicated ambUL12 DNA is structurally distinct from wt 
HSV-l DNA, (vi) the majority of intact, encapsidated ambUL12 DNA has a different 
mobility to wt HSV -1, (vii) only encapsidated genomes that are full length and 
possessed both tennini were released from ambUL12 infected cells. 
Previous studies on nuc mutants revealed that although the UL12 gene was not 
absolutely essential, UL12 null mutants were inefficient at producing viable virus 
(Weller et al., 1990; Martinez et al., 1996; Gao et al., 1998). Studies by Patel et al. 
(1996), and confinned here, showed that an amber mutation inserted into the UL 12 
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ORF of ambUL12 generated a virus with a similar phenotype to previously described 
nuc mutants (Figure 1; Weller et al., 1990; Martinez et al., 1996; Gao et al., 1998). 
Through the use of a marker rescued virus (ambULI2R) it was demonstrated that the 
amber mutation was the only lesion in ambUL12 contributing to the phenotype of the 
virus (Patel et al. (1996); Figure 1, 2, 3 and 11). 
The major defect in nuc mutants has been described as the inability of capsids to egress 
from the nucleus into the cytoplasm (Shao et al., 1996). Although there are reduced 
levels of viral DNA in the cytoplasm of ambUL12 infected cells (Figure 3 and 4) this is 
also due, at least in part, to defects in the viral DNA replication and packaging 
processes. The replication defect also appears to be cell type dependent. Infected BHK 
and Vero cells showed an approximately 3-fold reduction in replication compared to wt 
HSV -1. In contrast, FG293 and the complementing S22 cells showed only a very slight 
reduction in the amount of DNA synthesised. As described in section 3.2.3 there is a 
precedent for the involvement of virally encoded nucleases in the replication of their 
DNA. Endonuclease VII, encoded by gene 46 of bacteriophage T4, is required at late 
times of infection to initiate recombination dependent replication (Kemper and Brown, 
1976; Kemper et al., 1981a and 1981b; Kemper and Janz, 1976). However it is unlikely 
that the alkaline nuclease has a role identical to that of endonuclease VII because, as can 
be seen in Figure 5, ambUL12 synthesises less DNA than wt HSV-1 from the earliest 
time points. This suggests that if there is a switch from origin-dependent to 
recombination-dependent replication initiation then the nuclease is not involved. It has 
also been shown that nuc mutants are capable of driving intramolecular inversion of 
plasmids suggesting that the nuclease is not directly involved in recombination events 
(Martinez et al., 1996a), and that the products of the seven DNA replication genes alone 
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are sufficient to drive inversion events (Weber et ai., 1988). However the association of 
the alkaline nuclease with the major DNA binding protein, encoded by UL29, means 
that a direct role in the replication of viral DNA cannot be dismissed (Littler et ai., 
1983; Thomas et ai., 1992; Vaughan et ai., 1984). 
Weller and co-workers have demonstrated in several papers, with various nuc mutants, 
that the cleavage and packaging of viral DNA is almost identical to wt HSV -1 (Weller 
et ai., 1993; Martinez et ai., 1996a and 1996b). However, the same conclusions cannot 
be drawn from the experiments presented here. Comparisons of DNase-resistant DNA 
obtained form wt HSV-1 and ambUL12 infected cells show a 15-20 fold drop in the 
packaging of ambUL12 DNA in three different cell lines (Table 1). Moreover Figure 7 
shows that the cleavage of DNA is also substantially reduced, as judged by the detection 
of reduced amounts of unit length DNA by PFGE analysis of replicating viral DNA. 
This is in agreement with previous reports demonstrating close linkage of the cleavage 
and packaging processes (Ladin et ai., 1980, 1982; Sherman and Bachenheimer 1987, 
1988). 
Encapsidated, unit length genomes are expected to produce equimolar amounts of joint, 
Land S termini. As expected, examination of DNase-resistant wt HSV-l DNA 
obtained from whole cell extracts showed that the ratio of joint to L terminus and joint 
to S terminus were both close to one (Figure 15). However in ambUL12 samples the 
j oint fragment was generally in excess over both the Land S termini suggesting that 
cleavage at both termini was frequently aberrant. Recently the UL25 null mutant 
KUL25NS was examined for its ability to package DNA (McNab et ai., 1998; Stow, 
2001). Stow observed that in KUL25NS DNase-resistant DNA there was an 
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overrepresentation of the L terminus and an underrepresentation of the S terminus 
indicating that the majority of packaging events failed to encapsidate a full length 
genome. These data additionally supported a model where polarity of packaging is 
from UL to Us. In contrast, it appears that ambUL12 has a different phenotype with 
both termini underrepresented compared to the joint fragment (Figure 15). Figure 16 
shows PFGE separation of full length, encapsidated DNA that has been hybridised to 
probes for RL (pBE 1) and Rs (pSTI7) and demonstrates that the majority of molecules 
are slightly smaller than full length genomes. If packaging does occur from UL to Us 
then pBEl would be expected to detect molecules from 3 - 150 kbp whereas pST17 
would only detect molecules over 128 kbp. This is the case for both wt HSV-l and 
ambUL12 suggesting that packaging of ambUL12 does occur from UL to Us. If the 
pST17 probe detected molecules shorter than 128 kbp then aberrant cleavage would 
have to have either occurred at both termini or packaging, alternatively, initiated from 
either terminus. In any case Figure 15, in conjunction with Figure 16 suggest that 
although many cleavage events in ambUL12 infected cells produce molecules with 
either appropriately sized RL or Rs termini few contain both. As a result the majority of 
molecules are below unit length. 
Figure 19 illustrates possible cleavage events that could also explain the results 
observed in Figure 15 and 16. In the first model the two cleavage events are identical to 
wt HSV-l, with the initial cleavage event directed by the pac2 site within Uc in the TRL 
region, and the second cleavage by the pac 1 site within Vb in the TRs region, resulting 
in a genome length molecule with the correct termini being packaged. In the second 
model cleavage occurs as normal at the pac2 site but the second cleavage takes place 
before the pac 1 site, and outside the region hybridising to the pST17 probe. The third 
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model predicts that the initial cleavage is aberrant, occurring outside the region of the 
pBE 1 probe but the final cleavage at the pac 1 site takes place as normal. The important 
aspect of models two and three is that they produce molecules that are shorter than unit 
length with one terminus underrepresented. It is also possible that in ambUL 12 full 
length molecules are packaged (model 1) but either one or both termini are left 
protruding form the capsid, resulting in their susceptibility to degredation upon DNase I 
treatment. 
Two potential explanations can be postulated for abnormal cleavage of ambUL12 DNA. 
Firstly, as ambUL12 DNA is more complex than wt HSV-l, in that it contains many 
more branched structures (Martinez et al., 1996a), it is possible that the cleavage / 
packaging machinery cannot access the appropriate cleavage sites. The increased 
complexity of ambUL12 DNA can be clearly seen in Figure 8, in which smearing of 
large fragments of restriction enzyme digested hmw DNA was observed. Also, 
expected restriction fragments above 50 kbp could not be detected or were present at 
reduced levels. Martinez and co-workers have also shown that, in contrast to wt HSV-
1, several nuc mutants were unable to release DNA from the wells of pulsed field gels 
when digested with enzymes that cut only a few times per genome (Martinez et al., 
1996). A second possibility is that the alkaline nuclease is directly involved in 
providing cleavage specificity. Although in vitro studies with purified alkaline nuclease 
show non-specific cleavage of DNA (Goldstein and Weller, 1998; Henderson et al., 
1998), Chou and Roizman, (1989) demonstrated that the nuclease was one of several 
viral proteins that could bind the a sequence, and although the binding was non-specific 
the nuclease may act in conjunction with other viral proteins which confer specificity. 
In the absence of UL 12, sites not normally cleaved to initiate or terminate packaging 
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Figure 19 - Possible cleavage mechanisms in ambULl2. 
Map of the HSV-l genome showing where the pBEl (- ) and pST17 (- ) probes 
hybridise. (I) Cleavage and packaging progress normally producing a full length 
packaged genome with correct termini . (2) Cleavage and packaging initiate 
correctly but abort at some stage within the S segment. (3) An initial aberrant 
cleavage event within the L segment is followed by termination at the correct site 
within TRs. See text for details. 
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might become susceptible to cleavage. This can be easily envisaged at the late stages of 
the head filling process where more energy is required to package the DNA (Smith et 
al., 2001) and the rate of packaging is reduced. Further evidence for reduced cleavage 
specificity is presented in chapter 5 of this thesis. 
High molecular weight HSV -1 DNA was previously shown to contain a small amount 
of free long termini but no free short termini (McVoy and Adler, 1998; Severini et al., 
1994). In the experiment shown in Figure 18 a small amount of free long terminus was 
present in both hmw wt HSV-1 and ambUL12 DNA. It has been suggested for wt 
HSV -1 that after the initial cleavage event between two a sequences the pac 2 sequence 
within RL is inserted into capsids while the pac 1 sequence is degraded (McVoy and 
Adler, 1994; McVoy et ai, 2000; Stow, 2001). In contrast to previously published 
results similar amounts of Sand L termini were present in the hmw wt HSV -1 samples. 
The hmw DNA found with nuc mutants, including ambULl2, also contains S termini 
which are detected as a heterogeneous smear (Figure 18; Martinez et al., 1996a). It is 
not clear if this product is another example of aberrant cleavage or represents 
degradation of the joint fragments of concatemeric DNA. In any case, the result again 
suggests an impairment in the cleavage mechanism of nuc mutants or difference in the 
structure of their DNA. 
In addition to the differences described above, ambUL12 DNA is generally of "poorer 
quality" than wt HSV-l. Restriction enzyme digests of ambUL12 DNA from whole 
cells are more smeared and they do not contain expected restriction fragments above 50 
kbp in size (Figure 8) indicating that the replicated DNA probably contains many 
unresolved branched structures resulting from replication events. This has implications 
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for both the translocation of DNA into the capsid (the internal diameter of the portal 
protein is only 5 nm (Newcomb et al., 2001)) and the stability of packaged capsids that 
may contain branched DNA products. The use of 2D agarose gel electrophoresis 
(Severini et al., 1996) would be useful to further determine the structure of both hmw 
and packaged ambUL12 DNA. 
Although there is a definite block in the egress of capsids into the cytoplasm of 
ambUL12 infected cells, a small number do mature into the cytoplasm. Analysis of 
DNA purified from extracellular ambUL12 virions reveals that: (i) The DNA has the 
same mobility as wt HSV -1 (Figure 9), (ii), restriction enzyme digests of extracellular 
DNA are identical to wt HSV -1 (Figure9), (iii) extracellular virion DNA contains the 
correct proportions of terminal fragments (Figure 16). These observations indicate that 
cleavage was more specific for these molecules, although direct investigation of the 
DNA ends will be necessary to conclude that cleavage occurs at an identical position to 
wt HSV-l. Nevertheless, these results, taken together, imply that only capsids 
containing correctly processed DNA molecules will egress from the nucleus. In 
addition S 1 nuclease digestion of DNA obtained from extracellular virions revealed that 
wt HSV-l and ambUL12 DNA contain similar amounts of single stranded nicks (Figure 
10). In agreement with previous reports (Wilkie, 1973; Goldstein and Weller, 1998b) 
the smeared product of S 1 digestion suggests that the nicks are randomly distributed. 
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Chapter 4: Interaction of the alkaline nuclease with other replication and 
packaging proteins 
4.1 Introduction 
There are two mutant herpesviruses; KUL25NS, an HSV -1 mutant which does not 
express UL25 (McNab et al., 1998; Stow, 2001), and an HCMV UL97 null mutant 
which does not express the homologue of the HSV -1 UL 13 protein (Wolf et al., 2001), 
which have phenotypes quite similar to the ambUL12 mutant. Both mutants cleave 
concatemeric DNA at wt levels but packaging events are frequently aborted, resulting in 
the accumulation of A-capsids. In addition the HCMV UL97 null mutant synthesises 
DNA 4-6 fold less efficiently and produces 100-1000 fold less virus than wt HCMV. 
The similarity in phenotype suggests that HSV-1 UL12 may interact with one or both of 
these proteins or have a role at the same point in the replication / packaging process. 
The phenotype of nuc mutants also suggests the possibility that the alkaline nuclease 
may directly interact with other components of the viral packaging machinery or be 
modified by other viral proteins such as the protein kinase encoded by UL 13. Indeed 
Chou and Roizman, (1989) reported that the alkaline nuclease was one of several viral 
proteins that formed a complex with the a sequence, although it could not be confirmed 
if this was a direct or sequence-specific interaction. The interaction of the alkaline 
nuclease with at least one other protein, the major single stranded stranded DNA 
binding protein (mDBP) encoded by UL29, has been reported (Vaughan et aI., 1984; 
Thomas et al., 1988 and 1992). Therefore, a preliminary investigation into the 
interaction of the alkaline nuclease with selected other viral proteins, known to be 
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involved in the replication and packaging processes, was performed using a panel of 
recombinant baculoviruses expressing various HSV -1 proteins. 
4.2 Co-immunoprecipitation of UL12 and UL29 
Since the interaction of UL12 and UL29 had already been reported in several 
publications (Vaughan et al., 1984: Thomas et al., 1988 and 1992) this was chosen as 
the first interaction to be examined. 
12 well plates seeded with 1.2 x 106 Sf cells were singly or dually infected with 5 p.f.u. 
/ cell of the recombinant baculoviruses AcUL12 and AcUL29, expressing the alkaline 
nuclease and the mDBP respectively. The proteins were labelled with 35S methionine as 
described in methods, and extracts prepared. The extracts were incubated with MAb Q 1 
(anti-UL12) or MAb 7381 (anti-UL29) and the complexes recovered with Protein-A 
sepharose beads. The immunoprecipitates were resolved on an 8% SDS-PAGE gel 
along with samples of total proteins and the soluble protein extracts. 
UL12 and UL29 (85 and 136 kDa respectively) were readily detectable in the total and 
soluble protein fractions from singly and dually infected cells (Figure 20A and 20B). 
MAb Q1 efficiently precipitated UL12 from both AcUL12 infected samples (Figure 
20A). Although a significant amount of UL29 was present in the precipitate from the 
co-infection when using the Q1 Ab (Figure 20A) the result is inconclusive because of 
the presence of a strong band of similar size in the AcUL29 single infection. Figure 
20B shows that when using the anti-UL29 antibody, MAb 7381, the presence ofUL29 
is required for precipitation of ULl2 to occur. These results, therefore, support 
previous reports of an interaction between UL12 and UL29 in HSV-1 infected cells, 
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Figure 20 - Co-immunoprecipitation of UL12 and UL29 proteins. 
S.f. cells were singly or dually infected with AcUL12 (12) or AcUL29 (29) and 
labelled with 35S-methionine. The cell extracts were incubated with antibody Q 1 
(A) or antibody 7381 (B). The total proteins, starting extracts and 
immunoprecipitates were resolved on an 8% SDS-PAGE and exposed to a 
phosphorimager screen. The position of selected radiolabelled Rainbow Marker 
(M) are shown. The position of the UL12 and UL29 bands are also indicated. Note 
that in (A) the immunoprecipitations were performed in duplicate. 
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although more stringent washes would be required to demonstrate a definitive 
interaction. 
4.3 Immunoprecipitation of UL12 and UL2S 
Because of the similarity in phenotype between UL 12 and UL25 mutants, UL25 was 
examined for a possible interaction with UL12. 
12 well plates of Sf cells were infected with 5 p.f.u. / cell AcUL12 and/or AcUL25 and 
processed as described in section 4.2 except the antibodies used were MAb Ql and 
PAb BwP12 against ULI2, and MAb anti-UL25 against UL25. 
Figure 21A showed that MAb Ql precipitated UL12 from cells infected with AcUL12 
alone or in conjunction with AcUL25. However, UL25 could not be detected in either 
sample infected with AcUL25 even though the protein was present in the soluble 
extract. A similar result was obtained when the polyclonal antibody BwPI2, specific 
for UL12, was used (Figure 21B). When the MAb anti-UL25 was used, UL25 was 
precipitated strongly from the single and double infections using AcUL25 (Figure 21e). 
Although there is a weak band co-migrating with UL12 in the dual infected sample it is 
also present at a slightly higher amount in the singly infected AcUL12 sample 
indicating that precipitation of this protein is not dependent upon the presence ofUL25. 
Taken together, this data suggests that UL12 and UL25 do not directly interact. 
4.4 Immunoprecipitation ofUL12, ULIS and UL28 
The products of UL15 and UL28, which are essential for the packaging of viral DNA, 
have recently been shown to interact (Koslowski et al., 1999; Abbotts et al., 2000). 
106 
N tv tv 
+ + + N N N N N N Vl Vl N Vl N Vl N Vl Vl A 
----- . 
---
total extract immunoprecipitate 
N N N 
+ + + N N N N N N N Vl Vl N Vl Vl N Vl Vl 
B 
total extract immunoprecipitate 
N N N 
+ + + 
N N N N N N N Vl Vl N Vl Vl N Vl Vl 
C 
--
-
total extract immunoprecipitate 
Figure 21 - Immunoprecipitation of UL12 and UL25. 
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S.f. cells were infected with AcUL12 (12), AcUL25 (25) or dually infected (12 + 
25) and labelled with 35S-methionine. Cell extracts were incubated with Q 1 (A), 
BwP12 (B) or anti-UL25 (C). Total protein extracts (total), the soluble fraction 
(extract) and the immunoprecipitate were resolved on an 8% SDS-PAGE gel and 
exposed to a phosphorimager screen. The position of the UL 12 and UL25 proteins 
are indicated. 
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Several lines of evidence suggest they may function in a manner analogous to the 
terminase complexes of dsDNA bacteriophage; these include limited sequence 
homology (Davison, 1992) and a consensus ATP binding motif which, through 
mutation studies, was demonstrated to be essential for the function of UL15 (Yu and 
Weller, 1998). To determine if either protein, or the complex, interacts with UL12, S.f 
cells were infected with AcULI2, AcUL15-pp65 or AcUL28 in the various 
combinations shown in Figure 22. The labelled soluble extracts were incubated with 
Mab Ql or anti-pp65 antibody and precipitated with ProteinA beads (Figure 22). 
As before MAb Q1 precipitates UL12 in the single or dual infected samples (Figure 
22A and B). However, neither UL15 nor UL28 was efficiently co-precipitated with 
UL12 suggesting no interaction occurred between the individual proteins. 
To determine whether the UL15-UL28 complex can interact with UL12, Sf cells were 
triply infected and immunoprecipitations performed with MAb Q1, (Figure 22C) and 
MAb anti-pp65, (Figure 22D). In both panels all three proteins produced from the triple 
infection can be clearly seen in the total and soluble fractions. In Figure 22C only 
UL12 was precipitated. In contrast the anti-pp65 antibody co-precipitates both pp65 
tagged UL15 and UL28, in agreement with previous results (Abbotts et al., 2000), 
although UL12 was not detected. Therefore, the preliminary results presented in Figure 
22 suggest that UL12 does not interact with UL15 or UL28 alone or when complexed. 
However, since UL15 and UL28 migrate so closely with major UL12 related bands a 
western blot would be necessary to exclude the possibility of weak interactions. 
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Figure 22 - Immunoprecipitation of UL12 and UL15 and UL28. 
S.f. cells were infected with AcUL12 (12), AcUL15 (15), AcUL28 (28) in the 
combinations indicated and labelled with 35S-methionine. Cell extracts were 
incubated with Ql (A), (B) and (D) or anti-pp65 (C). Total protein extracts (total), 
the soluble fraction (extract) and the immunoprecipitate were resolved on an 8% 
SDS-PAGE gel and exposed to a phosphorimager screen. The positions of ULI2, 
UL 15 and UL28 proteins are indicated. 
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4.5 Immunoprecipitation of UL12 and UL6 
The product of UL6 is one of the proteins essential for the packaging of viral DNA and 
has recently been shown to form the portal through which the DNA is inserted into the 
viral capsid (Newcomb et al., 2001). To determine whether UL6 interacts with UL12 
Sf cells were infected with AcULl2 and/or AcUL6 and precipitated using MAb QI or 
PAb BwP12. Figures 23A and B demonstrate that with each antibody, UL12 was 
precipitated from both the single and dual infection samples but co-precipitation ofUL6 
could not be detected. Since the UL6 protein was poorly soluble the samples from the 
Q1 precipitated samples were re-run on an SDS-PAGE gel and western blotted using 
the PAb YE583, specific for UL6 (Figure 23C). It is clear that UL6 can be detected in 
the total and soluble fractions but not in the immunoprecipitated samples. Taken 
together these results indicate that UL12 and UL6 do not detectably interact. 
4.6 Discussion 
The aim of this section was to investigate possible interactions of the UL12 protein with 
other viral proteins which are involved in the replication and packaging of the viral 
genome. 
The interaction of UL12 and UL29 (the major single stranded DNA binding protein, an 
essential component of the viral DNA replication machinery) had been reported 
previously in HSV-I infected cells (Vaughan et al., 1984: Thomas et al., 1988 and 
1992). The ability ofbaculovirus expressed UL12 to co-immunoprecipitate baculovirus 
expressed UL29, and vice versa (Figure 20), further suggests an interaction between 
these two proteins, although due to the relatively high background bands in the control 
lanes a definitive result cannot be reached in the absence of further experiments. 
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Figure 23 - Immunoprecipitation of UL12 and UL6. 
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S.f. cells were infected with AcUL12 (12), AcUL6 (6) or dual infected (12 + 6) and 
labelled with 35S-methionine. Cell extracts were incubated with Q 1 (A) or BwP 12 
(B). Total protein extracts (total), the soluble fraction (extract) and the 
immunoprecipitate were resolved on an 8% SDS-PAGE ge l and exposed to a 
phosphorimager screen. The samples from (A) were re-run, western blotted and 
UL6 detected with Pab YE583 (C). The position of UL 12, UL6 and IgG is 
indicated. 
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Nevertheless, previously published data of an interaction between UL12 and UL29, in 
conjunction with the results presented in in section three, which demonstrated that the 
ambUL12 null mutant was deficient in the replication of viral DNA, suggest a 
mechanism by which UL12 may be directly involved in the replication of viral DNA. 
The UL25 null mutant, KUL25NS, shows a similar phenotype to UL12 null mutants 
(Shao et al., 1993; McNab et al., 1998; Stow, 2000), suggesting that they may have 
related roles in the packaging of viral DNA. However, the results presented in Figure 
21 failed to detect co-immunoprecipitation of the two proteins using three separate 
antibodies, even though both proteins are readily detectable in the total and soluble 
extracts. It is therefore unlikely that these proteins interact. The possibility that the two 
monoclonal antibodies, Q1 and anti-UL25, both recognise epitopes that are masked in a 
protein complex seems unlikely since the polyclonal antibody BwP12 (specific for 
UL12) also did not reveal any interaction. Although the two proteins do not appear to 
interact this does not exclude the possibility that they may have interconnected roles in 
the packaging of viral DNA. 
During the packaging of viral DNA any aberrant DNA structures (e.g. branches) 
encountered by the terminase complex could result in the termination of packaging 
unless the aberrant structure was resolved. Therefore, it was conceivable that UL15 and 
UL28, which are presumed to form the HSV-1 terminase complex (Yu and 
Weller,1998), might interact with UL12 thereby coupling the translocation of viral 
DNA into the capsid with the detection and resolution of any complex DNA structures. 
However, co-immunoprecipitation of UL15 or UL28, either separately or as a complex 
with UL12 was not be detected (Figure 22). Although there was no apparent physical 
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interaction between UL12 and the ULI5-UL28 complex, the possibility of UL12 
independently modifying non-linear DNA forms trapped at the terminase cannot be 
excluded. 
The reason for studying a possible interaction of UL12 with UL6 uses a similar 
argument to that for UL15 and UL28; any non-linear DNA would be expected to either 
inhibit or abrogate the translocation of the viral genome through the UL6 portal 
complex (Newcomb et al., 2001). Resolution of these structures would therefore be 
required for packaging to continue. The results presented in section 4.5 indicate that 
UL 12 and UL6 do not interact. 
These results, although preliminary, indicate that UL12 does not detectably interact with 
the packaging proteins described above. The observed interaction ofUL12 with UL29 
may indicate that UL12 functions to resolve aberrant structures as they are formed 
during replication and recombination, its actions being spatially and temporally distinct 
from the packaging machinery. In any case it is clear that more work is needed to 
define the interactions of UL12 with other viral and cellular proteins. This would help 
further elucidate the role of UL12 in the replication and packaging process and may 
give some clues as to the mechanism which must presumably control the potent 
nuclease activity ofUL12. 
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Chapter 5: Replication and packaging of amplicons using ambUL12 
5.1 Introduction 
This section describes the use of a transient assay, originally described by Stow et al. 
(1983), to further investigate the role of the alkaline nuclease in the replication and 
packaging of HSV -1 DNA. This assay involves transfection of amplicons, plasmids 
that contain the HSV -1 origin of replication and packaging signals, into cells permissive 
for HSV -1 growth. The cells are subsequently superinfected with a helper virus, wt 
HSV -1 or a derivative thereof, which provides functions necessary to replicate and 
package the amplicon. This assay allows the cis and trans-acting factors required for 
the replication and packaging of viral DNA to be studied in detail (Deiss et at., 1986; 
Stow and McMonagle, 1983; Stow et at., 1998). 
5.2 Cloning UL12 and UL12.5 into expression vector pCMV10 
5.2.1. Introduction 
To further characterise the role of UL12 and UL12.5 (the N-terminally truncated form 
of the protein) in the replication and packaging of viral DNA plasmids were produced 
which could would constitutively express the proteins when transfected into mammalian 
cells. 
5.2.2 Cloning ofUL12 and UL12.5 into pCMVI0 
The UL12 and UL12.5 ORFs had previously been cloned by N. Stow from HSV-l 
strain 17 syn + into the baculovirus transfer vector pAc YM 1 to generate the vectors 
pAc12 and pAC12.5. The ORFs were excised from the pAc12 and pAc12.5 constructs 
by digesting 20 ug of vector with BamHI and separating the DNA on a 1 % TBE agarose 
III 
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gel. The bands corresponding to the ORFs were cut from the gel and purified as 
described in Methods. The ORFs were ligated into the MCS of plasmid pCMVlO 
which contains the constitutive HCMV major IE promoter and transformed into 
competent XL 1 O-Gold E. coli (Stratagene). EcoRI / XhoI digests of plasmids isolated 
from the resulting colonies were performed to identify those containing inserts and 
determine their orientations. If inserted in the correct orientation the UL12 and UL12.5 
containing plasmids would each produce a major band of 5.4 kbp and minor bands of 
0.8 and 0.45 kbp respectively (Figure 24). If inserted in the opposite orientation bands 
of 4.6 and 1.6 kbp would be produced for UL12 and 4.25 and 1.6 kbp for UL12.5. 
Large scale DNA preparations were made from two colonies containing plasmids with 
the UL12 and UL12.5 ORFs in the correct orientation and the resulting expression 
constructs were named pE12 and pE12.5, respectively. 
5.2.3 Expression ofUL12 and UL12.5 from pE12 and pE12.5 in BHK cells 
To ensure that pE12 and pE12.5 were expressing the correct products western blots 
were performed on lysates of transfected BHK cells. 
35 mm BHK plates were transfected with 0.5 Ilg of pE12, pE12.5 or mock transfected 
using the calcium phosphate technique described in methods. Separate mono layers were 
also infected with 3 p.f.u. / cell wt HSV-1 or ambULl2. 24 hours post transfection 
(h.p.t.) or 16 h.p.i. cells were harvested, resuspended in 50 III boiling mix, boiled for 10 
min and 10 III of each sample was separated on duplicate 8% SDS-PAGE gels. The 
gels were electroblotted and probed with MAb Ql or PAb BwP12 at a dilution of 
1 :2500. HRP-conjugated Protein A sepharose was added as secondary antibody at a 
dilution of 1: 1000 to detect bound antibody. The membranes were treated with ECL 
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Figure 24 - Restriction enzyme digests of pE12 and pE12.5. 
The ethidium bromide stained agarose gel shows EcoRI (E) digests of pCMV 10, 
pE12 and pE12.S; and EcoRI / XhoI (EIX) digests of pE12 and pE12.S. Sizes of 
particular bands from the hyperladder I (Hyp I) are indicated at the side of the gel . 
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reagent and exposed to autoradiography film. To determine the transfection efficiency 
plates of BHK cells were also transfected with pElacZ. 24 h.p.t. the cells were treated 
with X-gal as described in Methods and the number of positive cells counted. The 
transfection efficiency for BHK cells was generally 10- 30% positive cells. 
Figure 25 shows that pE 12 produced a major band of approximately 85 kDa that 
migrated with the corresponding major band ofwt HSV-1 infected cells. Although the 
85 kDa band was detected with both monoclonal or polyclonal antibodies the Q1 
antibody detected many other breakdown products. Cells transfected with pE12.5 
produced two products, although in reduced amounts compared to pE 12, and these were 
detected only by the BwP12 antibody. The upper band migrated with predicted 
molecular weight of approximately 60 kDa, correlating with the previously reported size 
for UL12.5 (Costa et al., 1983; Martinez et al., 1996b; Bronstein et al., 1997). The 
lower band of approximately 55 kDa has not been previously reported but probably 
represents a breakdown product. This experiment demonstrates that the UL 12 and 
UL12.5 products are expressed by pE12 and pE12.5 respectively. 
5.3 Transient replication and packaging assays using ambUL12 
5.3.1 Introduction 
To determine if the amplicon system yielded results similar to those in virus infected 
cells (see Chapter 3), the levels of replication and packaging of amplicons achieved 
following infection with wt HSV-1 or ambUL12 were compared. In addition the ability 
of the ambUL12 defect to be complemented by the expression of UL12 or ULI2.5, 
supplied in trans, was assessed. 
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Figure 25 - Expression of UL12 and UL12.5 from pE12 and pE12.5. 
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(A) BHK monolayers were transfected with 1 J.lg pE12 (12), pE12.5 (12.5) or mock 
transfected (M). Two mono layers were also infected with 3 p.f.u. / cell wt HSV-1 
(wt) or ambUL12 (amb). 24 h.p.t. or 16 h.p.i. cells were harvested, resuspended in 
50 J.lI boiling mix and boiled for 10 min. Duplicate 10 J.lI samples were separated 
on a 8% SDS-P AGE gel, blotted and probed with MAb Q 1 or P Ab BwP 12. Cells 
were harvested 16 h.p.i. or 24 h.p.t. and Protein A conjugated HRP was used as 
secondary antibody, the membrane washed with ECL reagent and exposed to 
autoradiographic film. (B) A dilution series of wt HSV -1 infected or pE 12 
transfected cells from A were probed with BwP12. The migration of specific bands 
from a Rainbow marker are indicated and the major UL 12 and UL 12.5 bands are 
indicated. Note that the (wt) and (amb) lanes in (A) are also shown in Figure 2. 
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5.3.2 Transient replication and packaging of pSA1 byambUL12 
The amplicon pSA 1 contains the viral origin of replication, oris, and the minimal 
functional packaging signal, Uc-DR1-Ub, which represents the joint between two 
tandem a sequences (Hodge and Stow, 2001). 
BHK monolayers were transfected with 1 /-lg pSA1 in the presence or absence of 1 /-lg 
pE12 or pE12.5 as indicated in Figure 26. The cells were DMSO boosted 4 h.p.t. as 
described in Methods and superinfected 6 h.p.t. with 3 p.f.u. / cell wt HSV-l or 
ambULl2. 16 h.p.i. the cells were harvested and processed for total and DNase-
resistant DNA. Samples representing the DNA recovered from one sixth of a plate were 
digested with EcoRI and DpnI (DpnI digests only the input unreplicated, methylated 
amplicon DNA) and separated on a 0.8% LB-agarose gel. The gel was then Southern 
blotted and probed with 32p labelled pAT153, the parental vector for pSAI. 
From Figure 26 it is clear that both wt HSV-l and ambUL12 are able to replicate and 
package pSAI. Moreover, ambUL12 shows a similar deficiency in replicating and 
packaging pSAl as it does its own genome. Over many experiments the fold decreases 
in replication and packaging ofpSAl, when compared to wt HSV-l, were 5.27 ± 1.83 
and 15.59 ± 7.37 respectively. In an attempt to complement these defects, pE12 or 
pE12.5 was co-transfected along with pSAl. As can be seen in Figure 26 the 
co-transfection ofpE12 is able to complement ambUL12 to a small degree but pE12.5 is 
not. In five separate experiments in BHK cells the fold increase in the replication and 
packaging of pSAI by ambUL12 when pE12 or pE12.5 were co-transfected was 
calculated (Table 2). In support of Figure 26 there was an approximately 2-fold 
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Figure 26 - Transient replication and packaging of pSAl byambUL12. 
BHK mono layers were transfected with 1 ~g pSA 1 either alone (-), or with 1 ~g 
pE12 (12) or pE12.5 (12.5) and superinfected with 3 p.f.u. I cell wt HSV-l (wt) or 
ambUL12 (ambULI2). 16 h.p.i. the cells were harvested and processed for total 
and DNase-resistant DNA. Samples representing one sixth of a plate were digested 
with EcoRI and DpnI and separated on a 0.8% LB-agarose gel. The gel was then 
Southern blotted and probed with 32p labelled pAT153. 4 ng, EcoRI digested pSAI 
was used as a marker. The left panel shows a 2h exposure of the total DNA 
samples to a phosphorimager screen. The right panel shows a 16 h exposure of the 
DNase-resistant samples, taken from the same membrane. 
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increase in the replication and packaging of pSAl when pE12 was co-transfected with 
the amplicon whereas no complementation was seen with pE12.5. 
Table 2. Complementation of pSAl replication and packaging by pE12 and 
pE12.5 
no additional a 
plasmid pE12a pE12.5a 
Replication 1.0 2.24 ± 0.40 0.79 ± 0.15 
Packaging 1.0 2.54 ± 1.06 0.83 ± 0.32 
(a)Replication and packaging ofpSAl by ambUL12 in the absence of added plasmid were assigned 
a value of 1.0 
The average fold increase in replication and packaging upon co-transfection ofpEl2 or pE12.5 were 
calculated .± SD from 5 independent experiments. 
5.3.3 Level of expression of the product expressed by pE 12 
One possible explanation for the low complementation by pE12 seen in the previous 
section was that UL 12 was not expressed at a high enough level. Although the western 
blots in Figure 25 showed apparently similar levels of alkaline nuclease being detected 
in pE 12 transfected cells and wt HSV -1 infected cells it is not clear whether the 
amounts of UL12 present were saturating the antibody. Therefore a series of dilutions 
were performed on celllysates of pE 12 transfected or wt HSV -1 infected BHK cells. 
From the 5 and 10-fold dilution samples shown in Figure 25B it is evident that the 
amount of alkaline nuclease in pE12 transfected cells is reduced approximately 2 - 3-
fold compared to wt HSV -1 infected cells. However, if we consider that only 10 - 30% 
of the transfected BHK cell population will express UL 12 compared to ~ 1 00% of BHK 
cells infected by wt HSV -1, each pE 12 expressing cell probably produces a similar 
115 
Chapter 5: Results 
amount of alkaline nuclease to a virus infected cell. Therefore it is unlikely that the 
actual level of expression of UL 12 from pE 12 is affecting the complementation. 
Interestingly Figure 25B, and to a lesser extent Figure 25A, show that the product 
expressed by pE 12 has a slightly different pattern of breakdown products to that 
expressed by wt HSV -1. It has long been established that the UL 12 product is 
extensively phosphorylated (Marsden et al., 1978; Wilcox et al., 1980; Banks et al., 
1985) and the possibility of further modifications cannot be dismissed. These observed 
differences suggest that viral proteins may have at least some role in the modification or 
breakdown of ULI2. This could be investigated by comparing the UL12 related 
proteins in cells transfected with pE12 and either mock-infected or infected with 
ambULl2. 
5.3.4 Transient replication of amplicons with plasmids expressing the seven DNA 
replication genes 
It has been demonstrated that seven genes encoded by HSV -1 are sufficient and 
necessary for the replication of plasm ids containing either oris or oriL (Wu et al., 1988). 
The HSV-l genes UL5, UL8, UL9, UL29, UL30, UL42 and UL52 were cloned into 
pCMVI0 to create a series of plasmids: pE5, pE8, pE9, pE29, pE30, pE42 and pE52 
(Stow et al., 1993). Transfection of these seven plasmids along with an amplicon are 
sufficient for amp Ii con replication. 
To determine if the co-expression ofUL12 or UL12.5 would augment the replication of 
amplicons in this system 1 ~g of pSAI or pSI (the parent plasmid of pSAI which 
contains oris but no packaging signal) was transfected into BHK cells along with the 
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seven replication plasmids alone, or additionally supplemented with either pE12 or 
pEI2.5. The cells were DMSO boosted, harvested 16 h.p.t. and processed for total 
DNA. Following EcoRl and DpnI digestion the samples were Southern blotted and 
probed with pAT153. 
The fold increase in the replication of pSAI upon co-transfection of pE12 or pE12.5 
was calculated for three separate experiments (Table 3). In contrast to the results using 
wt HSV-l or ambUL12 (section 5.3.2) there is very little increase in replication in the 
presence of ULI2. The small increase in the replication of pSAI samples when 
co-transfected with pE12.5 is difficult to explain since no increase in the replication of 
pS 1 was observed. 
Table 3. Fold increase in replication of pSAI and pSI by the seven HSV-I 
replication genes upon co-transfection of pE12 or pE12.5. 
expt. 1 expt. 2 expt. 3 Average 
pSAI pE12 1.5 1.6 1.5 1.53 
pE12.5 3.3 2.2 2.1 2.53 
pSI pE12 1.4 1.2 1.5 1.36 
pE12.5 2.1 0.6 1.2 1.3 
The failure to observe increased replication of the amplicon in the presence of UL12 
could be due to the levels of expression achieved or may reflect differences between 
replication complexes in transfected and infected cells. As mentioned previously it is 
also possible that UL 12 is differentially modified in transfected versus infected cells 
(Figure 20). 
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5.3.5 Tenninal fragments in packaged pSAI 
The tennini of packaged amp Ii cons can be detected in a similar way to those of genomic 
DNA. Figure 27B shows that digestion of packaged pSA 1 with Sall will give a major 
4.3 kbp band representing the amplicon monomer and minor bands of 1.3 and 3.1 kbp 
signifying Uc (L) tennini and Vb (S) tennini, respectively. Digestion with PstI will 
similarly generate a 3.5 kbp band representing Uc and a 0.9 kbp band representing Vb. 
To investigate the effect of the UL12 gene product on the generation of amplicon 
tenninal fragments, BHK mono layers were transfected with 1 ~g pSA 1 and then 
superinfected with 3 p.f.u. / cell wt HSV-l or ambULl2. 16 h.p.i. the cells were 
harvested and processed for DNase resistant DNA. Duplicate samples were then 
digested with either Sall or PstI, separated on a 0.8% LB-agarose gel and Southern 
blotted. The blot was then probed with radiolabelled pAT153. 
It can be seen in Figure 27C that when wt HSV-l or ambUL12 were used as helper 
virus the larger Pst! and Sall tenninal fragments, representing the equivalent of the long 
and short tennini of viral DNA, respectively, were readily detected in both instances 
(The smaller fragments were more difficult to detect because they shared much less 
homology with the probe). 
5.4 Amplicon Recombination Studies 
5.4.1 Introduction 
It is clear from the previous section that ambUL12 shows similar impainnent in the 
replication and packaging of amplicons as it does its own genome. However, when 
compared to the HSV -1 genome, amplicons have a much simpler structure suggesting 
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Figure 27 - Termini of packaged pSAl. 
(A) Diagram representing pSAl. The regions containing oris and the a sequence 
(Ub-DRI-Uc) are indicated by thickened boxes. The cleavage site between Ub and 
Uc is indicated by an arrow. The Sail and Pstl cleavage sites are indicated. (B) 
Diagram represents packaged concatemers, although only two full monomer repeats 
are shown. The Sail and Pst! cleavage sites are indicated with the expected 
restriction fragment sizes shown below. (C) BHK monolayers were transfected with 
pSAI and superinfected with wt HSV-l (wt) or ambUL12 (amb). Cells were 
harvested 16 h.p.i. and processed for DNase-resistant DNA, digetsed with SaIlor 
Pstl , blotted and probed with radiolabelled pAT153. The 3.5 and 3.1 kbp 
fragments , generated by Sail and Pstl digestion, respectively, and the 4.3 kbp 
monomer are indicated by arrows. 
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that their replication and packaging intermediates may not be as complex. Many studies 
have shown that amplicons recombine during replication driven by wt HSV -I helper 
viruses (Dutch et al., 1992; Dutch et al., 1994) and also by a nuc mutant helper virus 
(Martinez et al., 1996a). However these experiments examined inversion events that 
occur through intra-molecular recombination. Only a recent paper by Fu et al. (2002) 
has examined intermolecular recombination of plasmids replicated by HSV-l. In an 
effort to study the effects of intermolecular recombination when using ambULI2 as the 
helper virus, modifications were made to the pSA 1 amplicon to allow detection of 
intermolecular recombination and to limit the extent to which branch migration can 
occur along amplicon concatemers. 
5.4.2 Cloning ofpSAlx 
To be able to detect intermolecular recombination between two concatemers a 
derivative of pSAI in which the unique EcoRI site was changed to a unique XbaI site 
was constructed. Figure 28 shows a schematic representation of the cloning strategy. 
An oligonucleotide was designed that would create an XbaI restriction site when self 
annealed and ligated into an EcoRI restriction site. 5 I-lg of oligonucleotide was self 
annealed by heating to 70°C for 10 min, followed by 2 min at 100°C and finally 
incubated at 37°C for 30 min. The annealed oligonucleotide was ligated into EcoRI 
digested pSAI and the product EcoRI digested to relinearise any self ligated vector. 
The reaction was heat inactivated, phenol/chloroform extracted and the product 
transformed into competent DH5 E. coli. Colonies were picked and the plasmid DNA 
from transformed cells was tested for the presence of the new XbaI site (Figure 28). A 
plasmid with the required restriction site was designated pSAlx. 
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Figure 28 - Cloning of pSAlx. 
(A) Schematic representation of cloning strategy and position of restriction sites 
within the plasmids: (1) The oligonucleotide was self annealled, (2) pSA 1 plasmid 
was EcoRl digested, (3) the annealed oligo was ligated into the digested plasmid to 
create a new XbaI site and remove the EcoRl site. (B) Ethidium bromide stained 
agarose gel demonstrating the insertion of the XbaI restriction site. 1 Ilg of pSA 1 
and pSAlx were each digested with EcoRl (E) andXbaI (X). 
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5.4.3 Cloning ofpSAlinv 
When recombination occurs between two homologous DNA sequences spontaneous 
branch migration can occur in both directions. In theory branch migration along 
homologous plasmid concatemers can continue until another Holliday junction is met or 
the junction is resolved when the end of a concatemer is reached. Due to the frequent 
ULand Us segment inversions that occur within replicating HSV -1 concatemers 
(Slobdeman and Simmons, 1997) during replication of the HSV -1 genome any branch 
migration would be curtailed when segments with the opposite orientation were 
encountered. In order to mimic the HSV -1 sequence inversion events in replicating 
amplicons, the plasmid pSAlinv was constructed where the sequence around oris was 
inverted (Figure 29). If pSAI and pSAI inv molecules recombine, branch migration 
would be expected to be blocked by the inverted sequence, limiting branch migration to 
approximately 3.5 kbp. 
pSAlinv was constructed by performing a double digest of pSAI with EcoRV and 
PshAI to produce two fragments of 3.3 and 1.0 kbp. Due to the differing optimal 
digestion temperatures, the PshAI digestion was performed first at 25°C. The products 
were phenol/chloroform extracted then digested with EcoRV. The fragments were 
re-ligated and transformed into DH5 cells and the resultant colonies picked and 
screened for plasmids containing both fragments but with the shorter fragment in the 
opposite orientation relative to pSAI. EcoRI / Sail digestion of the derived plasmid 
should produce fragments of 3.8 and 0.5 kbp whereas pSAI will produce fragments of 
3.0 and 1.3 kbp. As can be seen in Figure 29C both bands of pSAI can be clearly 
detected. A plasmid, pSAI inv, was identified with the insert in the opposite orientation. 
Figure 29C demonstrates the presence of the predicted 3.8 kbp fragment of pSAlinv. 
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Figure 29 - Cloning of pSAlinv. 
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(A) Schematic representation of pSAI showing the position of various restriction 
enzyme cleavage sites. The relative orientation of oris is indicated by the arrow. 
(B) Schematic representation of pSAlinv. Note the changed orientation of oris. 
The inverted region of the plasmid is marked in red. The new position of the Sail 
restriction site is shown. The EcoRV and PshAI sites are absent in pSA 1 inv. 
(C) 1 /-lg of pSAI and pSAlinv were double digested with EcoRI and Sail and 
separated on a 0.8% TBE-agarose gel. 
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Although the smaller 0.5 kbp band cannot be detected in Figure 29C it was seen as a 
very faint band in other digests. 
5.4.4 Recombination between pSAI, pSAlx and pSAIinv amplicons 
To analyse recombination between replicating amplicons pSAI or pSAlinv were 
transfected either alone or with pSAlx and superinfected with wt HSV-l or ambULI2 
as helper virus. Cells were then processed for total DNA 16 h.p.i., the DNA digested 
with DpnI in combination with EcoRI and/or XbaI and separated on a 0.6% LB-agarose 
gel. The gel was Southern blotted and probed with 32p labelled pAT153 (Figure 31). 
If no recombination occurs between pSAI and pSAlx or between pSAlx and pSAI inv 
concatemers digestion with either EcoRI or XbaI alone should produce two distinct 
bands representing the cleaved monomeric form of one amplicon and the hmw 
undigested concatemeric product of the other. However, if recombination does occur 
then digestion by either enzyme alone would be expected to produce a ladder of bands 
(Figure 30). As can be seen in Figure 3IA digestion of replicated pSA 1 or pSA 1 inv by 
EcoRI produced only the monomer band when using either wt HSV-l or ambUL12 as 
the helper virus (lanes 1, 2, 11 and 12). However, EcoRI digests of samples co-
transfected with pSAlx and either pSAI or pSAIinv produced a ladder of bands from 
the monomer up to the region of non-resolution (lanes 3, 5, 7 and 9). This occurred 
when either wt HSV-I or ambULI2 provided the helper functions, although with 
ambUL12 the ladder of bands was fainter (lanes 5 and 9). Digestion of the DNA from 
co-transfected samples with a combination of EcoRI and XbaI resulted in only a 
monomer band, which was present at approximately twice the amount of the monomer 
obtained from the single EcoRI digestion. This indicates that pSAlx was contained 
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Figure 30 - Potential structures of amplicon concatemers after co-transfection 
and replication of pSAl and pSAlx. 
(A) Structure of pSAl and pSA l x indicating the unique EcoRI and XbaI restriction 
sites, respectively. The position of the a sequence and origin or replication (oris) 
are shown. (B) In the absence of recombination, concatemeric replication products 
of the amplicons will contain only the unique EcoRI (E) or XbaI (X) site. The 
position of the a and oris sequences have been omitted for clarity. (C) In the event 
of intermolecular recombination events concatemeric molecules will contain both 
EcoRI (E) or XbaI (X) restriction sites, giving rise to ladders of bands depending on 
the distances between cross-over points. 
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Figure 31 - Recombination of pSAlx with pSAl and pSAlinv. 
Monolayers of BHK cells were transfected with a combination of pSA 1, pSA 1 x and 
pSAlinv as indicated and superinfected with (A) wt HSV-l (wt) or ambUL12 
(amb), or (B) ambUL 12. 16 h.p.i. the cells were harvested and processed for total 
DNA. All samples were digested with DpnI and EcoRI (E) and/or XbaI (X) as 
indicated. Samples were separated on 0.6% LB-agarose gels, Southern blotted and 
probed with 32p labelled pAT153. The positions of amplicon monomers are 
indicated with an arrow. 
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mostly within the ladder of bands above the monomer band. In a separate experiment 
using ambUL12 as a helper virus, pSAl and pSAlx were transfected alone or together 
and processed for replicated DNA. As can be seen in Figure 31 B when the pSA 1 or 
pSAlx products were digested with XbaI or EeaRI, respectively (lanes 2 and 3), no 
digestion occurred and the hmw concatemers migrated in the region of non-resolution. 
In contrast, digestion of these DNA with EeaRI or XbaI, respectively, resulted in the 
expected monomeric product (lanes 1 and 4). The presence of a ladder when the 
product of co-transfected cells were digested with EeaRI (lane 6), confirms that pSAl 
and pSAlx recombine when using ambUL12 as a helper virus. 
5.4.5 Replication and packaging ofpSAl, pSAlx and pSAlinv 
To ensure that pSAlx and pSAlinv behaved in a similar manner to pSAl their ability to 
be replicated and packaged was tested. BHK mono layers were transfected with a total 
of 1 /-lg of pSA1, pSAlx, pSAlinv, pSAl plus pSAlx or pSAlx plus pSAlinv, 
superinfected with wt HSV-l or ambUL12 and harvested 16 h.p.i .. Total and DNase-
resistant DNA was prepared from the cells and digested to a monomeric product with 
DpnI and EeaRI and/or XbaI as appropriate. The DNA was separated on a 0.8% LB-
agarose gel, Southern blotted and probed with 32p labelled pAT153. 
From Figure 32 it is evident that wt HSV -1 is able to replicate and package all the 
amplicons with similar efficiency. AmbUL12 also replicated and packaged all the 
amplicons and combinations thereof to similar levels, although at reduced efficiency 
compared to wt HSV -1. Although the complexity of the various amplicon DNA 
replication intermediates was not studied directly it was predicted that the 
pSAlx/pSAlinv co-transfection might produce the most complex intermediates because 
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Figure 32 - Replication and packaging of pSAl, pSAlx and pSAlinv. 
total 
DNase 
res istant 
BHK mono layers were transfected with 1 Ilg pSA 1, pSA 1 x, pSA 1 inv or co-
transfected with 0.5 Ilg pSA1 and pSA1x, or pSA1x and pSA1inv. The mono layers 
were then superinfected with wt HSV-1 (wt) or ambUL12 (amb). Total and DNase-
resistant DNA was prepared 16 h.p.i. The pSA1 and pSA1inv samples were 
digested with DpnI and EcoRl. pSA1x was digested with DpnI and XbaI and the 
pSAl/pSA1x and pSA1x/pSA1inv samples were digested with DpnI, EcoRl and 
Xba!. The fragments were then resolved on a 0.8% LB-agarose gel , Southern 
blotted and probed with 32p labelled pAT153. 
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the migration of branches might become stalled at positions where homology ceased 
due to the inversion. However, with this combination of amplicons there was no effect 
in the level of DNA packaged suggesting either that these products are not more 
complex, or that any increased complexity does not inhibit packaging even in the 
absence of the UL 12 product. 
5.5 Effect of the arrangement of the packaging signal on the packaging of 
amplicons by ambUL12 
5.5.1 Introduction 
To determine if the packaging defect found in the ambUL12 mutant was due to the 
manner in which it detected and utilised the cleavage and encapsidation signal, 
packaging assays were performed on amplicons containing different a sequence 
arrangements or more specific mutations within the various a sequence motifs. 
5.5.2 Gross rearrangement of a sequences and effect on packaging 
The amplicon pSA 1 contains the minimal sequence, spanning the junction of two 
tandemly repeated a sequences, that is required to direct packaging of HSV -1 viral 
DNA (Hodge and Stow, 2001). To determine if other arrangements of a sequences 
would affect the packaging process, replication and packaging assays were performed 
with amplicons pYl and pZ1 (Figure 33), containing a single complete, or two 
tandemly repeated a sequences, respectively. 
The amplicons pSA1, pY1 and pZ1 were transfected into mono layers of BHK cells in 
35 mm dishes. The cells were DMSO boosted 4 h.p.t. and superinfected with 3 p.f.u. / 
cell ambUL12 or wt HSV-1 at 6 h.p.t.. The cells were harvested 16 h.p.i. and total and 
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Figure 33 - Arrangement of packaging signals in pSAI, p YI and pZl. 
Structure of the packaging signal within (A) pSAl , (B) pYI and (C) pZl. The 
arrangement of the DRl , Ub and Uc sequences within each of the amplicons is 
shown with the coloured boxes. The dotted line represents the remainder of the 
plasmid 
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DNase-resistant DNA was prepared. After digestion with EcoRI and DpnI the samples 
were separated on a 0.8% LB-agarose gel, Southern blotted and the membrane probed 
with radiolabelled pAT153. 
Figure 34A shows a typical result from one such experiment and demonstrates that wt 
HSV-l is able to replicate and pSAl, pZl and pYl to similar levels. Although 
ambUL12 exhibited a reduced replication and packaging efficiency compared to wt 
HSV1, it was also able to package all three amplicons to similar levels. The apparent 
reduced replication of pYI and pZI compared to pSAl in the presence of ambUL12 
(Figure 34A) was not reproducibly observed. Figure 34B shows that over seven repeat 
experiments all three plasmids exhibited a similar 5 - 8 fold decrease in replication in 
the presence of ambUL12 compared to wt HSV-l. Similarly, 15 - 25 fold reductions in 
packaging were observed with all three plasmids in the presence of ambUl2. Because 
the standard deviations are relatively high it is not possible to conclude whether the 
relatively greater impairment ofpYl packaging in the presence of ambUL12 represents 
a real effect. 
5.5.3 Ability of ambUL12 to package and propagate amplicons with mutations in the 
packaging signal 
Although there was no significant difference in the ability of ambUL12 to replicate and 
package amplicons that contained different permuted forms of complete a sequences, a 
recent study by Hodge and Stow, (2001) showed that deletion and substitution 
mutations affecting various a sequence motifs within the Uc-DRI-Ub sequence ofpSAl 
altered the ability of the amplicon to be packaged or propagated in the presence of wt 
HSV -1. In particular, deletions within the pac 1 motif allowed the modified amplicon to 
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(A) Monolayers ofBHK cells were transfected with pSAI , pZI or pYI as indicated 
and superinfected with 3 p.f.u. / cell wt HSV-I (wt) or ambUL1 2 (amb). 16 h.p.i . 
the mono layers were harvested and total and DNase-resistant DNA prepared. The 
DNA was then digested with EcoRI and DpnI, Southern blotted and probed with 32 p 
labelled pA TI53. (B) Graphical representation of the fold-decrease in the 
replication and packaging of each of the amplicons when using ambUL 12 as 
helpervirus compared with wt HSV -I. The chart shows the mean of seven separate 
experiments ± the S.D. 
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be packaged to the same level as pSAl but caused a reduction in efficiency with which 
it could be serially propagated. The amplicons pPH 11 and pPH 12 have deletion and 
substitution mutations, respectively, affecting the pac 1 distal GC element. The pPH21 
and pPH22 constructs have deletion and substitution mutations which affect the pac 1 
proximal GC element. If the alkaline nuclease has no direct role in recognising or 
interacting with the a sequence then we would expect these amplicons to be packaged 
and propagated with the same efficiencies relative to pSAI by either ambUL12 or wt 
HSV-l. Any differences between wt HSV-I and ambUL12 may indicate that the 
nuclease does have a more direct interaction involving these pac 1 motifs. 
BHK mono layers were transfected with pPHll, pPHI2, pPH21 or pPH22 also using 
pSAl and pSI as positive and negative controls. Following transfection the cells were 
superinfected with 3 p.f.u. / cell wt HSV-I or ambULl2. The medium was removed 
from the mono layers 16 h.pj., cell debris pelleted and the supernatant, containing 
released virus particles, retained. Total and DNase resistant DNA were then prepared 
from the cells. Fresh mono layers were inoculated with 0.5 ml samples of the media 
along with 3 p.f.u. / cell wt HSV-l. The addition of fresh wt HSV-I helper was 
required to facilitate the replication of amplicons packaged by ambUL12 since the yield 
of infectious mutant helper virus is insufficient to enable infection at an appropriate 
m.oj.. After one hour the inoculum was removed and the monolayers washed with acid 
glycine to inactivate any virus that had not penetrated the cells. The infected 
monolayers were then harvested 24 h.pj and total DNA was prepared. All samples 
were then digested with DpnI and EcoRI, Southern blotted and probed with 32p labelled 
pATl53 (Figure 35). 
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Figure 35 - Propagation of amplicons with mutations in the pac! sequence. 
Monolayers of BHK cells were transfected with the amplicons as indicated and 
superinfected with 3 p.f.u. / cell wt HSV-1 or ambUL12 . Total (A) and DNase-
resistant (B) DNA were prepared 16 h.p.i. The media removed from the monolayers 
were used to infect fresh monolayers along with an additional 3 p.f.u. / cell wt 
HSV -1. 1 hr after the addition of the inoculum the monolayers were washed with 
acid glycine. The monolayers were harvested 24 h.p.i. and total DNA prepared (C). 
All samples were digested with EcoRI and DpnI, separated on an agarose gel , 
Southern blotted and probed with 32p labelled pAT153. The gels were exposed to a 
phosphorimager screen for the times indicated. 
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Figure 35A shows that all the amplicons replicated to similar levels when using either 
wt HSV-I or ambULl2 as helper virus, although as before more DNA accumulates in 
the presence ofwt HSV-I than ambULl2. The middle panel also shows that wt HSV-l 
packages all the amplicons to a similar level apart from pS I which lacks any a 
sequence. A very faint band of packaged pSI was visible but represented only 0.2% of 
the pSAl signal. AmbULl2 also packaged the amplicons containing mutated packaging 
signals to similar levels as pSAl. Surprisingly pS 1 was packaged in greater amounts by 
ambUL12 than wt HSV-I, representing 14% of the ambULl2 pSAI signal. The lower 
panel clearly shows that all the mutant amplicons derived using wt HSV-I or ambUL12 
as helper are propagated with reduced efficiency compared to pSAI. It is interesting to 
note that the pSI amplicon derived from ambUL12 but not wt HSV-I infected cells was 
able to be serially propagated. 
The mean packaging and propagation efficiencies of the amplicons compared to pSAI 
over three separate experiments were determined and are shown in Figure 36. It is clear 
from Figure 36A that the packaging efficiencies relative to pSAl of all the amplicons 
except pSI were similar whether either wt HSV-l or ambULl2 was providing helper 
functions. The only significant difference between the two viruses was the ability of 
ambUL12 to package relatively greater amounts of pSI. In agreement with previous 
results the mutated amplicons were propagated less efficiently than pSAI when using 
wt HSV-l helper virus (Hodge and Stow, 2001). This was also true for the amplicons 
from ambUL12 infected cells but the patterns of impairment differed from those seen 
with wt HSV-I. In relative terms pPHll and pPHl2 were propagated 3-8 fold more 
efficiently from cells that were initially infected with ambULl2. In contrast pPH21 and 
pPH22 were propagated relatively more efficiently from cells initially infected with wt 
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Figure 36 - Ability of amplicons with mutated Uc-DRI-Ub motifs to be 
packaged and propagated. 
The mean and standard deviation of three independent experiments performed as 
described in Figure 35 were calculated and displayed graphically. The packaging 
(A) and propagation (B) efficiencies were calculated relative to pSA 1 when using 
either wt HSV-l (wt) or ambUL12 (amb) as original helper virus. 
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HSV -1. In fact the pS 1 amplicon was propagated as efficiently as pPH2I and pPH22 
from cells infected with ambULI2 even though it contains no recognised packaging 
signal. It should be noted that although DNase-resistant pS 1 was occasionally detected 
at very small levels in wt HSV -1 samples no product was ever detected in passaged 
samples. These results indicate that there may be subtle differences between the 
recognition and use of the packaging signal in wt HSV-I and ambULI2 infected cells 
giving rise to differences in the efficiencies with which packaged molecules can be 
propagated. Moreover, it was possible to package and propagate molecules derived 
from plasmids that contain no known packaging signal following infection of the 
transfected cells with ambULI2. 
5.6 Packaging of the pSI amplicon by ambULI2 
5.6.1 Introduction 
The packaging of the pSI amplicon by ambULI2 suggests that the nuclease may 
function, in part, to control specificity of the packaging substrate. The next section aims 
to demonstrate that the detected pS 1 molecules were truly encapsidated and not just an 
artefact of the assays described. 
5.6.2 Packaging of pSI by ambULI2 is reduced upon co-transfection ofpEI2 
If, as suggested by the above experiments, the alkaline nuclease is involved In 
increasing specificity of packaging, co-transfection of the ULI2 expressing plasmid 
pEI2 should reduce the packaging levels of pSI when ambULI2 is used as a helper 
VIruS. 
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To test this hypothesis BHK mono layers were transfected with 1 ~g each of pSA I, pS 1, 
pSI plus pEI2 or pCMVIO. The monolayers were superinfected with 3 p.f.u. / cell wt 
HSV-I or ambULl2. To con finn that the pSI molecules were packaged into viral 
capsids and had not become DNase-resistant by some other means, the HSV -1 UL 19 
null mutant K5~Z (Desai et al., 1993) was also used as a helper virus. UL19 encodes 
the major capsid protein and therefore capsids do not fonn in a non-complementing cell 
line infected with K5~Z. BHK or 19-1 cells (a cell line complementing ULI9 null 
mutants: V. Preston, unpublished) were similarly transfected with pSAI, pSI or 
pCMVIO and infected with 3 p.f.u. / cell K5~Z. All monolayers were harvested 16 
h.p.i. and processed for total and DNase-resistant DNA, digested with DpnI and EcoRI, 
Southern blotted and probed with 32p labelled pATI53 (Figure 37). 
As can be seen, wt HSV-l replicated pSAI and pSI to similar levels but only pSAI was 
packaged to significant levels. There is a very faint band in the DNase-resistant pSI 
lane but it represents less than 0.5% of the corresponding pSAI signal. In BHK cells 
K5~Z also replicated pSAI and pSI to the same level as wt HSV-l but no DNase-
resistant DNA was detected with either amplicon. However, in the complementing 19-1 
cells DNase-resistant DNA was present in the pSAI lane indicating that the resistance is 
a result of insertion into viral capsids. When amb UL 12 was used as helper virus both 
pSAI and pS I were again replicated to similar levels, although reduced compared to wt 
HSV -1 and K5~Z. Nonetheless, both amplicons were evidently packaged. Although 
ambUL12 packaged pSI slightly less efficiently than pSAI the amount packaged was 
significantly greater than when wt HSV-I was used as helper. Also, when pEI2 was 
co-transfected with pSI and ambULI2 used as helper virus, the replication of pSI was 
increased but the level of DNase-resistant DNA was decreased. This confirms earlier 
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Figure 37 - Reduction in packaging of pSI by ambULl2 upon co-transfection 
ofpEl2. 
BHK or 19-1 monolayers were transfected as indicated and superinfected with 3 
p.f.u. / cell wt HSV-1 (wt), ambUL12 (amb) or K5~. Cells were harvested 16 
h.p.i . processed for total DNA (upper panel) and DNase-resistant DNA (lower 
panel). Samples were digested with DpnI and EeaR!, separated on an 0.8% agarose 
gel, Southern blotted and probed with 32p labelled pAT153. The lower panel shows 
an approximately 10-fold longer exposure to a phosphorimager screen than the 
upper panel . 
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results that the alkaline nuclease is required for maximum levels of DNA synthesis and 
provides further evidence that the enzyme may be involved in conferring substrate 
specificity during viral genome packaging. 
Since a small amount of DNase-resistant DNA was present in the wt HSV-lIpSI 
samples a similar experiment was performed in both BHK and Vero cells to determine 
whether this was a cell type specific phenomenon. The plasmids pSA 1, pS 1, pE 12 and 
pEI2.5 were transfected into Vero or BHK cells as indicated in Figure 38 and 
superinfected with wt HSV-I or ambULI2. The cells were then processed for total and 
DNase-resistant DNA, digested with DpnI and BamHI, Southern blotted and probed 
with radiolabelled pGXI53 (which detects both the viral Bam HI P fragment and the 
replicated amplicon). 
Figure 38 shows that wt HSV-I genomes were replicated and packaged to similar levels 
in the two cell lines; the same is true of the ambULl2 genomes although at lower levels. 
In agreement with the results of Figure 37, wt HSV-I replicated pSAI and pSI to 
similar levels in BHK cells but only pSAI was packaged to a significant degree 
(although a very small amount of DNase-resistant DNA was detected in the pSI 
sample). No DNase-resistant pSI was detectable in the wt HSV-I Vero samples even 
though the plasmid had been replicated to the same extent as pSAl. In contrast, 
ambULl2 clearly packaged pSI in both cell lines. The co-transfection of pEI2 with 
pS I when using ambULl2 as helper again increased replication and decreased 
packaging of the amp licon, but not the viral DNA. Although the co-transfection of 
pE12.5 appears to increase the level of replication of pSI by ambULI2 in BHK cells 
this was a not reproducibly observed (see Table 2) and did not occur in the Vero cells 
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Figure 38 - Replication and packaging of viral and amplicon DNA in BHK and 
Vero cells. 
BHK (A) and Vero cells (B) were transfected with the plasmids pSA 1, pS 1, pE 12 
and pE12.5 as indicated or mock transfected (-) and superinfected with wt HSV-l 
(wt) or ambUL12 (amb). Total and DNase resistant DNA were prepared 16 h.p.i. , 
digested with DpnI and BamHI, Southern blotted and probed with 32p labelled 
pGX153. Total DNA panels are 2 hr exposures whereas the DNase-resistant DNA 
panels are 18 hr exposures. The position of the amplicon and viral DNA bands are 
indicated. 
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(Figure 38). Nevertheless, in both the BHK and Vero samples, co-transfection of 
pE12.5 lowered the level of packaging of pSI to a similar extent to pE12. 
5.6.3 Propagation of pSAl and pSI in BHK cells using wt HSV-l, ambUL12 and 
ambUL12R 
To confirm that the observed packaging of pSI by ambUL12 was a consequence of the 
lesion in the UL12 gene, the ambUL12 rescuant, ambUL12R, was used alongside wt 
HSV -1 and the null mutant in a packaging and propagation assay. 
BHK mono layers were transfected with 1 ~g ofpSAl or pSI and infected with 3 p.f.u. / 
cell wt HSV-1, ambUL12 or ambUL12R. 16 h.p.i. the cells were harvested and total 
and DNase-resistant DNA prepared. The growth medium was retained from the 
harvested cells and sonicated extensively. Duplicate plates of fresh BHK cells were 
inoculated with 0.5 ml of these media supplemented with 3 p.f.u. / cell wt HSV -1. One 
hour after the addition of inoculum the plates were acid glycine washed and to one set 
of plates 200 ~g mr! phosphonoacetic acid (P AA) was added to inhibit viral DNA 
synthesis. Total DNA was prepared 24 h.p.i.. All samples were digested with DpnI and 
EeaR!, Southern blotted and probed with 32p labelled pAT153. 
Figure 39 shows that wt HSV-1 and ambUL12R replicated pSAl and pSI to similar 
levels. Only pSAl was present in significant amounts in the DNase-resistant samples, 
although very faint pSI bands were visible. Again ambUL12 replicated the amplicons 4 
to 5-fold less efficiently than the other viruses, and DNase-resistant DNA was present in 
both the pSA 1 and pS 1 samples. Propagation of the virus from the plates originally 
infected with wt HSV-l or ambUL12R (in the presence of additional wt HSV-l helper) 
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Figure 39 - Propagation of pSAI and pSI using wt HSV-I, ambULl2 and 
ambUL12R. 
Monolayers of BHK cells were transfected with pSAl or pS 1 and superinfected 
with 3 p.f.u. / cell wt HSV-1 (wt), ambUL12 or ambUL12R (12R). Total and 
DNase resistant DNA was prepared 16 h.p.i. Duplicate monolayers of fresh BHK 
cells were each inoculated with 0.5ml of media retained from the harvested cells 
along with 3 p.f.u. / cell wt HSV -1. 1 hour after inoculation the plates were washed 
with acid glycine and medium added. 200 ~g ml- 1 P AA was added to one set of 
plates. 24 h.p.i. total DNA was prepared. All samples were digested with DpnI and 
EcoRl , blotted and probed with 32p labelled pAT153 . 
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showed that pSA I but not pS I molecules could be efficiently passaged. In contrast, 
similar passaging of the virus from the plates originally infected with ambUL12 resulted 
in the propagation of both pSAI and pSI. The control infections in the presence of 
P AA demonstrate that the signals detected following propagation result from replication 
and not the presence of residual input DNA. It should be noted that if additional wt 
HSV-I is not added the low yield of infectious ambUL12 allows serial propagation to 
be performed at only a low m.o.i. «1) and as a consequence packaged amplicons can 
not be efficiently passaged (data not shown). 
5.6.4 Packaging of pS I by wt HSV -1 at different multiplicities of infection and in 
different cell lines 
It was possible the low level packaging of pS 1 by wt HSV -1 might be a consequence of 
infecting the cells at a relatively high m.o.i.. To determine if this was the case 
mono layers of BHK cells were transfected with pS I and then superinfected with wt 
HSV -1 at an MOl of 0.1, 1, 3 and 10. As a control monolayers of BHK cells were also 
transfected with pSAI or pSI and superinfected with 3 p.f.u. / cell wt HSV-l or 
ambULI2. All mono layers were harvested 16 h.p.i. and processed for total and DNase-
resistant DNA. The samples were digested with DpnI and EcoRI, Southern blotted and 
probed with 32p labelled pAT153. 
From Figure 40 it is apparent that the m.o.i. with wt HSV -1 did not have a great effect 
on either the replication (upper panel) or packaging (lower panel) of pS 1. Although the 
levels of replication of pSI and pSAI were very similar when using wt HSV-l as helper 
virus, pSI was packaged at less than I % of pSAI levels at each m.o.i. tested. In 
contrast, ambUL12 packaged pSI at approximately 35% of the pSAI level. In absolute 
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Figure 40 - Packaging of pSI by wt HSV-I at different MOIs. 
BHK mono layers were transfected with pS 1 or pSA 1 and superifected with wt 
HSV-l or ambUL12 at the m.oj. indicated. Total (upper panel) and DNase-
resistant DNA (lower panel) was prepared 16 h.pj. , digested with EcoRl and DpnI, 
blotted and probed with 32p labelled pAT153. The numbers below the DNase-
resistant lanes indicate the percentage of total DNA that is detected in the DNase-
resistant samples. 
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terms, ambUL12 packaged 2 - 10-fold more pSI than wt HSV-I, which is also 
consistent with previous experiments. 
The ability of wt HSV -1 to package pS 1 was also examined in 293 cells. Monolayers of 
Vero, 293 and BHK cells were transfected with 1 ~g pSA 1 or pS I, superinfected with 3 
p.f.u. / cell wt HSV-1 and incubated for 16 h. The cells were harvested and DNase-
resistant DNA prepared. This was digested with EcoRI and DpnI, blotted and probed 
with 32p labelled pAT153. 
The 2 h exposure of the blot shown in Figure 41B demonstrates that pSAl was readily 
packaged in all three cell lines, although at varying levels. This was probably due to the 
varying transfection levels between the cell lines. DNase-resistant pS 1 was detected 
only in the BHK sample even on a 24 h exposure of the blot. It should be noted that the 
pSAl bands from 293 and Vero cells in the long exposure are more intense than the 
BHK band in the 2 h exposure in which packaging of pS 1 in BHK cells was 
nevertheless apparent. Therefore, some property of BHK cells appears to allow pS 1 to 
be packaged at low levels by wt HSV -1. 
5.6.5 pS 1 is not integrated into the viral genome 
It was shown in section 4.3.3 that the pSAl amplicon recombined at a high frequency. 
This suggests the possibility that replicated pS 1 concatemers might be able to integrate 
into the viral genome DNA through oris, thereby becoming linked to a cis-acting a 
sequence and gaining the ability to be packaged. 
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Figure 41 - Packaging of pS 1 by wt HSV -1 in 293, BHK and Vero cells. 
Monolayers of 293 , BHK and Vero cells were transfected with pSAl or pS 1 and 
superinfected with 3 p.f.u. / cell wt HSV -1. 16 h.p.i. DNase-resistant DNA was 
prepared, digested with DpnI and EcoRI, blotted and probed with 32p labelled 
pAT153. The upper and lower panels show 2 and 24 h exposures of the same blot, 
respectively. 
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To determine if this was the case the Structure of the packaged amplicons was examined 
in greater detail. BHK monolayers were transfected with pSAI or pS 1 and 
superinfected with 3 p.f.u. I cell wt HSV-l or ambUL12 and incubated for 16 h. The 
cells were harvested and DNase-resistant DNA prepared. The samples were digested 
with EcoRlIDpnI, KpnIIDpnI or DpnI alone, blotted and probed with pAT153 (Figure 
42A). After exposure to a phosphorimager screen the membrane was stripped and 
reprobed with 32p labelled HSV -1 genomic DNA (Figure 42B). 
When digested with EcoRl (Figure 42A, lanes 1-4 and 42B, lanes 1-4) pSAI and pSI 
produce the expected monomer bands whereas the viral DNA produces a typical EcoRI 
restriction pattern. In agreement with the results described in section 3.3.5, ambUL12 
produced a less distinct pattern that contains considerable smearing. When the samples 
were digested with KpnI, which digests viral DNA but not amplicon DNA the viral 
DNA produced the expected restriction pattern (Figure 42B, lanes 4-8) while the 
majority of the amplicon DNA ran in the region of non-resolution (Figure 42A, lanes 4-
8). The ladder of weaker bands below the region of non-resolution in Figure 42A (lanes 
4-8) represent a ladder of packaged monomeric, dimeric, trimeric, etc. molecules that 
have been described previously (Vlazny et al., 1982). Digestion of the samples with 
DpnI will digest only unreplicated amplicon DNA. In Figure 42A the migration of the 
replicated amplicon DNA is unaltered when compared with the KpnI digest but the viral 
DNA (Figure 42B) now runs in the region of non-resolution. 
These results indicate that the pS 1 molecule is being packaged independently from the 
viral DNA. Although it is difficult to exclude that a small amount of pS 1 is integrated 
there are three strong arguments against this: (i) the pS 1 amplicon behaves like pSA 1 
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Figure 42 - Restriction patterns of DNase-resistant amplicon and viral DNA. 
Monolayers of BHK cells were transfected with pSAl or pS 1 and superinfected 
with wt HSV-l (wt) or ambUL12 (amb). DNase-resistant DNA was prepared 16 
h.p.i. and digested with EcoRI and DpnI (E/D) , KpnI and DpnI (KID) or with DpnI 
alone (D). The DNA was separated on a 0.6% agarose gel, Southern blotted and 
probed with 32p labelled pAT153 (A). The blot was then stripped and re-probed 
with 32p labelled HSV -1 genomic DNA (B). 
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which is known to be independently replicated and packaged, (ii) taken together, the 
EcoRI, KpnI and DpnI samples indicate that the replicated pS 1 DNA is concatemeric, 
(iii) physical packaging limits of the viral capsid would allow approximately only 12 
kbp of integrated pS 1 to be incorporated into the virus and the bands running in the 
region of non-resolution are at least 28 kbp in length. 
5.7 Studies of replicated amplicons by Pulsed Field Gel Electrophoresis 
5.7.1 Introduction 
To further investigate the structure of amplicon DNA, PFGE was used to examine the 
replication products generated from pSAI and pSI when using wt HSV-l and 
ambUL12 as helper-viruses. 
5.7.2 Pulsed field gel analysis of replicated amplicon DNA 
To determine if amplicons produced hmw intermediates analogous to viral DNA, 
mono layers of BHK cells were transfected with pSAI and superinfected with 3 p.f.u. / 
cell wt HSV-l or ambULl2. The cells were harvested 16 h.p.i., embedded in agarose 
blocks and total DNA prepared in situ. One third of each block was then placed in a 1 % 
pulsed field agarose gel and subjected to PFGE for 16 h at 6 v / cm, 14°C with a switch 
time of 1 - 15 secs. The gel was blotted and probed with 32p labelled pAT 153 (Figure 
43A). The blot was subsequently stripped and re-probed with radiolabelled HSV-l 
genomic DNA (Figure 43B). 
The probe specific for the amplicon DNA shows that with both helper viruses pSA 1 
forms hmw concatemers that are unable to enter the pulsed field gel and are trapped in 
the wells of the gel (Figure 43A). In addition, a 150 kbp genome sized band is evident 
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Figure 43 - PFGE analysis of replicated amplicon DNA. 
Monolayers of BHK cells were transfected with pSAI and superinfected with 3 
p.f.u. / cell wt HSV-I or ambULl2. The cells were harvested 16 h.p.i. and 
embedded in agarose blocks. Total DNA was prepared in situ and one third of each 
block was subjected to PFGE. The gel was blotted and probed with radiolabelled 
pAT153 (A), stripped and re-probed with radiolabelled HSV -1 genomic DNA (B). 
The position of various bands from a size marker are indicated. 
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III the wt HSV -1 sample although there is considerable smearing below the band. 
There is a large amount of smearing in the ambUL12 lane which could be obscuring 
small amounts of a similarly sized product. When the blot was stripped and re-probed 
with genomic DNA the wt HSV -1 sample produced a distinct band at 150 kbp whereas 
ambUL12 yielded a smear from approximately 130 - 150 kbp. As expected, viral DNA 
was also detected in both "well" DNAs. Since cleavage of DNA is coupled to 
packaging the result suggests that, at least in the case of wt HSV -1, packaged amplicon 
molecules are up to genome length in size. 
Interestingly two extra bands were detected with the pAT153 probe which migrated 
with estimated sizes of 5 and 35 kbp and were generated by both wt HSV -1 and 
ambULl2. These bands were routinely detected only with a pAT153 probe; the faint 
bands present in Figure 43B probably represent incomplete stripping of the pAT153 
probe from the membrane. 
5.7.3 Replication intennediates ofpSAI and pSI 
To investigate whether the 5 and 35 kbp bands which were detected in Figure 43A were 
products of the packaging process, BHK cells were transfected with pSA 1 or pS 1 
(which lacks a packaging signal) and superinfected with 3 p.f.u. I cell wt HSV-l or 
ambULl2. The cells were harvested 16 h.p.i. and total DNA was prepared in agarose 
blocks and separated on a pulsed field gel at 6 v I cm for 16 h at 14°C with switch times 
ranging linearly from 1 - 15 sec throughout the run. The gel was then blotted and 
probed with 32p labelled pAT153. 
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Figure 44 - PFGE analysis of pSAt and pSt replication intermediates. 
BHK cells were transfected with pSA1 or pS 1 and superinfected with wt HSV -lor 
ambUL12. The cells were harvested 16 h.p.i. , embedded in agarose blocks and 
total DNA prepared. The DNA was separated by PFGE, blotted and probed with 
32p labelled pAT153. The position of various size markers are indicated. 
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Figure 44 shows that the 5 and 35 kbp bands appeared with a similar intensity in all the 
lanes irrespective of the amplicon or helper-virus used. There were also a number of 
intermediate bands between the two major bands. This, and the observation that the 
bands in the pSI samples migrated slightly faster than those of the corresponding pSAI 
samples, reflecting the different sizes of the amplicons, suggests that the bands may 
contain various numbers of repeats of the amplicons. Moreover, the fact that the bands 
also appear in the pS 1 samples suggests that these bands are related to replication rather 
than packaging. 
To confirm that these bands were replication products, one third of each plug was 
digested with DpnI, subjected to PFGE as before, blotted and probed with radiolabelled 
pAT153. As can be seen in Figure 45 the upper 35 kbp bands were sensitive to DpnI 
digestion indicating that only the lower bands are replication products. In contrast to 
Figure 44, the intermediate bands between 5 and 35 kbp were less evident and, in repeat 
experiments their appearance was inconsistent. There was also great variation in the 
levels of the 5 and 35 kbp bands between experiments, both in relation to each other and 
to the 150 kbp genome length band. In fact the genome length bands seen in Figure 43 
are not apparent in Figures 44 and 45. The reason for this variation is unknown, but in 
the case of the 150 kbp band it could represent different overall levels of replication 
between experiments. 
5.7.4 PFGE analysis of amplicons replicated by co-transfection of viral DNA replication 
genes 
In order to determine if the viral DNA replication proteins alone could generate the 5 
and 35 kbp bands BHK cells were co-transfected with 1 llg each of pSAl, pE5, pE8, 
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Figure 45 - PFGE analysis of DpnI digested amplicon replication products. 
BHK cells were transfected with pSAl or pS 1 and superinfected with wt HSV -lor 
ambUL12. The cells were harvested 16 h.p.i. , embedded in agarose blocks and 
total DNA prepared. One third of each block was digested with Dpni. The DNA in 
digested (D) and undigested (-) blocks was analysed by PFGE, the gel was blotted 
and probed with 32p labelled pAT153 . The sizes of two bands from the 5 kbp 
marker ladder (M) are indicated. 
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pE9, pE29, pE30, pE42 and pE52. As a control BHK cells were also transfected with 
pSAl and superinfected with 3 p.f.u. / cell wt HSV-l or ambULl2. The cells were then 
harvested 24 h.p.t. or 16 h.p.i., embedded in agarose plugs and total DNA prepared. 
One third of each block was subjected to PFGE using the same parameters as in section 
4.7.3, the gel was blotted and probed with 32p labelled pAT153. 
Figure 46 demonstrates that pSAl forms hmw concatemers when replicated in the 
presence of only the seven DNA replication genes. However, in contrast to amplicon 
replicated by helper virus no 5 or 35 kbp bands were observed, instead there was a 
smear ranging from approximately 40 - 90 kbp. An aliquot of the pSA1 plasmid 
preparation used in the transfection was included in this gel and it is interesting to note 
that the 5 and 35 kbp bands migrate with the presumptive supercoiled and open circular 
form, respectively, of the plasmid. 
Taken together, the results presented in Figures 43 to 45 suggest that the 5 kbp band 
may represent a pSAl replication intermediate comprising a supercoiled monomeric 
circle. Such a structure is compatible with initial replication occurring by a theta form 
mechanism. 
5.7.5 PFGE analysis of DNase-resistant amplicon DNA 
Studies by Vlazny et at. (1982) and more recently by Stow (2001) demonstrated that, in 
the nucleus of wt HSV -1 infected cells, packaged defective genomes and amplicons are 
made up of integral numbers of repeats of a single unit, from one copy up to the size of 
a full length HSV -1 genome. However, only the largest molecules are translocated into 
the cytoplasm. In an effort to determine the size of pSAl and pS 1 molecules packaged 
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Figure 46 - PFGE analysis of pSAl replicated by co-transfection of plasmids 
expressing the seven essential viral replication genes. 
BHK cells were transfected with pSAl and superinfected with wt HSV-l (wt) or 
ambUL12 (amb), or co-transfected with plasmids expressing the seven viral 
replication genes (7 rep). The cells were harvested 16 h.p.i. , embedded in agarose 
blocks and total DNA prepared, separated by PFGE, blotted and probed with 32p 
labelled pAT 15 3. 4 ng of the pSA 1 plasmid preparation used in the transfecti on 
was also run on the gel (pSAl). The position of various size markers are indicated. 
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by ambULl2, PFGE studies were perfonned on DNase-resistant DNA from transfected 
and subsequently superinfected cells. 
Plates of BHK cells were transfected with pSAI or pS 1 and superinfected with 3 p.f.u. / 
cell wt HSV -lor ambUL 12. The cells were harvested 16 h.p.i. and processed for total 
and DNase-resistant DNA directly in agarose blocks. One third of each block was then 
loaded into a 1 % pulsed field agarose gel and electrophoresed for 16 h at 6 v / cm, 14°C 
with a switch time ramped from 1 - 15 secs. The gel was blotted and probed with 32p 
labelled pAT153 (Figure 47). 
The total DNA samples show results consistent with Figures 43 - 46. High molecular 
weight 'well' DNA, a distinct genome length band in the wt HSV -lIpSA 1 lane and the 
presence of 5 and 35 kbp bands in all the samples can be seen. In contrast, only the wt 
HSV-lIpSAI sample contains detectable DNase-resistant DNA which is present as two 
distinct bands; one of 150 kbp and another band migrating between 130 and 140 kbp. 
These bands are consistent with the sizes of packaged amplicon molecules described by 
Stow (2001). Increased exposure of the DNase-resistant samples did not detect any 
genome length packaged amplicons in any of the other samples. However, small 
amounts of the 5 and 35 kbp bands present in the total DNA appeared to be resistant to 
DNase. As in section 3.4.3 the experimental conditions used for DNase I treatment 
resulted in the recovery of only a very small portion of the genome length (presumably 
packaged) molecules present in the wt HSV-lIpSAI sample. 
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Figure 47 - PFGE analysis of total and DNase-resistant amplicon DNA 
prepared in agarose embedded cells. 
BHK cells were transfected with pSAI or pS 1 and superinfected with wt HSV-l 
(wt) or ambUL12 (amb). The cells were harvested 16 h.p.i. , embedded in agarose 
blocks and total or DNase-resistant DNA was prepared. One third of each block 
was separated by PFGE, blotted and probed with 32p labelled pAT153. * and ** 
show the 150 and 130-140 kbp bands discussed in the text. 
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5.7.6 PFGE analysis of DNase-resistant amplicons prepared by gentle lysis 
Although the preparation of DNA from infected cells embedded in agarose blocks 
prevents shearing of bmw products, the results of section 3.4 demonstrated that if 
prepared gently, DNase-resistant genome length molecules could be efficiently and 
more reproducibly recovered by conventional techniques with minimal shearing. 
Therefore this method was used to further study DNase-resistant amplicon DNA. 
35 mm plates of BHK cells were transfected with 1 f.lg of pSA1 or pS 1 and 
superinfected with 3 p.f.u. I cell wt HSV-1 or ambUL12. The cells were harvested 16 
h.p.i., split into nuclear and cytoplasmic fractions and DNase-resistant DNA was 
prepared by gentle lysis as described in section 3.4.2. Samples representing one third of 
a plate of cells were loaded into a 1 % pulsed field agarose gel and separated at 6 v I cm 
for 16 h at 14°C with a switch time of 1 - 15 sec, ramping linearly throughout the run. 
The gel was then Southern blotted and probed with radiolabelled pAT153 (Figure 48, 
left panel). 
The distinctive ladder of packaged molecules described by Vlanzy et al. (1982) can be 
seen in the pSAlIwt HSV-1 sample with most of the DNA concentrated within two 
regions ranging from approximately 130 - 140 kbp and 150 - 155 kbp. Faint bands of 
approximately 110 - 150 kbp are evident in both the ambUL12/pSA1 and 
ambUL12/pSI lanes indicating that both amplicons are packaged to near genome length 
by ambULl2. No DNA of a similar size was detected in the wt HSV-lIpS1 lane. In 
general agreement with Vlazny et al. (1982) and Stow (2001) only the 130-140 and 
150-155 kbp bands could be detected in the cytoplasmic wt HSV-l/pSAl sample along 
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Figure 48 - PFGE analysis of total and DNase-resistant amplicon DNA 
prepared by the gentle lysis method. 
BHK cells were transfected with pSA 1 or pS 1 and superinfected with wt HS V-1 
(wt) or ambUL12 (amb). The cells were harvested 16 h.p.i. , split into nuclear and 
cytoplasmic fractions and DNase-resistant DNA prepared. One third of each 
sample was separated by PFGE, blotted and probed with 32p labelled pA T153 (left 
panel). The blot was then stripped and reprobed with 32p labelled genomic HSV-1 
DNA. The position of the 130 and 150 kbp marker are indicated. 
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with a faint smear of smaller products. However, no amplicon was detected in the 
ambUL12 cytoplasmic lanes. 
To ensure that the absence of signal from certain lanes was not due to unequal loading, 
the blot was stripped and re-probed with radiolabelled HSV -1 genomic DNA. The right 
panel of Figure 48 demonstrates that near identical amounts of genomic length wt 
HSV -1 DNA were present in the nuclear or cytoplasmic samples from the cells which 
received pSAI or pSI. Similarly the amount of genomic DNA present in the 
corresponding samples from ambUL12 infected cells was also very similar, although as 
previously observed packaging was reduced compared to wt HSV -1. The DNA 
packaged by ambUL12 exhibited slightly increased mobility compared to wt HSV-l, in 
agreement with the results of section 3.4.1. The DNase-resistant amplicon DNA 
detected in ambUL12 infected cells in earlier figures (e.g. Figures 26, 35 and 37) is 
presumably distributed in a weak smear down the gel. 
5.8 Discussion 
The results presented in this section demonstrated that the transient assay, employing 
amplicon plasmids, was a useful and reliable method of studying the ambUL12 mutant 
and its defects in the replication and packaging processes. Various amplicons used in 
this study were shown to behave in an analogous manner to DNA of the helper virus in 
that: (i) the replication and packaging of the amplicons were proportionally reduced by 
almost identical amounts to viral DNA when using ambUL12 as a helper virus 
compared to wt HSV -1, (ii) the replication and packaging defect could be partially 
complemented by the co-transfection of a UL12 but not a UL12.5 expressing plasmid, 
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(iii) the amplicons were shown to recombine at a high frequency and produce high 
molecular weight concatemers comparable to viral DNA and, (iv) a significant 
proportion of packaged pSAI amplicon molecules were close in size to the viral 
genome. In addition, the amplicon system was a convenient way to study the effect of 
different a sequence arrangements and mutations on the packaging of molecules by wt 
HSV-I and ambULl2. These experiments revealed that: (i) alternative arrangements of 
a sequence components did not affect the packaging of the amplicon by either virus, (ii) 
the packaging machinery in ambUL12 infected cells may interact with mutated a 
sequences in a manner different from wt HSV-l and, (iii) ambUL12 can package and 
propagate an amplicon that contains no recognised packaging signal. Finally, the 
transient assay, in combination with pulsed field gel electrophoresis, gave preliminary 
evidence that amplicon replication may involve both rolling circle and theta form 
mechanisms. These findings are discussed in further detail below. 
Because amplicons had not been used extensively in the characterisation of nuc mutants 
it was important to establish that the replication and packaging of amplicons resembled 
that of genomic DNA in ambULl2 infected cells. The initial experiments focused on 
the ability of ambUL12 to replicate and package the pSAI amplicon, an amplicon 
which had been characterised previously (Hodge and Stow, 2001). The results 
presented in Figure 26 and Table 2 demonstrated that, relative to wt HSV-l, ambUL12 
was as deficient at replicating and packaging amplicons as its own genome. Moreover, 
the cleavage of replicated pSAl by wt HSV-l or ambUL12 helper proteins was shown 
to occur specifically at the packaging signal, generating DNase-resistant terminal 
fragments of the sizes predicted for cleavage within the Uc-DRI-Ub fragment (Figure 
27). The results from these experiments also demonstrated that the addition ofUL12 in 
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trans was sufficient to at least partially complement the mutant, and indicated that the 
absence ofUL12 was responsible for the observed defects. 
The observation that co-expression of UL 12 with the HSV -1 DNA replication proteins 
does not significantly enhance replication of an HSV -1 origin containing plasmid 
(Table 3) suggests that for UL12 to function in DNA synthesis it may have to be 
modified by some viral protein other than the seven essential viral replication proteins 
which were supplied in trans. Further evidence suggestive of differential modification 
of UL12 in virus-infected cells comes from the results of Figure 25 which show 
different UL 12 breakdown products depending on whether the protein is expressed by 
wt HSV-l or from the pE12 expression construct. Since UL12 is known to be 
phosphorylated (Wilcox et at., 1980; Preston and Cordingley, 1982) this modification is 
most likely required for efficient complementation and may also represent a possible 
control mechanism for the nuclease. It is possible that the protein kinase encoded by 
UL13 may playa role in the phosphorylation of UL12 since an HCMV UL97 null 
mutant that fails to express the HCMV homologue of UL13 has a similar phenotype to 
HSV-l UL12 null mutants (Wolf et at., 2001). 
An important feature of HSV -1 replication is the high frequency of intra and 
inter-molecular recombination. Recombination of HSV -1 genomes not only causes 
inversion of UL and Us relative to one another but also generates a highly branched 
DNA network of complex concatemeric intermediates (Severini et at., 1996). 
Traditionally, only intra-molecular recombination has been observed during the 
replication of amplicons (Dutch et at., 1992; Dutch et at., 1994). Recently, however, 
intermolecular recombination of amplicons was reported in HSV -1 infected cells (Fu et 
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al., 2002). The results presented in this chapter confirm these findings (Figure 31) and 
demonstrate that the recombination occurs in the absence of UL12. Moreover, 
recombination between the parental pSAl plasmid and the modified daughter plasmids, 
pSAlx and pSAl inv, does not alter the levels of replication and packaging when using 
either wt HSV-l or ambUL12 as helper virus (Figure 32). Although recombination 
occurs in the absence of UL12 it cannot be determined form these studies whether the 
presence of UL12 influences the recombination event itself or perhaps modifies the 
resultant structures at a later juncture. 
Another feature of HSV -1 replication is the formation of high molecular weight 
concatemers which are subsequently cleaved into unit length genomes. To determine if 
the replicated amplicon DNA also formed bmw concatemers analogous to HSV -1, 
pulsed field gel analysis was applied to replicated amplicon DNA. The results 
presented in Figure 43 demonstrate that amplicons replicated by both wt HSV -1 and 
ambUL12 generate structures that are unable to migrate from the well of the pulsed field 
gel and which presumably consist of complex branched bmw concatemers. 
Furthermore, the results shown in Figure 46 demonstrate that the seven essential 
replication genes are sufficient to form similar structures. 
Pulsed field gel studies also confirmed the work of Vlazny et al. (1982) and Stow 
(2001) showing that, when used as helper virus, wt HSV-l packaged pSAl concatemers 
comprising integral numbers of the monomeric repeats up to approximately genome 
length and only the higher molecular weight species (130 - 155 kbp) were present in the 
cytoplasm (Figure 48). In addition it was demonstrated that ambUL12 was able to 
package small amounts ofpSAl, also of approximately viral genome length. Although 
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no pSAI molecules were detected in the cytoplasm of these cells, the propagation 
experiments described in sections 5.5.3 and 5.6.3 show that ambUL12 infected cells are 
capable of producing mature virus particles that contained pSAI molecules, and hence 
packaged pSAI molecules are presumably capable of exiting the nucleus. 
The above results established that the amp Ii con system was a convenient way to further 
characterise the ambUL12 mutant. The amplicons behaved in a similar manner to viral 
DNA: they were replicated and packaged to similar relative extents as the genomes of 
their helper viruses, recombined at a high frequency and formed hmw replication 
intermediates. To determine whether the defect in ambUL12 packaging might be 
mediated by a direct or indirect interaction with specific regions of the a sequence the 
studies were extended to amp Ii cons containing different arrangements of a sequences or 
amplicons containing mutated a sequences. 
The pSAI amplicon contains only the 200bp Uc-DRI-Ub fragment, the minimal 
sequence thus far shown to act as a packaging signal (Nasseri and Mocarski, 1998; 
Hodge and Stow, 2001). Studies by Hodge and Stow demonstrated that pSAI was 
packaged by wt HSV -1 as efficiently as amplicons containing a single unpermuted a 
sequence or two tandem a sequences (Figure 33). The results presented in Figure 34 
confirm those of Hodge and Stow for wt HSV-l and also show that ambUL12 replicates 
and packages all the amplicons with a similar reduced efficiency compared to wt 
HSV-l. These results indicated that like wt HSV-l, ambUL12 utilised the minimal 
Uc-DRI-Ub sequence as efficiently as a single a sequence, in which the Uc and Vb 
elements are separated by approximately 300 bp, or two tandem complete a sequences 
where the Uc-DRI-Ub fragment is present. 
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Four mutated amplicons (pPHll, pPHI2, pPH21 and pPH22), which contain lesions in 
the pacl motif (Hodge and Stow, 2001), were used in propagation assays. The results 
obtained using wt HSV -1 as helper virus confirmed those of Hodge and Stow 
demonstrating that all four amplicons could be packaged to near pSA 1 levels but were 
propagated with reduced efficiency, especially the pPHll and pPH12 amplicons which 
contained substitution/deletion mutations affecting the distal GC element. These studies 
were extended by using ambULl2 as the helper virus. The packaging efficiencies of the 
four mutant plasmids were similar to pSAI (Figure 36). Relative to pSAl, pPHll and 
pPH12 exhibited a 3-8 fold greater impairment in propagation when packaged in the 
presence of wt HSV -1, whilst pPH2I and pPH22 were more impaired when packaged 
using ambUL12 as helper. In fact, under these conditions the propagation of pPH21 
and pPH22, initially packaged by ambULl2, was similar to that observed with pSI 
which completely lacks the Uc-DRI-Ub fragment. This suggests that the packaging 
machinery of ambUL12 may recognise or interact, either directly or indirectly, with the 
a sequence differently from that of wt HSV -1 during the cleavage and packaging 
processes. 
Perhaps the most interesting observation from the propagation experiment using the 
amplicons with mutated a sequences was that the pS 1 amplicon, which contains no 
known packaging sequence, was packaged to a significant level by ambULI2 but not wt 
HSV-l. In addition pSI which had been packaged by ambUL12 was propagated as 
efficiently as the pPH21 and pPH22 amplicons even though the levels of DNase-
resistant DNA detected in the cells transfected with these amplicons were 5-fold higher 
than for pS I (Figure 36). This suggests that the majority of the capsids containing 
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pPH21 or pPH22 did not mature into infectious virions although further studies are 
required to determine at what stage capsid maturation was inhibited. 
Upon further investigation of the ability of ambUL12 to package pSI it was evident that 
co-transfection of a UL 12 expressing plasmid increased the replication of the plasmid 
but inhibited its packaging (Figure 37 and 38), again suggesting a direct role for the 
nuclease in the packaging of viral DNA. This experiment also included the Vero cell 
line and demonstrated that the packaging of pSI by ambUL12 was not a BHK cell line 
specific phenomenon. Interestingly, co-transfection of a UL12.5 expressing plasmid 
also reduced the level of pS 1 packaging in both cell lines when ambUL12 was 
providing helper functions suggesting that this protein may have some limited 
functionality. In Figure 38A it also appeared to slightly increase the replication of the 
amplicon but this effect was not consistently observed. 
To ensure that the detected DNase-resistant pS 1 molecules were encapsidated and not 
protected from the DNase by some other means two controls were used. Firstly, the 
HSV -1 packaging deficient mutant K5~Z demonstrated that in BHK cells all replicated 
amplicon DNA was digested to completion but in the complementing cell line pSA 1 
was efficiently packaged (Figure 37). Secondly, packaged pSI molecules from 
ambUL12 but not wt HSV-1 or ambUL12R infected cells could be propagated (Figure 
39), indicating that this property is attributable to the lack of a functional alkaline 
nuclease. 
It was possible that the packaging and propagation of pS 1 molecules was due to 
integtration of the amplicon with the helper-virus genome. Analysis of packaged viral 
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and amplicon molecules usmg a restriction enzyme that cleaved only viral DNA 
demonstrated that digestion of the viral genome did not alter the migration of the 
amplicon molecules (Figure 42). In addition, the majority of pS 1 signal was detected in 
the region of non-resolution comprising fragments over 28 kbp. Since the viral capsid 
can accommodate genomes only approximately 10-12 kbp longer than standard length 
(Gage et al., 1992; Sauer et aI., 1987; F. Rixon, personal communication) these larger 
pS 1 molecules must have been independently packaged. 
In a number of experiments a small amount of DNase-resistant pS 1 was detectable 
following infection with wt HSV-l. This product was also recently observed by Hodge 
and Stow (2001). In the experiments presented here the amount of packaged pS 1 
detected in wt HSV-l infected cells represented less than 1% of that of pSAl, in 
agreement with the results of Hodge and Stow. Three observations, however, 
distinguish between pSI encapsidated by ambUL12 and wt HSV-l. Firstly, although 
ambUL12 packages 15-fold less pSAI than wt HSV-l, it packages 2-3 fold more pSI. 
Secondly, packaging of pS 1 by wt HSV -1 appears to be a BHK cell specific effect, not 
seen in Vero or 293 cells (Figure 38 and Figure 41). Thirdly, only pS 1 encapsidated in 
ambUL12 infected cells can be propagated in fresh mono layers (Figure 36 and Figure 
39). Therefore, the mechanism of packaging of pS 1 may differ in wt HSV -lor 
ambUL12 infected BHK cells. 
Finally, the pulsed field gel (PFG) analysis of replicated amplicon DNA has provided 
preliminary evidence that, at some point during the transient assay, amplicons may be 
replicated by a theta-like mechanism. In addition to the genome length and hmw 
products detected in PFGs of virally infected cells, the PFGs described in sections 5.7.1, 
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5.7.2 and 5.7.3 contained two extra amplicon bands of approximately 5 and 35 kbp. 
The 5kbp but not the 35 kbp product represents replicated DNA as judged by DpnI 
digestion (Figure 45). These products are not packaged since they are present in similar 
amounts in pSAI and pSI transfected cells (Figure 44). The observation that the 5 and 
35 kbp bands in the transfected cells co-migrate with the presumably supercoiled and 
open-circular forms, respectively, of the pSAI plasmid used for the transfection 
suggests that the bands detected may represent similar topological forms. Moreover, 
some gels also contained a ladder of faint bands between the 5 and 35 kbp bands, 
possibly representing transfected plasmids with decreasing numbers of negative 
supercoils. The simplest way to account for the replicated 5 kbp molecules that 
co-migrate with the supercoiled plasmid is for a portion of the input plasmid to be 
replicated by a theta-like mechanism. 
Although indicative of theta like replication, the results presented require a number of 
experiments to ensure that, a) the 5 and 35 kbp products are circular molecules (possibly 
by attempting to relax the product through nicking or Topoll treatment or by analysing 
purified DNA by restriction enzyme digestion) and, b) the 5 kbp product is replicated by 
the HSV-I DNA replication machinery (e.g. the product does not appear with an oris-
plasmid or in the presence of P AA). Nonetheless, these results are not without 
precedent; work by Pruller and Hammerschmidt, (1996) demonstrated that following 
induction, episomally maintained plasmids containing the Epstein-Barr Virus oriP and 
oriLyt sequences would initially replicate by a theta-like mechanism before producing 
complex, hmw products. 
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My characterisation of the HSV-l ambUL12 virus demonstrated that this UL12 null 
mutant is inefficient at replicating and packaging both viral and amplicon DNA 
compared to wt virus. Previous studies had indicated that the major defect in nuc 
mutants was in the egress of DNA containing capsids from the nucleus (Shao et al., 
1993). Although the results presented in this thesis cannot exclude an additional defect 
in capsid egress, it is clear that, in contrast to previous reports using the AN-l and 
AN-Fl nuc mutants (Weller et al., 1990; Shao et al., 1993; Martinez et al., 1996b), the 
HSV -1 alkaline nuclease plays a significant role in the processing and packaging of 
concatemeric DNA. This conclusion is supported by the observation that in transient 
amplicon assays ambUL12 packaged considerable amounts of concatemeric DNA that 
contained no recognised packaging signal. 
The replication of both genomic and amplicon DNA by ambUL12 was reduced 3-5 fold 
compared to wt HSV -1 in Vero and BHK cells. This replication defect was detectable 
as early as 6 h.p.i. In transient assays for HSV -loris dependent DNA synthesis the 
replication defect could be partially complemented by supplying UL12 in trans, 
indicating that the reduced levels of DNA were due to the absence of the alkaline 
nuclease. Similarly, comparable packaging defects were observed when encapsidation 
of either viral or amplicon DNA was examined. In BHK and Vero cells a 15 - 20 fold 
reduction in packaging compared to wt HSV -1 was observed, and again this defect 
could be partially complemented in transient assays when UL12 was supplied. 
Examination of the termini of encapsidated ambUL12 genomes demonstrated that 
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inefficient and aberrant cleavage of concatemeric DNA appears to be at least partially 
responsible for the packaging defect. The irregular cleavage events occurring during 
ambUL12 infection were also apparent when DNase-resistant DNA was examined by 
PFGE. In these experiments the majority of resistant ambUL 12 DNA migrated faster 
than that of wt HSV -1, suggesting that incomplete genomes had been packaged. An 
alternative possibility is that these molecules represent full length genomes that, due to 
the absence ofULl2, contain structural aberrations, which increase their mobility. 
The use of amplicons containing mutations in the viral cleavage/packaging signal (a 
sequence) suggested that in the absence of the alkaline nuclease the viral 
cleavage/packaging machinery may interact with the a sequence in a different way. In 
addition, ambUL12 was able to package molecules lacking a known packaging signal. 
These molecules could be subsequently propagated in the presence of helper virus. 
Finally, in a preliminary co-immunoprecipitation screen no convmcmg interactions 
were observed between the alkaline nuclease and four of the viral proteins (UL6, UL 15, 
UL25 and UL28) which are necessary for the packaging of viral DNA. 
Although UL 12 is not essential for the replication of viral DNA the work presented in 
this thesis consistently demonstrated that it does have a direct or indirect role in 
origin-dependent DNA replication. While the interaction of UL12 with UL29 
(Vaughan et al., 1984; Thomas et al., 1988, 1992; Section 4.2) would suggest a more 
direct involvement in the replication process, immunofluoresence and electron immuno-
gold staining studies report that UL12 and UL29 have distinct nuclear localisation 
patterns. UL29 has been shown to localise to defined replication compartments 
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(Quinlan et al., 1984; de Bruyn-Kops and Knipe, 1988) whereas UL12 has a more 
diffuse nuclear staining pattern (Goldstein and Weller, 1998a). Moreover, in immuno-
gold electron microscopy studies UL 12 has been shown to associate with electron-dense 
bodies while UL29 is excluded (Puvion-Dutilleul et al., 1985; Puvion-Dutilleul and 
Prichard, 1986). These results suggest that the role ofUL12 in DNA replication may be 
indirect, although it must also be considered that the diffuse immunofluoresence 
staining may reflect multi-functional properties ofUL12. 
It has been postulated that the role of UL 12 is to process complex replication 
intermediates into linear substrates, more suitable for packaging (Martinez et ai., 
1996a). It is also possible that the accumulation of these DNA intermediates inhibits 
replication, perhaps by causing replication forks to stall more frequently. Therefore, it 
is feasible that UL 12 also provides, or promotes, some form of repair function by 
resolving these complex DNA intermediates. 
Work by Bogner et al. (1998) identified a number of HCMV viral and cellular proteins 
which would bind specifically to either the HCMV pac 1 or pac2 motifs. In particular, 
the homologue of the HSV -1 UL28 protein, UL56, was shown to bind specifically to 
the pac 1 motif. A recent report has indicated that modification of the secondary 
structure of the a sequence may play an important role in its recognition by the UL28 
protein (Adelman et al., 2001). In these studies UL28 could bind an oligonucleotide, 
comprising the HSV -1 pac 1 motif sequence, only if the oligonucleotide had been 
denatured and renatured to form a novel secondary structure. This binding was also 
primary sequence specific, and pac2 motif oligonucleotides were not recognised by 
UL28. Although these novel structures were generated in vitro it has also been 
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demonstrated that the DR2 motifs within the a sequence are capable of forming unusual 
secondary structures in vivo when present in supercoiled plasmid DNA (Wohlrab et at., 
1987), suggesting that the pac motifs may form similar structures in vivo. 
Since the absence of UL12 appears to alter both packaging specificity and efficiency, it 
is possible that UL12 may be involved in the in vivo generation of the pac motif 
secondary structures. In such a model UL12 could work in both a spatially and 
temporally distinct location from the cleavage/packaging machinery while imparting 
packaging specificity. This could explain the inability to detect any interaction ofUL12 
with the packaging proteins tested in the immunoprecipitation assays. In support of 
this, UL 12 has been reported to interact with the a sequence in an apparently sequence-
independent manner (Chou and Roizman, 1989). It is, however, possible that UL12 
could interact with another as yet unidentified protein that did impart sequence 
specificity . 
6.1 Future Work 
Since ambUL12 is defective in both replication and packaging it is difficult to 
determine if the alkaline nuclease is directly involved in packaging or whether the DNA 
replication intermediates formed in the absence of UL12 are inherently poor packaging 
substrates. One way to address this problem might be to use a packaging mutant with a 
reversible temperature sensitive defect. A possible mutant is ts 120 1, which carries a 
lesion in the capsid associated protease, UL26 (Preston et al., 1983). The viral DNA 
could be replicated at the non-permissive temperature in the presence of UL12. After 
replication had been allowed to proceed UL 12 could be inhibited by using a recently 
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identified inhibitor specific to the alkaline nuclease (Bronstein and Weber, 2001) and 
packaging allowed to proceed by shifting down to the permissive temperature. If DNA 
was packaged to wt levels it would suggest that UL 12 is not directly involved in the 
packaging process. 
Complex hmw DNA replication intermediates are formed during the replication of both 
wt HSV-l and ambUL12 DNA. The branches in wt are composed of both X and Y 
junctions, although the Y junctions are more prevelant (Severini et ai., 1996). The 
DNA replication intermediates in nuc mutants are more complex (Martinez et at., 
1996a; section 3.3) although the nature of this complexity is not known. Examination 
of both packaged DNA and hmw DNA replication intermediates of ambUL12 using 
neutral agarose two-dimensional gel electrophoresis could give insights as to why 
cleavage is inefficient and often aberrant (e.g. do the branched structures differ from X 
or Y type junctions, or does the DNA merely contain an increased number of X or Y 
junctions compared to wt HSV -1). In addition, this approach could also determine if 
the abortive packaging events and instability of DNA containing capsids is due to the 
retention of branches or other abnormal structures in the DNA. 
In the light of work which demonstrates that both oris and the a sequence are capable of 
forming novel conformations in vitro (Aslani et ai., 2000; Baker et ai., 2000; Adelman 
et ai., 2001) it would be interesting to determine whether similar structures are formed 
in vivo and also ifUL12 was involved in forming these novel secondary structures. 
Although the preliminary protein interaction studies produced no evidence of novel 
interactions it is still possible that the function of UL12 involves interactions with a 
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number of viral and/or cellular proteins in addition to UL29. It would therefore be 
useful to identify other proteins with which UL12 interacts to gain possible additional 
information on both functional and regulatory aspects of the protein. Further 
immunoprecipitation experiments with the baculovirus system described in this thesis 
might identify other viral proteins which interact with UL12. However, to determine if 
UL 12 interacts with any cellular proteins it would be more useful to generate a 
recombinant HSV -1 virus that expressed a functional His-tagged version of UL 12. This 
could then be used to identify and characterise viral or cellular proteins that 
co-precipitate with UL12. Alternatively, protein-protein interactions involving UL12 
could be investigated by yeast two-hybrid screens. 
It is known that UL12 is a highly phosphorylated protein. It would therefore be 
interesting to know what effects, if any, the levels of phosphorylation have on the 
activity of the protein. It has never been conclusively established whether viral or 
cellular proteins phosphorylate UL12 or if this phosphorylation acts as a control 
mechanism. 
Finally, a full understanding of the role of UL12 reqUIres definition of its in vivo 
biochemical activities and the development of appropriate enzyme assays (e.g. 
processing of appropriate substrates and reconstruction of functional complexes it may 
form with other proteins). Identification of the precise role of UL12 in replication and 
packaging will be greatly facilitated once cell free systems that can perform these 
processes have been developed. 
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